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Abstract
Understanding how a single genome that is common to all cells in an organism can
give rise to many different and highly specialized, cell types has been one of the major
questions in biology over the past century and still many aspects remain unanswered.
Over the last 15 years, incredible progress has been made in pinpointing the regulatory
mechanisms that establish, maintain, and change cellular identities. In particular, the
role of histone modifications and DNA methylation in the spatio-temporal control of
gene expression and genome organization has been greatly appreciated. These histone
and DNA modifications have been shown to be an integral part of epigenetic control
mechanisms. They ensure stable silencing of not-required genes and gene regulatory
elements as well as maintenance of active genes and gene regulatory elements that are
required in a particular cellular context.
In addition to the identification and functional characterization of these mechanisms,
the sequencing of many complex genomes and the advent of high-throughput sequenc-
ing technology has allowed us to precisely chart the location of all modified histones
and methylated bases across the entire genome. In contrast to the genome sequence,
the epigenome turns out to be highly variable between distinct cell types and reflective
of their specific biology. Comprehensive mapping efforts of the epigenome provide a
starting point for understanding the epigenetic basis of macroscopic phenotypes such
as distinct cell types and states. Integrative analysis of many different types of histone
modifications combined with gene expression data across several distinct cell types also
revealed that certain histone modifications can be used to annotate and predict the ac-
tivity of different types of gene regulatory elements such as promoters or enhancers.
This thesis takes advantage of these recent advances in the identifiability of gene regula-
tory elements and first establishes that the integration of epigenetic and transcriptional
data on specific cellular states can be used to gain insights into the underlying regulatory
logic maintaining and establishing these states. Second, it demonstrates the utility of
this approach to generate experimentally testable hypothesis on the molecular mecha-
nisms mediating specific cell state transitions.
While great progress has been made on mapping changes in histone modifications and
identification of their demarcated gene regulatory elements, less is known about methy-
lation of the DNA. In particular, it is still unclear to what extend and where DNA
methylation changes over the course of human development and what the likely func-
tions of these changes are. To fill this gap, we mapped DNA methylation patterns using
whole-genome bisulfite sequencing across 30 distinct human cell and tissue types. Sur-
prisingly, we find that only around 20% of all CpG dinucleotides, the main target of
DNA methylation in mammals, change their methylation state across normal develop-
ment. Interestingly, we find that most differentially methylated regions (DMRs) coincide
with gene regulatory elements, such as enhancers or transcription factor binding sites,
that are relevant for the biology of a particular cell type. Most of these DMRs are
constitutively hyper-methylated and only become hypo-methylated in a cell type where
the underlying gene regulatory element becomes relevant. This study not only deter-
mined the extent to which DNA methylation is dynamic during normal development,
but also established DNA methylation dynamics as an excellent marker of active, cell
type-specific gene regulatory elements.
The first part of this thesis examined primarily differences in the DNA methylation
landscape of distantly related stable steady state cell types and states. This experimen-
tal design is similar to the strategy chosen by most previous investigations of histone
modification changes. However, much less is known about the epigenetic changes at high
temporal resolution during cell fate transitions. To shed more light on the epigenetic re-
modeling events that establish and distinguish closely related cell types, we investigated
the epigenetic and transcriptional dynamics during the in vitro differentiation of human
embryonic stem cells to three distinct early-derived populations of each embryonic germ
layer. This analysis revealed comprehensive epigenetic remodeling, particularly at en-
hancers and frequently converse dynamics between different germ layer populations. In
addition, we identified an unexpected, epigenetic transition where a repressed locus first
transiently gains H3K27me3 at an early stage of differentiation before becoming fully
activated at a later time point.
While these experiments and analyses were very informative from an observational point
of view, it still is unclear in many cases what are the key drivers of the cell state tran-
sitions and in particular of the epigenetic remodeling events. To shed light on this
important problem, we developed a computational analysis strategy that leverages epi-
genetic information to identify key transcription factors (TFs) that are likely to mediate
epigenetic changes and orchestrate particular cell state transitions. We then applied this
approach to a 200-day time series of a novel, in vitro differentiation scheme of human
embryonic stem cells towards the neural lineage. This analysis revealed a core network
of transcription factors around PAX6 and OTX2 that is active during the entire pro-
cess of in vitro neural differentiation. Furthermore, these core factors show evidence of
differentiation stage-specific co-binding with other TFs as well as binding site redistri-
bution across the genome. These results highlight the utility and general applicability of
this framework for integrated epigenetic analysis. In particular, this approach provides
a TF-centric perspective on the interpretation of epigenetic changes during cell state
transitions.
In summary, this work has contributed to our understanding of the dynamic regulation
of DNA methylation and provided a high-resolution, in-depth investigation of epigenetic
dynamics during differentiation of embryonic stem cells to three distinct, differentiated
cell populations. Furthermore, we provided a detailed view on the regulatory network
activity and architecture orchestrating in vitro neural differentiation. In addition, this
work yielded novel tools and perspectives to interpret the rapidly rising number of epi-
genetic profiles.
Kurzfassung
Wie kann ein einziges Genom, das in nahezu allen Zellen eines Organismus gleich ist,
eine derartige Vielfalt an hochgeradig spezialiserten Zelltypen hervorbringen wie sie in
komplexen Organismen zu finden sind?
Obwohl diese Frage einen der Forschungsschwerpunkte der Biologie der letzten 100 Jahre
darstellt, sind viele Aspekte nach wie vor ungekla¨rt. In den vergangenen 15 Jahren
hat die Aufkla¨rung der regulatorischen Mechanismen, die zur Generierung, Erhaltung
und Vera¨nderung verschiedener zellula¨rer Identita¨ten beitragen, enorme Fortschritte
gemacht. Diese neuen Erkenntnisse untermauren die zentrale Rolle der ra¨umlich-zeitlichen
Kontrolle von Histonmodifikations und DNA-Methylierungsmustern entlang des Genoms.
Histon- und DNA-Modifikationen bilden dabei eine entscheidende Komponente der epi-
genetischen Kontrollmechanismen der Genexpression und der Organisation des Genoms.
Auf der einen Seite stellen sie die stabile Repression in einem spezifischen zellula¨ren Kon-
text von nicht beno¨tigten Genen und genregulatorischen Elementen sicher. Auf der an-
deren Seite sind diese Mechanismen wesentlich an der Erhaltung und Stabilisierung des
aktiven Zustands von zell-relevanten Genen und genregulatorischen Elementen beteiligt.
Neben der Entdeckung und Charakterisierung dieser Mechanismen hat vor allem die
Sequenzierung zahlreicher komplexer Genome sowie die Einfu¨hrung von Hochdurchsatz-
Sequenzierungsverfahren es ermo¨glicht, die exakte genomische Position modifizierter und
methylierter Basen zu kartieren. Im Gegensatz zur statischen Genomsequenz, variiert
das Epigenom stark zwischen verschiedenen Zelltypen und Zellzusta¨nden. Die umfan-
greichen Bemu¨hungen zur Kartierung zahlreicher verschiedener Zelltypen liefern heute
einen Startpunkt, um die epigenetische Basis der verschiedenen makroskopischen zel-
lula¨ren Pha¨notypen zu verstehen. Durch die kombinierte Analyse unterschiedlicher His-
tonmodifikationen sowie Genexpressionsmessungen ist es des Weiteren mo¨glich, die Posi-
tion und den Aktivita¨tszustand von genregulatorischen Elementen wie Promotoren und
Enhancern vorherzusagen.
Diese Arbeit baut auf diesen, erst vor kurzem erzielten Fortschritten in der Interpre-
tation des Genoms auf und demonstriert zuna¨chst, dass die Integration von Epigenom-
und Transkriptomdaten von eng verwandten zellula¨ren Zusta¨nden es gestattet, die den
Zellzusta¨nden und Zellzustandsu¨berga¨ngen zugrundeliegenden Mechanismen besser zu
verstehen. Im na¨chsten Schritt der Arbeit wird dann aufgezeigt, wie sich ein derartiger
integrativer Ansatz zur Generierung spezifischer, experimentell direkt u¨berpru¨fbarer Hy-
pothesen u¨ber die molekularen Mechanismen nutzen la¨sst, die den Zellzustandsu¨berga¨ngen
zugrunde liegen .
Als Ausgangspunkt fu¨r dieses Unterfangen dienen Karten verschiedener Histonmodi-
fikations- und DNA- Methylierungsmuster in diversen Zelltypen. Die umfangreichen
Anstrengungen zur Kartierung von Histonmodifikationen finden jedoch keine Entsprechung
im DNA-Methylierungsfeld. Hier ist es vor allem unklar, wie stark sich die DNA-
Methylierungsmuster im Zuge der menschlichen Organismusentwicklung in verschiede-
nen Zelltypen vera¨ndern. Weiterhin ist nicht klar, wo genau im Genom diese Vera¨nde-
rungen und welche Funktionen sie haben. Um diese Lu¨cke zu schließen, haben wir
die DNA- Methylierungsmuster in 30 verschiedene menschliche Zell- und Gewebeklassen
genomweit kartiert. U¨berraschenderweise a¨ndern lediglich etwa 20% aller CpG-Dinukleotide
- das Hauptsubstrat von DNA-Methylierung in Sa¨ugetieren - ihren Methylierungszus-
tand im Zuge der normalen Organismusentwicklung. Dabei stellt sich heraus, dass der
Großteil der differentiell methylierten Regionen (DMRs) mit genregulatorischen Ele-
menten wie Enhancern und Transkriptionsfaktor-Bindestellen u¨berlappen, die fu¨r die
Biologie des jeweiligen Zelltyps relevant sind.
Die grosse Mehrheit dieser DMRs ist dabei konstitutiv hypermethyliert und wird nur in
dem Zelltyp hypomethyliert, in dem das unterliegende generegulatorische Element von
Bedeutung ist. Diese Untersuchung hat nicht nur das Ausmaß der DNA-Methylierungs-
vera¨nderungen wa¨hrend der menschlichen Entwicklung ermittelt, sondern auch demon-
striert, dass DNA-Methylierungsvera¨nderungen ein exzellenter Marker fu¨r aktive, zelltyp-
spezifische generegulatorische Element sind.
Im vorangegangen Teil dieser Arbeit wurden prima¨r Vera¨nderungen von DNA-Methylie-
rungsmustern u¨ber entfernt verwandte Zelltypen untersucht. Diese Art von experi-
mentellem Design folgt dabei der Strategie der meisten vorausgegangen Studien zu
Vera¨nderungen in Histonmodifikationsmustern. Im Gegensatz zu den umfangreichen
Kenntnissen zu epigenetischen Unterschieden zwischen statischen, entfernt verwandten
und zeitlich stabilen Zellpopulationen, ist u¨ber die Natur der epigenetischen Dynamiken
bei hoher zeitlicher Auflo¨sung und eng verwandten, transienten Zelltypen deutlich weniger
bekannt.
Um die epigenetischen Vera¨nderungen die zur Etablierung neuer, eng verwandter Zell-
typen genauer zu verstehen, haben wir daher die epigenetischen und transkriptionellen
Vera¨nderungen wa¨hrend der in vitro Differenzierung von menschlichen-, embryonalen
Stammzellen zu drei verschiedenen fru¨hen Zellpulationen der embryonalen Keimbla¨tter,
Endoderm, Mesoderm und Ectoderm, untersucht. Im Rahmen dieser Studie konnten wir
umfangreiche epigenetische Remodellierungsprozesse, vor allem in Enhancern, beobachten.
Weiterhin haben wir festgestellt, dass die epigenetischen Vera¨nderungen an spezifis-
chen genregulatorischen Elementen vielfach komplementa¨r zwischen den verschiedenen
Zellpopulationen ablaufen. Neben diesen generellen Trends konnten wir eine unerwartete
Abfolge epigenetischer Vera¨nderungen identifizieren, in der ein abgeschalteter genomis-
cher Locus zuna¨chst tempora¨r mit H3K27me3 markiert wird, bevor dieser Locus in
einem spa¨teren Differenzierungsschritt H3K27me3 wieder verliert und aktiviert wird.
Obwohl diese Experimente a¨usserst informativ hinsichtlich der Beschreibung und Charak-
terisierung epigenetischer Vera¨nderungen im Zuge von Zellzustandsu¨berga¨ngen sind, so
sind die treibenden Kra¨fte, welche diese Vera¨nderungen auslo¨sen und dirigieren, vielfach
unklar. Um diesen Aspekt genauer zu beleuchten, haben wir eine computergestu¨tzte
Methode entwickelt, die es gestattet, aus den genomweiten Verteilungen epigenetischer
Modifikationen in verschiedenen Zelltypen die Transkriptionsfaktoren zu identifizieren,
die mit hoher Wahrscheinlichkeit an der Organisation der epigenetischen Vera¨nderun-
gen beteiligt sind oder diese dirigieren. Im na¨chsten Schritt haben wir dann dieses
Verfahren zur Analyse einer 200-ta¨gigen in vitro Differenzierung humaner-, embryonaler
Stammzellen in verschiedene neurale Zelltypen genutzt. Im Rahmen dieser Analyse ist
es uns gelungen, ein Kernnetzwerk von Transkriptionsfaktoren wie OTX2 und PAX6 zu
identifizieren, das wa¨hrend des gesamten Prozesses der in vitro Differenzierung aktiv ist.
Weiterhin scheinen diese Kernfaktoren ihre Bindungspartnerfaktoren in Abha¨ngigkeit
zur Differenzierungsstufe zu vera¨ndern sowie eine allgemeine Relokalisation entlang des
Genoms zu durchlaufen. Diese Resultate sind nicht nur biologisch interessant, sondern
untermauern auch die Nu¨tzlichkeit und generelle Anwendbarkeit des pra¨sentierten Anal-
yseverfahrens.
Zusammenfassend hat dise Arbeit zum besseren Versta¨ndnis der dynamsichen Regula-
tion von DNA-Methylierung beigetragen. Des Weiteren wurde eine hochauflo¨sende, de-
taillierte Untersuchung von epigenetischen Vera¨nderungen wa¨hrend der Differenzierung
von embryonalen Stammzellen in drei verschiedenen, differenzierten Zellpopulationen der
drei Keimbla¨tter pra¨sentiert. Schließlich wurde eine detaillierte Untersuchung der Ak-
tivita¨t und Architektur des genregulatorischen Netzwerks der neuralen Differenzierung
dargelegt. Zusa¨tzlich wurden im Rahmen dieser Arbeit verschiedene neue Verfahren
vorgestellt, die zur Interpretation der rasant wachsenden Zahl epigenetischer Daten ver-
wendet werden ko¨nnen.
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Chapter 1
Introduction
One of the oldest questions in biology explores how living beings are created and de-
velop. The first written attempt to address this question dates back to Aristotle who
investigated this matter by collecting time course data on the development of chicken
embryos (Aristotle and Lawson-Tancred, 1998, Gilbert, 2006). His observations gave rise
to the theory of epigenesis (Aristotle and Peck, 1943), stating that organisms develop
from seeds or eggs in a sequence of steps producing new structures and organs. This
strategy that became the heart of the anatomical approach to developmental biology and
dominated the perspective of the field for almost 2,000 years focused on observing mor-
phological changes of the developing embryo and its structures (Gilbert, 2006). Among
the key observations of this early era was the discovery and characterization of the three
germ layers: ectoderm, mesoderm, endoderm. These three regions of the embryo are
formed during gastrulation of almost all embryos when the single-layered blastula is
re-organized into a three-layered structure. They give rise to distinct structures in the
developed organisms such as the brain and spinal cord (ectoderm), liver and kidney
(endoderm) and blood and muscle (mesoderm) (Gilbert, 2006). However, how these dif-
ferentiation processes were functioning in an operational sense could not be addressed
and was only at the periphery of the research agenda. This rapidly changed with the
advent of the cell theory in the beginning of 19th century (Serafini, 1993) and a new per-
spective on organism development emerged: from simply observing and reconstructing
the distinct steps of embryo development towards understanding the causal relationships
and driving forces orchestrating the developmental process. One of the central goals of
this research agenda was to uncover the “Entwicklungsmechanik” (causal embryology)
1
Chapter I. Introduction 2
of the developing embryo: to understand how the development of specialized cell types
from a single cell occurs; or, in short, how differentiation works (Gilbert, 2006). To
achieve these goals, this new field started to rely heavily on experimental approaches to
functionally characterize distinct parts of a developing embryo.
One of the early key observations stated that cells do not change their morphology and
functional properties instantaneously, but rather that differentiation happens gradually,
starting with the commitment of a cell to a certain fate (Gilbert, 2006). The process of
cell differentiation can be split up into two phases: specification and commitment (Har-
rison, 1933). While cells that are specified will develop into their respective fate when
placed in a neutral environment devoid of differentiation-inducing cues, they remain ca-
pable of reverting back to their original unspecified state when confronted with proper
environmental cues. When the latter property is lost and the cells will differentiate
towards their specified state regardless of environmental signals, the cells are considered
to be committed to a certain cell fate (Gilbert, 2006).
Subsequently, novel experimental approaches to characterize the underlying mechanics
of this process led to the discovery of the organizing center of gastrulation by Spemann
(Spemann and Mangold, 2001). At the same time, the field of embryology was vividly
debating the question of what part of the egg - the cytoplasm or the nucleus - was
responsible for the transmission of inheritable information (Gilbert, 1991). However,
even after the rediscovery of Mendel’s theory of inheritance and growing support for the
existence of genes (Morgan, 1909), the field of causal embryology had little use for the
gene theory. Instead, genetics evolved as a separate discipline (Gilbert, 1991), relying
more and more on statistical approaches to understand inheritance (Fisher, 1930). In
fact, the predominant opinion within the field of embryology stated that genetics was
solely concerned with transmission of inherited traits, whereas embryology was focused
on studying the expression of these traits (Gilbert, 1991, Morgan, 1926). This view was
particularly prominent since according to the major embryologists of the time such as
Spemann and Just, genetics failed to explain how presumably identical chromosomes
(gene sets) within each cell could give rise to many different cell types and to provide
evidence that genes are relevant for the early stages of embryo development (Gilbert,
2006). More drastically, many people believed that genes were only relevant for the
adult organism (Gilbert, 2006). The latter question was addressed in the later 1930s by
Salmon Gluecksohn-Schoenheimer and Conrad Waddington, who identified mutations
in genes that affect early mouse development such as the Brachury gene - the genetic
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basis of the organizer - and genes causing malformations in the wings of the fruit fly
(Gilbert, 1991, Gluecksohn-Schoenheimer, 1938, 1940, Waddington, 1940).
With proof of the genetic basis of embryonic development, one major obstacle for a
grounding of embryology in gene theory remained: How is it possible that nuclear genes
direct development when they are presumably all the same in every cell type (Gilbert,
2006)? From a locigal point of view it seemed possible that different cell types have
different sets of genes and genomes. However, this hypothesis did not fit well with the
fact that all cells arise from a single egg. This question of genomic equivalence was
answered starting in the 1950s with somatic nuclear transfer experiments by Briggs and
King (Briggs and King, 1952, Gilbert, 2006, King and Briggs, 1956). These early ex-
periments showed that cell nuclei from blastula could direct the development of entire
tadpoles when transferred into an activated enucleated frog egg. Despite these successes,
Briggs and King were unable to reproduce these results with further developed somatic
cells (Gilbert, 2006). It was John Gurdon and colleagues, who were able to demonstrate
over a series of nuclear transplantation experiments in the 1960s and 1970s that a single
somatic cell nucleus is capable of giving rise to all cell types of a young Xenopus (Gilbert,
2006, Gurdon et al., 1975, Wabl et al., 1975).
The final proof of genomic equivalence was achieved with the cloning of a mammalian
organism by Ian Wilmut in 1997, creating the sheep Dolly (Wilmut et al., 1997). How-
ever, even with the problem of genomic equivalence resolved, the question of how exactly
the same genome can give rise to many different cell types remained, leading to the for-
mulation of the differential gene expression paradigm (Gilbert, 2006). This paradigm
states that over the course of development as well as in fully differentiated cell types
distinct combinations of genes are active or repressed at various levels, producing dif-
ferent sets and concentrations of proteins and regulatory RNA (Gilbert, 2006). On this
background, all different cell types and physiological cell states can be interpreted in
a unified framework as distinct cellular states (Huang et al., 2005), corresponding to
distinct points in a high dimensional gene/RNA expression space. In the post genomic
digital era, these distinct gene activity profiles are often referred to as molecular pro-
grams.
The characterization of cell types and physiological cell states through global profiling
approaches such as entire transcriptome measurements starts to introduce a paradigm
shift in the definition of cell types/states, extending and complementing morphological
and functional approaches towards a molecular definition.
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However, the molecular mechanisms of establishment and maintenance of distinct gene
expression programs - despite having the same genomic background - are still an area of
active investigation. The molecular programs are established and controlled by a variety
of mechanisms discussed below.
1.1 Outline and key questions
Great progress has been made in understanding the molecular mechanisms underly-
ing maintenance and changes of cellular identity. However, even though many general
molecular principles of cell state changes have been uncovered, numerous open questions
about (1) the involvement of specific epigenetic marks such as DNA methy-
lation, (2) the integration and coordination of transcriptional and epigenetic
changes during cellular differentiation, and (3) the structure of the underly-
ing transcription factor control networks orchestrating cell state maintenance
or differentiation remain elusive. The paradigm proposed in this work states that
a causal understanding of cell state maintenance and dynamics can be achieved through
a transcription factor-centric perspective, explaining epigenetic and (resulting) tran-
scriptional changes through the differential binding of transcription factors to specific
gene regulatory elements. This paradigm, in turn, forms the basis of this work’s key
hypothesis that the distribution of epigenetic states across DNA together with transcrip-
tional information allows for inferences of cell-type-specific active regulatory networks
and pathways, ultimately permitting the reconstruction of the regulatory logic mediat-
ing cell state maintenance and transitions.
The major goal of this work is therefore twofold: First, establish that integration of
epigenetic state and transcriptional information on specific cellular states can
be used to understand the underlying regulatory logic mediating cell state
transitions and second to apply this rationale to obtain a mechanistic un-
derstanding of specific cell state transitions and pinpointing the underlying
regulatory networks of gene regulatory elements and transcription factors.
The ultimate objective of this endeavor is to generate quantitative, predictive regu-
latory models of cellular states, integrating genetic, epigenetic, transcriptional, post-
transcriptional, environmental and phenotypic information to explain differentiation into
other cell types and the causes and consequences of deviations from the normal cell state
trajectory, leading to diseases such as cancer.
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To move closer to this goal it is crucial to (1) understand which epigenetic signatures can
be used to gain insights into the functional characteristics (e.g. differentiation poten-
tial) and active regulatory networks of a cellular state. Several combinations of histone
modifications such as H3K4me3, H3K4me2, H3K4me1, H3K27me3 and H3K27ac have
been shown to be informative to identify key cell type specific regulatory transcription
factors in distantly related cell types (Ernst and Kellis, 2010, Ernst et al., 2011, Heintz-
man et al., 2009, Maston et al., 2006) and are associated with differentiation capacity
(Bernstein et al., 2006, Rada-Iglesias et al., 2011). However, less is known about the
utility of DNA methylation in this context, the most widespread epigenetic modifica-
tion. At this point it is unclear to what extent DNA methylation is dynamic over the
course of development and disease, given that the vast majority of the genome is highly
methylated. Furthermore, it remains open whether DNA methylation changes are in
general associated with regulatory function. In particular, it is unclear whether or not
DNA methylation can be used as a suitable epigenetic mark to gain insights into the
active regulatory networks of a particular cellular state. These questions are addressed
in Chapter 4. In the presented work we determine to what extend the DNA methyla-
tion landscape of the human genome changes between normal cell types and how these
changes compare to DNA methylation dynamics observed in diseased cell types. Fur-
thermore, this work establishes DNA methylation changes as an excellent marker of
gene regulatory elements and demonstrates that genome wide methylation changes can
be used to infer key cell type-specific transcription factors. To obtain insights into the
cell type-specific regulatory networks, the new concept of DNA methylation footprints
of transcription factor binding is introduced. In addition, this work highlights the utility
of cell type specific DNA methylation signatures derived from a large cohort of samples
with respect to classifying unknown samples and deconvoluting DNA methylation mea-
surements of heterogeneous populations.
To understand these matters, it is essential to robustly determine differences in DNA
methylation levels between two conditions given next generation sequencing (NGS) mea-
surements. While most previous methods relied on off-the-shelf statistical methods such
as Fisher’s exact test or Student’s t-test, this work puts forward a novel method for the
detection of differentially methylated regions in bisulfite sequencing data, which is pre-
sented within the Methods section in Chapter 4. This method is specifically tailored
to the statistical problems arising in single-base pair bisulfite sequencing datasets. The
method overcomes several limitations of previous approaches by providing a statistical
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framework to integrate replicates, capturing not only variation occuring due to sampling
but also due to normal, biological variation. The method therefore represents the under-
lying random process more accurately than for example the assumptions made by the
Fisher’s exact test. In addition, the novel DMR finder allows to determine confidence
intervals on differential methylation levels between conditions and allows to integrate
individual methylation measurements on a genomic region level.
In order to mechanistically dissect cell state transitions and determine key epigenetic
remodeling events, it is important to (2) investigate cell state dynamics at a high tem-
poral resolution. However, all previous studies, including our own in Chapter 4 focused
on collections of distantly related cell types, frequently with different genetic background
and not developmentally related.
To overcome these limitations, we devised an in vitro model system of differentiation of
human embryonic stem cells into progenitor cells from the three germ layers, ectoderm,
mesoderm, and endoderm. Using this unique model system, we are able to interrogate
the mechanisms of three distinct cell fate decisions from the same starting point and
perform a horizontal comparative analysis, focusing on dynamics in transcription, chro-
matin modifications, DNA methylation and transcription factor binding in Chapter
5. This study design for the first time allowed for a high-resolution view of epigenetic
changes during cell state transitions. Furthermore, this high-resolution view allowed us
to identify transient epigenetic changes characterized by a gain of the repressive mark
H3K27me3 at regions of high DNA methylation, coinciding with a loss of DNA methy-
lation and binding of the pioneering transcription factor FOXA2. Interestingly, many of
the associated regions were located within open chromatin or localized in close proximity
of gnees expressed at later stages of development, suggesting a multi-stage de-repression
of the associated loci.
In addition, this study demonstrated that the majority of epigenetic changes during in
vitro differentiation of hESC to these early germ layer populations were not associated
with transcriptional changes and rather seemed to be related to the shutdown of alterna-
tive lineage programs or the absence of pluripotency factor binding. Finally, the study
also emphasizes the usefulness of different epigenetic signatures such as H3K4me1 and
H3K27ac which mark lineage specific gene regulatory elements and are highly dynamic
during differentiation.
Given the encouraging findings from this study, we wanted (3) to expand on the possi-
bility to dissect cell state transitions and determine key regulators and active regulatory
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modules from transcriptional and epigenetic data. To that end we took advantage of a
novel differentiation paradigm of hESCs to the neural lineage giving rise to a time-course
of six consecutive stages of in vitro neural differentiation. We devised a new computa-
tional methodology to understand the molecular basis of this process and interpret the
transcriptional and epigenetic dynamics employing a partial least square approach. The
methodology and insights into general principles of cell state transitions as well as the
specifics of the in vitro neural differentiation are presented in Chapter 6. This study
together establishes a novel platform to not only study neural development in vitro and
dissect the underlying molecular mechanisms and gene regulatory networks of various
stages of neural development. It is the unique contribution of this thesis to provide a
framework to utilize the resulting complex, multidimensional datasets and extract the
pan-neural and stage-specific regulatory networks. The proposed computational frame-
work is of general applicability and provides a new perspective and approch to utilize
and integrate epigenomic datasets. It can be used to dissect other differentiation trajec-
tories or a collection of cellular steady states.
In particular, the presented study uncovers the underlying molecular driving force of the
continous remodeling of the differentiation potential of the distinct stages of neural pre-
cursor development by linking it to specific, dynamic regulatory networks and predicted
differential binding of key transcription factors. Furthermore the analysis suggests that
a stably expressed core transcription factor network comprising PAX6 and OTX2 coop-
erates with stage specific factors and signaling pathways to regulate commitment and
proper differentiation towards neuronal and glial cell types.
Finally, concluding remarks and next steps for further research are presented in Chapter
7.
Chapter 2
Background
2.1 Chromatin and chromatin modifications
Double strand DNA itself does not exist as a long, solitary molecule in the nucleus but
is rather wrapped around the nucleosome core particle, a protein octamer consisting
of four core histone proteins (H3, H4, H2A and H2B) (Zhou et al., 2011). This basic
organizational unit of the chromatin comprises 147 bp of DNA and gives rise to several
higher order structures. The formation of these structures is based on the compaction of
”beads on a string” through physical linkage of the individual nucleosomes by the linker
histone H1 (Zhou et al., 2011). The resulting condensed fibers achieve a 50-fold higher
compaction level (Bell et al., 2011), that form the basis of large blocks of tightly packed
heterochromatic regions of the genome (Zhou et al., 2011).
The nucleosome packaging density greatly influences the DNA’s accessibility to pro-
tein binding, in particular to transcription factors and the transcriptional machinery.
Therefore, modulating the local DNA accessibility harbors great regulatory potential
to influence gene expression and silencing as well as DNA replication and repair (Bell
et al., 2011). Studies over the last 15 years have shown that local chromatin structure is
indeed highly dynamic and varies from cell type to cell type (Lee et al., 2004, Mikkelsen
et al., 2007) thus providing the molecular basis for the differential expression paradigm.
Multiple factors determine the level of DNA accessibility including sequence context,
chemical modification of histone tails and in particular transcription factor binding
(Bell et al., 2011). The tails of histone proteins can be subjected to a plethora of
8
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Figure 2.1: Schematic showing the principal organization of DNA around histones.
Grey spehres represent nucleosomes with black lines indicating stretches of DNA. Black
balls symbolyze methylated CpGs while colored balls on the tails of each histone
represtent distinct histone modifications. General gene regulatory elements coinciding
with specific histone marks are indicated on the bottom. The two principal chromatin
environments are displayed on the left for high packaging density/heterochromatin and
on the right for low packaging density, corresponding to open or euchromatin.
distinct modifications such as acetylation, phosphorylation, ubiquitination, and methy-
lation (2.1) (Strahl and Allis, 2000) . Some of these modifications physically affect DNA
compaction through electrostatic forces when an acetyl group is added to histone tails,
neutralizing the positive charge of the tail and therefore weakening the contact with the
negatively charged backbone, reducing the energetic cost of nucleosome eviction (Dorigo
et al., 2003, Shogren-Knaak et al., 2006).
However, most histone modifications exert their regulatory function through interaction
with proteins capable of recognizing a particular modification, termed chromatin readers
(Chen and Dent, 2013). This observation gave rise to the concept of a histone code, sug-
gesting that distinct histone modifications, on one or more tails, act sequentially or in
combination to form a histone code that is read by other proteins to bring about distinct
downstream events (Strahl and Allis, 2000). More specifically, the histone modifications
act in a combinatorial fashion forming binding modules (Ruthenburg et al., 2007) and,
depending on the particular combination of modifications on a particular histone, attract
or repel a specific set of proteins to a genomic locus (Kouzarides, 2007). Recent studies
have provided strong evidence for the histone code concept, showing the coexistence
and crosstalk between distinct histone modifications (Bartke et al., 2010) at the same
genomic locus as well as the genome wide co-occurrence of chromatin regulator bind-
ing (Ram et al., 2011). There are many functions of these histone modifications, such
as the recruitment of nucleosome remodeling complexes (e.g. NURF) (Wysocka et al.,
2006), causing compaction or decompaction and providing a platform of open chromatin
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regions for transcription factor binding (Fig. 2.1). This process ultimately leads to the
activation or modulation of transcription (Wysocka et al., 2006) or to the recruitment of
repressive complexes such as the polycomb complex (Margueron and Reinberg, 2011),
leading to gene silencing.
The addition of modifications to the histone tails are catalyzed by histone modifying
enzymes that are frequently recruited by transcription factors or other chromatin mod-
ifying enzymes (Kouzarides, 2007). Despite enormous efforts, the exact mechanisms of
action of many histone modifications and their associated readers and writers is poorly
understood (Weiner et al., 2012). Recent years have seen dramatic progress in the
genome- wide mapping of many of the histone marks, as well as transcription factor
binding sites and DNA methylation in hundreds of different cell lines and tissues (e.g.
by the ENCODE and Epigenome Roadmap projects). This has led to the widespread
usage of chromatin modification pattern to identify many distinct classes of gene regula-
tory elements and the assignment of putative functions by means of correlation analysis
(Ernst and Kellis, 2010, Ernst et al., 2011, Guttman et al., 2009, Heintzman et al., 2007,
2009, Mikkelsen et al., 2007, Roy et al., 2010). Distinct regulatory elements as well
as distinct states of these elements can be distinguished based on the combinations of
histone modifications and DNA methylation status (Ernst and Kellis, 2010, Mikkelsen
et al., 2007). The totality of these modifications to the DNA/histone is commonly re-
ferred to as the epigenome.
It has been noted early on that tri-methylation of lysine 4 on histone 3 occurs in pro-
moter regions of active genes or genes poised for rapid activation (Bernstein et al., 2006,
Mikkelsen et al., 2007). To date, many chromatin and general epigenetic signatures
demarcating numerous classes of classical gene regulatory elements such as promoters,
enhancer or insulators have been described.
In addition to the identification of these gene regulatory elements in terms of their
genomic locations, observations of the correlation of distinct chromatin signatures with
transcription and genome compaction allows the assignment of distinct chromatin states
to gene regulatory elements, summarizing our knowledge on the co-occurrence and likely
function of these chromatin signatures (Ernst et al., 2011, Mikkelsen et al., 2007). These
states, in turn, can change between cell types (Ernst et al., 2011, Rada-Iglesias et al.,
2011). For example, while the promoter regions of many key developmental transcrip-
tion factors are held in a repressed state by the polycomb group proteins in mouse
embryonic stem cells, a subset of these genes becomes expressed upon differentiation to
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neural progenitor cells. Concordantly, the promoter region of these genes changes their
chromatin signature from being polycomb-repressed (H3K27me3) to an open chromatin
conformation characterized by H3K4me3 and H3K9ac (Wang et al., 2008).
2.2 Gene architecture and genomic regulatory elements
In eukaryotic organisms a gene encodes the amino acid sequence for a protein. However,
in addition to the coding part of a gene, the DNA sequence that is transcribed into
mRNA contains many non-coding elements such as the 5’ and 3’ untranslated region as
well as intronic sequences that separate the coding sequence into distinct parts (exons).
These intronic sequences are removed at the mRNA level in the splicing process (Gilbert,
2006, Lodish, 2008).
In addition to the removal of introns, many genes are also capable of coding for diverse
proteins through the selective retainment of exons, a process called alternative splicing
(Matlin et al., 2005).
While regulation of protein isoforms can be achieved on the exon level, protein abundance
can be regulated on many stages. Prevalent mechanisms include regulation of mRNA
expression level and mRNA stability e.g. through microRNA induced degradation by
targeting of the 3’UTR (Fabian et al., 2010). In contrast, regulation of gene expression
occurs primarily on the DNA level. Specialized gene regulatory elements encoded in
the DNA such as the promoter and other regulatory regions further upstream/down-
stream of the transcription start site (TSS) function as regulatory platforms to initiate
and regulate gene expresssion. While the promoter region in immediate vicinity of the
TSS harbors the landing and assembly site of the transcriptional machinery with RNA-
Polymerase II at its core (Lodish, 2008), parts of the promoter region more upstream
(typically defined 2 kb upstream and 500 bp downstream) encompass many binding
sites for transcription factors that frequently have the capacity to unlock transcription
or modulate the rate of transcription when bound to the promoter region. This region is
the key control element of an individual gene and the gateway to its expression, highly
similar to the original operon model proposed by Jacob and Monod in 1961 (Jacob and
Monod, 1961).
However, even genomic regions up to hundreds of kilobases away from the TSS can im-
pact the transcription of a gene, although typically to a lesser extend than the promoter
region (Ong and Corces, 2011). Regions capable of increasing the transcription of a
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Figure 2.2: Schematic showing the general principal of enhancer-promoter looping
interaction mediated by enhancer binding transcription factors.
gene when brought in physical contact with the promoter are called enhancers (Ong and
Corces, 2011). By default, the physical interaction of promoter and enhancer does not
take place and is mediated by enhancer specific transcription factors which in turn can
recruit the mediator complex and cohesin (Kuras et al., 2003, Ong and Corces, 2011)
leading to the formation of a DNA loop to the target promoter, ultimately increasing the
expression level of the target gene (Fig. 2.2). Recent findings have shown that a single
enhancer region can interact with multiple promoter regions (Gibcus and Dekker, 2013)
when activated and a single promoter region can be the target of multiple enhancers
(Gibcus and Dekker, 2013).
Analogous to enhancer regions, other gene regulatory elements have been described such
as repressive and insulating elements. The former facilitates repression of a gene when
bound by an appropriate transcription factor while the insulating elements are capable
of blocking looping interactions such as between promoter and enhancers when occupied
by a proper transcription factors such as CTCF (Maston et al., 2006).
Together, all these non-coding-regulatory elements give rise to a complex regulatory
code allowing for spatially and temporally tightly regulated expression levels of genes
and non-coding RNAs. However, key players initiating and maintaining these interac-
tions are transcription factor proteins.
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2.3 Transcription factors
Transcription factors (TFs) are proteins that bind DNA in order to activate or repress
transcription, facilitate chromatin remodeling or direct a three-dimensional reorganiza-
tion of the genome (Gilbert, 2006, Jin et al., 2013). In a simple model, activation of gene
expression is achieved through TF binding to the promoter region of a particular gene
or non-coding RNA, followed by recruitment of the transcriptional machinery (Gilbert,
2006, Spitz and Furlong, 2012). Similarly, increased gene expression can be achieved
through TF binding to genomic regions distal to the TSS (inter- or intragenic) and
a subsequent looping interaction with the target promoter mediated by the mediator
complex, leading to enhanced transcription (Kuras et al., 2003, Ong and Corces, 2011).
Distal regions with these properties are defined as enhancers (Ong and Corces, 2011).
In contrast, TFs such as the REST protein (Schoenherr and Anderson, 1995) or lacZ
are capable of directly repressing transcription (Jacob and Monod, 1961).
Based on their structural properties, TFs can be grouped into several families (Pabo
and Sauer, 1992), which frequently participate in similar developmental processes such
as the HOX proteins in axis formation and patterning (Gilbert, 2006). Many TFs have
a high binding affinity to specific DNA sequences, typically between 8 and 20 bp long
which is referred to as the binding motif of the TF (Jolma et al., 2013, Pabo and Sauer,
1992). Closely-related TFs frequently share a similar binding motif (Jolma et al., 2013).
However, the DNA binding sequence preference of a particular TF can be modulated
through protein-protein interactions with specific co-factors or other TFs, giving rise to
homo- and heterodimeric complexes (Jolma et al., 2013, Slattery et al., 2011).
In addition to DNA sequence, the local chromatin environment and the DNA methyla-
tion status at a particular TF binding site (TFBS) can greatly influence the TF binding
capacity. While some TFs such as MYC or TCF4 require a non heterochromatin envi-
ronment in order to bind (Bartke et al., 2010), other factors such as the forkhead family
members FOXA1 and FOXA2 are capable of binding heterochromatic regions and in-
duceing chromatin de-compaction (Smale, 2010, Zaret and Carroll, 2011). Because of
their ability to bind and open heterochromatic regions and the resulting opportunity for
other factors to bind to newly created open chromatin, these factors have been named
pioneering TFs (Smale, 2010, Zaret and Carroll, 2011).
Furthermore, TFs are capable of interacting with a large variety of different proteins
that do not possess sequence specificity themselves and recruit them to specific genomic
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regions. Prominent interaction partners include chromatin modifying enzymes (Smith
and Shilatifard, 2010) and DNA methyltransferases (Fuks et al., 2001, Puto and Reed,
2008), that will ultimately cause a change in the epigenetic state of a genomic locus, po-
tentially leading to gene activation (e.g. recruitment of histone acetylases) or repression
through recruitment of LSD1 (Whyte et al., 2012). However, recent evidence challenges
the paradigm that a TF can function in a solely repressive or activating manner and
rather suggests a model where a specific TF can indeed carry out either function, de-
pending on the chromatin environment and available interaction partners (Jafari et al.,
2012).
Interestingly, TFBSs in promoter, enhancer or silencer regions occur not in an isolated
fashion, but are often flanked by functional binding sites of many other TFs that can
be expressed at the same time (Davidson and Erwin, 2006, Remenyi et al., 2004). Fre-
quently, several binding sites for the same factor occur within these gene regulatory
elements (Hardison and Taylor, 2012). Furthermore, it has been shown that many gene
regulatory elements such as promoters or enhancers can only carry out their function if
multiple different TFs are bound to them, giving rise to the paradigm of combinatorial
transcriptional control (Davidson and Erwin, 2006, Remenyi et al., 2004, Zinzen et al.,
2009). In Drosophila, a set of thousands of particularly large clusters of gene regula-
tory elements, termed cis-regulatory modules (CRMs) were found to control mesoderm
development in a combinatorial fashion (Hardison and Taylor, 2012, Negre et al., 2011,
Zinzen et al., 2009). Recently, a similar class of CRMs carrying out essential cellular
functions were also discovered in mammalian systems and were termed super enhancers
(Hnisz et al., 2013).
Over the course of the last 20 years, TFs have been identified as key components di-
recting and maintaining cellular fates. While knockdown of key TFs in different cell
types induces de-differentiation (Holmberg and Perlmann, 2012, Mikkelsen et al., 2008),
over-expression of a single factor such as MyoD is sufficient to convert human fibrob-
lasts to myoblasts (Weintraub et al., 1989), which can then be further differentiated
into muscle. Finally, combinations of TFs can dictate cellular identity and revert fully
differentiated somatic cells back to a pluripotent state that is equivalent to embryonic
stem cells (Takahashi and Yamanaka, 2006).
In summary, TFs appear to be the key control elements conferring specificity to a large
set of epigenetic modifying enzymes. Combinatorial TF control and the tight mutual
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regulation of their expression (Davidson and Erwin, 2006, Gerstein et al., 2012) gives
rise to a highly complex regulatory logic directing and maintaining cellular states.
2.4 DNA methylation
DNA can be subject to chemical modification through the addition of a methyl group to
the 5’ carbon atom of cytosine, giving rise to methyl-cytosine, sometimes called the 5th
base (Bird, 2002, Holliday and Pugh, 1975, Jones, 2012, Riggs, 1975). In mammalian
genomes, DNA methylation predominantly occurs in the context of CpG dinucleotides
(Bird, 2002, Jones, 2012), although low levels of non-CpG methylation have been found
in hESCs and neuronal cells (Lister et al., 2009, 2013, Ziller et al., 2011). CpG dinu-
cleotides are heavily depleted in mammalian genomes (Bird, 2002, Lander et al., 2001,
Venter et al., 2001) due to increased mutational burden of methylated CpGs through
spontaneous deamination, causing progressive loss of this dinucleotide (Shen et al., 1994).
Overall, there are only 28 million CpG dinucleotides as opposed to more than 400 million
CpAs in the human genome.
In addition to their low abundance, the distribution of CpGs across the genome is highly
asymmetric. Most of the genome is depleted of CpGs except for a set of small 500-2
kb regions that are highly enriched for CpGs (Bird, 2002, Gardiner-Garden and From-
mer, 1987, Lander et al., 2001, Venter et al., 2001). The latter regions are termed CpG
islands (CGIs) and are located near TSS of roughly half of all genes including almost
all housekeeping genes, as well as key developmental regulators (Jones, 2012) . While
CpG islands are constitutively hypo-methylated (Bird, 2002) the vast majority of the
mammalian genome (80%) is highly methylated (Bird, 2002), except during a short pe-
riod in pre-implantation development and primordial germ cell specification (Smith and
Meissner, 2013).
DNA methylation is deposited by a specialized DNA methylation machinery that is
traditionally grouped into two classes (Bestor, 2000). The first class is composed of
DNA methyltransferases DNMT3A and DNMT3B, which catalyze de novo methyla-
tion of unmethylated regions. DNMT1 exhibits a strong preference for hemimethylated
DNA, encountered during DNA replication. Therefore, this enzyme is considered the
maintenance methyltransferase as it copies the DNA methylation pattern to the newly
synthesized strand and follows the replication fork (Bestor, 2000). DNA methylation
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is essential for normal development (Bestor, 2000) and frequently misregulated in var-
ious diseases (Bergman and Cedar, 2013, Robertson, 2005) including different types
of cancers (Baylin and Jones, 2011, Bergman and Cedar, 2013). In the latter case,
particularly CpG islands located in the promoters of tumor suppressor genes become
hyper-methylated while large domains of the entire genome lose methylation (Baylin
and Jones, 2011, Bergman and Cedar, 2013).
Historically, the main function of DNA methylation was considered to be the repression
of gene expression by blocking transcription initiation when occurring in the vicinity
of the TSS and interference with TF binding either through direct physical repulsion
or the recruitment of methyl-binding proteins (Bell and Felsenfeld, 2000, Deaton and
Bird, 2011, Jones, 2012, Suzuki and Bird, 2008, Tate and Bird, 1993). However, recent
evidence suggests additional functions for DNA methylation outside of the promoter
context (Jones, 2012). These functions include stimulation of transcription elongation
in the gene body, maintaining genome stability through silencing of transposable ele-
ments and highly repetitive DNA (Jones, 2012).
Additionally, recent studies paint a complex picture of the relationship between DNA
methylation and TF binding (Lienert et al., 2011, Stadler et al., 2011). While early stud-
ies showed the capacity of DNA methylation to block binding of TFs and DNA binding
proteins such as SP1 and CTCF (Tate and Bird, 1993), more recent findings suggest
a strong factor dependence (Lienert et al., 2011, Stadler et al., 2011). In particular,
pioneering TFs such as FOXA2 have the ability to bind DNA regardless of methylation
state (Zaret and Carroll, 2011). Similarly, a recent study suggested that the transcrip-
tional repressor REST (Stadler et al., 2011) as well as the glucocorticoid receptor (GR)
exhibits a similar ability (Saluz et al., 1986, Wiench et al., 2011). Particularly the latter
finding has received great attention in the context of DNA methylation at enhancer re-
gions (Hon et al., 2013, Wiench et al., 2011). The binding of the GR to distal regulatory
elements was able induce de-methylation at the respective loci and subsequent activation
of the enhancer (Saluz et al., 1986, Wiench et al., 2011). More recent evidence further
supports the involvement of DNA methylation in enhancer functions since it was shown
that lowly methylated regions (LMRs) in mouse embryonic stem cells frequently coincide
with putative enhancer elements (Stadler et al., 2011). In addition, another study in T
cells showed that increased methylation in a subset of putative enhancer regions indeed
resulted in lower enhancer activity in reporter assays (Schmidl et al., 2009). However,
most evidence so far points towards a model in which DNA methylation of a particular
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genomic locus is not responsible for the initial silencing and repression of the locus, but
is rather a second or third step in stably maintaining repression, locking the locus in
a silent state (Bird, 2002, Jones, 2012). One particular model system that has greatly
facilitated our understanding of chromatin regulation, DNA methylation and its critical
role in cell fate determination are mouse and human pluripotent stem cells.
2.5 Pluripotent stem cells
In a functional sense, pluripotency is the capacity of a cell to give rise to differenti-
ated derivatives that represent each of the three primary germ layers (Chambers and
Tomlinson, 2009). Conceptually, pluripotency is understood as the potential ability of
a cell to differentiate into all cell types of an organism (Ng and Surani, 2011). In vivo,
pluripotency is encountered in the cells of the inner cell mass (ICM) of the developing
blastocyst. These cells can be explanted in vitro to obtain ES (ES) cell lines when kept
in proper culture conditions (Chambers and Tomlinson, 2009). These cells are capable
of contributing to all germ layers of a mouse when injected into the blastocyst of devel-
oping mouse embryos, giving rise to chimeric animals (Ng and Surani, 2011).
While ES cells from mice have been derived as early as in 1981 using Leukemia Inhibitory
Factor (LIF) and Bone Morphogenic Protein 4 (BMP4) as key cell culture ingredients
(Evans and Kaufman, 1981, Martin, 1981, Smith et al., 1988), ES cells from humans
(hESCs) were derived a decade later in 1998 relying on a distinct growth factor cock-
tail (Thomson et al., 1998). In contrast to mouse ES cells (mESCs), hESCs require
the presence of Fibroblast Growth Factor 2 (FGF2) and Activin/Nodal signaling for
establishment and maintenance (Ng and Surani, 2011). Despite distinct maintenance
requirements and transcriptional profiles (Tesar et al., 2007), numerous studies have
identified a shared transcriptional core network controlling the ES cell state in human
and mouse with the TFs OCT4, SOX2 and NANOG at the center (Chambers and Tom-
linson, 2009, Young, 2011).
Considering the ethically controversial derivation of pluripotent stem cells from human
embryos, a recent landmark study uncovered that fully differentiated somatic mouse
and human cell types can be reprogrammed to a pluripotent stem cell state using the
over-expression of a defined set of TFs (Takahashi and Yamanaka, 2006, Takahashi
et al., 2007). This study uncovered the molecular principles underlying John Gurdon’s
early transplantation experiments, and proved the enormous epigenetic plasticity of the
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genome. Induced pluripotent stem cells (iPSCs) are functionally and frequently molec-
ularly identical to ES cells (Bock et al., 2011, Guenther et al., 2010) and can contribute
to an entire organism (Zhao et al., 2009). Due to their self-renewing ability and ca-
pacity to differentiate into virtually all cell types, ES cells and iPS cells have become a
valuable tool to study the molecular basis of cell fate commitment and differentiation.
In addition, these cells hold great promise for regenerative medicine, if it is possible
to identify suitable differentiation protocols to generate specific healthy cell types in
sufficient numbers or even entire organs ex vivo.
Chapter 3
Materials and Methods
3.1 Introduction
The content of this chapter has in part been published previously in Ziller et al. (2013)
(Ziller et al., 2013), Gifford and Ziller et al. (2013) (Gifford et al., 2013) and Ziller et
al. (2014) (in revision). More detailed methods relevant to the individual studies are
presented in the corresponding chapter.
3.2 Experimental methods
3.2.1 Measuring DNA methylation
Over the last 30 years, a plethora of detection methods for the DNA methylation state
have been developed (Laird, 2010). In the context of this work, two bisulfite-based ap-
proaches were employed. The treatment of denatured genomic DNA with sodium bisul-
fite chemically deaminates unmethylated cytosine bases much faster than methylated
cytosines (Laird, 2010). If properly timed, almost all unmethylated cytosine residues
are converted to uracil while methylated cytosines remain unchanged. In a subsequent
PCR step, uracil bases get converted to thymines, effectively converting unmethylated
Cs to Ts. With the original DNA sequence known, the bisulfite-converted DNA can
then be sequenced and the DNA methylation state determined (Krueger et al., 2012,
Laird, 2010).
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3.2.2 Whole-genome bisulfite sequencing
In order to determine the methylation state of all cytosines in the genome at single-base
pair resolution, bisulfite treatment can be combined with genomic library production
and next-generation sequencing (Lister and Ecker, 2009), giving rise to a whole-genome
bisulfite sequencing (WGBS) library. Here, we employed the MethylC-Seq protocol
((Gifford et al., 2013, Lister and Ecker, 2009, Lister et al., 2008, 2009)) for WGBS library
production coupled with next-generation sequencing using the Illumina HiSeq2000.
3.2.3 Reduced representation bisulfite sequencing
While WGBS libraries capture almost all bases of the genome, their generation is a
very costly and inefficient process. In order to achieve sufficient genomic coverage for
statistically robust single-base pair methylation calls, a genomic coverage of 30x is rec-
ommended (Consortium, 2011). However, a large fraction of the resulting sequenced
reads (up to 60%) are not informative with respect to DNA methylation state since they
do not contain any CpG dinucleotides due to their genome-wide depletion and asymmet-
ric distribution (Bird, 2002, Ziller et al., 2013). However, this asymmetric distribution
of CpG dinucleotides can also be exploited to enrich specifically for CpG rich regions.
One of the most widespread approaches that takes advantage of this observation em-
ploys restriction enzymes to digest the genome coupled with fragment size selection and
next-generation sequencing library generation to enrich for higher CpG content. This
reduced representation bisulfite sequencing method (RRBS) allows to assay 8-10% (Gu
et al., 2010, Meissner et al., 2008, Smith et al., 2009) of all genomic CpGs while se-
quencing only 1% of the entire genome. To achieve this high level of CpG enrichment,
RRBS employs the restriction enzyme MspI that recognizes the DNA sequence CCGG,
ensuring that each digested fragment and therefore each sequencing read is informative
and contains at least one CpG (Gu et al., 2010, Meissner et al., 2008, Smith et al., 2009).
3.2.4 Chromatin immunoprecipitation coupled with bisulfite sequenc-
ing
In order to determine the co-occurrence of DNA methylation and histone modifications
or TF binding is not sufficient to perform a DNA methylation and ChIP-Seq experiment
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separately, even if carried out on the same cell population. Due to potential hetero-
geneity in the assayed cell population, an observed co-localization of protein/histone
modifications and DNA methylation based on next-generation sequencing data can sim-
ply arise due to the fact that half the cell population was bearing a histone modification
or protein protein at a particular locus but being devoid of any DNA methylation while
the other half exhibits high methylation levels but is depleted of DNA methylation. In
order to reliably determine the co-localization of protein/histone modification and DNA
methylation, we performed ChIP-bisulfite sequencing (Brinkman et al., 2012). This
technique combines immunoprecipitation with bisulfite sequencing to assess the DNA
methylation status of only those DNA fragments that were pulled down by the antibody
against the protein/histone modification of interest (Brinkman et al., 2012).
3.2.5 Chromatin immunoprecipitation coupled with next-generation
sequencing (ChIP-Seq)
To goal of a chromatin immunoprecipitation experiment for DNA interacting proteins is
to determine those DNA fragments that are enriched for binding of a particular protein
(Furey, 2012, Park, 2009). The main protein classes of interest are TFs and histones.
To obtain genome-wide maps of protein-DNA interaction, the DNA is cross linked in
vivo by treating the cells with formaldehyde and the chromatin is subsequently sheared
by sonication into small fragments in the range of 200-600bp (Park, 2009). Next, an
antibody against the specific protein or chromatin modification of interest is used to
immunoprecipitate the DNA-protein complex (Park, 2009). Finally, the protein-DNA
crosslinking is reversed, the released DNA extracted and used for the construction of
a next-generation sequencing library (Park, 2009). If the antibody was specific, only
DNA fragments associated with the specific protein or histone modification should be
present in the library. Mapping the resulting reads from the sequenced library to the
genome then allows to assess the genome-wide distribution of the assayed TF or histone
modification. Here, we employed several improved ChIP-Seq library construction pro-
tocols that are introduced in the subsequent methods section relevant to the individual
chapters.
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3.2.6 RNA-Seq library construction
RNA was extracted using the miRNeasy kit (Qiagen, 217004). Poly(A) RNA was iso-
lated using Oligo d (T25) beads (NEB, E7490L). The poly(A) fraction was then frag-
mented (Invitrogen, AM8740). Fragments smaller than 200 bps were eliminated (Zymo,
R1016) and the remaining fraction was treated with FastAP Thermosensitive Alka-
line Phosphatase (Thermo Scientific, EF0652) and T4 Polynucleotide Kinase (NEB,
M0201L). RNA was then ligated to a RNA adaptor using T4 RNA Ligase 1 (NEB,
M0204L), which was then used to facilitate cDNA synthesis using Affinity Script Multi-
ple Temperature Reverse Transcriptase (Agilent, 600105). RNA was then degraded and
the cDNA was ligated to a DNA adaptor using T4 RNA Ligase 1. Final library ampli-
fication was completed using NEB Next High Fidelity 2X PCT Master Mix (M054L).
3.3 Computational methods
3.3.1 Basic methylation data processing
WGBS libraries were aligned using maq (Li et al., 2008) in bisulfite mode and BSMap (Xi
and Li, 2009) to the hg19/GRCh37 reference assembly using default parameter values.
Subsequently, CpG methylation calls were made excluding duplicate reads, and bases
with a quality score ≥ 20 as well as reads with more than 10% mismatches. Here, a
methylation call is defined as the computation of the number of reads overlapping a
particular CpG harboring a C or a T at the cytosine coordinate of the CpG. Let m be
the number of C’s and u be the number of T’s. The value e = m/(m+u) then gives the
methylation ratio of each CpG. The methylation calling pipeline was implemented in
Python (http://python.org/) (Ziller et al., 2013) and mainly written by Fabian Mu¨ller.
The accompanying code can be found in the accompanying zip archive in the folder
Methylation Pipeline.
3.3.2 Basic ChIP-Seq data processing and analysis
ChIP-Seq data was aligned to the hg19/GRCh37 reference genome using bwa version
0.5.7 (Li and Durbin, 2009) or maq version 0.7.1(Li et al., 2008) with default parame-
ter settings. Subsequently, reads were filtered for duplicates and extended by 200 bp.
Visualization of read count data was performed by converting raw bam files to .tdf files
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using IGV tools version 2.2.1 (Thorvaldsdottir et al., 2013) and normalizing to 1 million
reads. To identify regions of chromatin modification enrichment we employed the ap-
proach suggested by Mikkelsen et al. (Mikkelsen et al., 2010), modeling the distribution
of unique read sequences in a genomic region of size l with a Poisson model. To deter-
mine the enrichment over background, we used the whole-cell extract (WCE) to model
our background distribution of read sequences. The WCE is generated in the same way
as the ChIP-Seq library except for omitting the IP step. Using the WCE as background
model has the advantage of implicitly accounting for shearing biases and read-mapping
artifacts. We defined a nominal p-value for enrichment against the control within a given
region i of length l in sample k harboring ri midpoints of uniquely aligned fragment size
extended sequencing reads as P (C ≥ rik) with (Mikkelsen et al., 2010):
C ∼ Poisson(max[1, c]× λk) (3.1)
ic =
ric
λc
(3.2)
λc = l × Tc/G (3.3)
λk = l × Tk/G (3.4)
with ric reads in the WCE control channel, Tc and Tk the total number of uniquely
aligned reads in the WCE and ChIP library respectivly, and G the mappable size of
the genome (for hg19: G = 2.7 × 109 (Zhang et al., 2008)). The coverage-adjusted
enrichment level of genomic region i of size l in sample k over WCE control sample c is
then defined as
eik =
ik
ic
with ik corresponding to the reads per kilobase per million reads sequenced (RPKM)
within the genomic region i in sample k or in the control c respectively as defined in
equation (3.2) .
For differential enrichment analysis between two ChIP experiments, the second ChIP
experiment is simply treated like the WCE control in (3.1) and (Mikkelsen et al.,
2010). For genome-wide significance testing, the resulting p-values are corrected us-
ing the Benjamini-Hochberg (Benjamini and Hochberg, 1995) method as implemented
in the R function p.adjust. All ChIP-Seq analysis was conducted in R (http://www.r-
project.org/)
In order to identify TFBS we employed traditional peak calling using MACS (Zhang
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et al., 2008) against the matching WCE, removing all duplicates and only retaining
peaks with p ≤ 10−5. The accompanying code can be found in the accompanying zip
archive in the folder ChIP-Seq analysis.
3.3.3 Gene set enrichment analysis
Gene set enrichment analysis for genomic regions was carried out using the GREAT
toolbox (McLean et al., 2010) and only categories with q-values ≤ 0.05 for both the
Hypergeometric and the binomial test as well as a minimal region enrichment level
greater than 2 were considered.
3.3.4 RNA-Seq data analysis
To assess expression levels of the entire transcriptome, we performed strand specific
RNA-Sequencing for polyadenylated RNA, capturing coding as well as non-coding tran-
scripts.
Reads were mapped to the human genome (hg19) using TopHat v2.0.6 (Trapnell et al.,
2009)
(http://tophat.cbcb.umd.edu) with the following options: ”-library-type firststrand”
and ”-transcriptome-index” with a TopHat transcript index built from RefSeq. Tran-
script expression was estimated with an improved version of Cuffdiff 2
(http://cuﬄinks.cbcb.umd.edu) (Trapnell et al., 2013). Cuffdiff was run with the fol-
lowing options: ”-min-reps-for-js-test 2 -dispersion-method per-condition” against the
UCSC iGenomes GTF file from Illumina. The workflow used to analyze the data is
described in detail in (Trapnell et al., 2012) (alternate protocol B).
Chapter 4
Charting a dynamic DNA
methylation landscape of the
human genome
4.1 Inroduction
The content of this chapter has previously been published in Ziller et al.
2013 (Ziller et al., 2013). The design of the analysis strategy as well as all analyses were
carried out by M.J. Ziller. All wet lab experiments including next-generation sequencing
library production were contributed by the co-authors. The manuscript was written by
M.J. Ziller.
Progress in the genome wide mapping and analysis of chromatin states across many
different cell types has not only broadened our understanding of epigenetic regulation,
but also gave rise to the notion that specific chromatin signatures demarcate distinct
classes and states of gene regulatory elements (Bernstein et al., 2012, Ernst and Kellis,
2010, Ernst et al., 2011, Heintzman et al., 2009, Maston et al., 2006, Mikkelsen et al.,
2007). Furthermore, these studies suggested that the distribution of specific histone
marks such as HK4me1,2,3, H3K27ac and H3K27me3 as well as DNAse I hypersensitive
sites provide insights into the active regulatory network of transcription factors within
a given cell type (Ernst et al., 2011, Neph et al., 2012). Therefore, the cell type-specific
distribution of these epigenetic signatures permits insights into the distinct architecture
of regulatory networks controlling each cellular state. While many different cell types
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have been investigated for histone modifications (Bernstein et al., 2012) and DNAse I
hypersenstivity (Neph et al., 2012), the roles and dynamics of DNA methylation are far
less clear. DNA methylation is a defining feature of mammalian cellular identity and es-
sential for normal development (Bestor, 2000, Reik, 2007). Most cell types, except germ
cells and pre-implantation embryos (Hackett and Surani, 2013, Seisenberger et al., 2012,
Smith et al., 2012), display relatively stable DNA methylation patterns with 70-80% of
all CpGs being methylated (Bird, 2002).
Despite recent advances we still have a too limited understanding of when, where, and
how many CpGs participate in genomic regulation. Here we report the in-depth analysis
of 42 whole-genome bisulphite sequencing data sets across 30 diverse human cell and
tissue types. We observe dynamic regulation for only 21.8% of autosomal CpGs within
a normal developmental context, most of which are distal to transcription start sites.
These dynamic CpGs co-localize with gene regulatory elements, particularly enhancers
and transcription factor-binding sites, which allow identification of key lineage-specific
regulators. In addition, differentially methylated regions (DMRs) often contain single
nucleotide polymorphisms associated with cell-type-related diseases as determined by
genome-wide association studies. The results also highlight the general inefficiency of
whole-genome bisulphite sequencing, as 70-80% of the sequencing reads across these data
sets provided little or no relevant information about CpG methylation. To demonstrate
further the utility of our DMR set, we use it to classify unknown samples and identify
representative signature regions that recapitulate major DNA methylation dynamics.
In summary, although in theory every CpG can change its methylation state, our re-
sults suggest that only a fraction does so as part of coordinated regulatory programs.
Therefore, our selected DMRs can serve as a starting point to help to guide new, more
effective reduced representation approaches to capture the most informative fraction of
CpGs, as well as further pinpoint putative regulatory elements.
Changes in DNA methylation patterns and the resulting DMRs have been the focus of
numerous studies in the context of normal development (Smith and Meissner, 2013) and
disease (Bergman and Cedar, 2013). These studies have characterized many different
DMR classes including partially methylated domains (Lister et al., 2009), condition-
specific (Nazor et al., 2012), cell-type-specific (Laurent et al., 2010, Lister et al., 2009,
Meissner et al., 2008, Weber et al., 2005) and tissue-specific DMRs (Irizarry et al., 2009,
Varley et al., 2013), as well as DMRs arising in diseases such as cancer (Berman et al.,
2012, Irizarry et al., 2009). Owing to the relatively small fraction of genomic CpGs
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assayed or small sample cohorts, the question of what fraction of genomic CpGs changes
its methylation state in the context of normal development as well as their regulatory
context remains underexplored.
4.2 Computational methods
4.2.1 Parametric description of CpG methylation levels
Given a single CpG at genomic coordinate i and two biological samples s1 and s2, we
observe m1,m2 reads where the genomic CpG is seen as methylated and u1, u2 reads
where the CpG is unmethylated. The ratio
eij =
mij
mij + uij
gives the methylation level eij of genomic CpG i in replicate j.
At the heart of DNA methylation data analysis lies the desire to identify differentially
methylated cytosines or DMRs between different conditions, for example distinct cell
types or normal and disease samples. Previous approaches to the analysis of bisulfite
sequencing relied heavily on statistical methods such as Fisher’s exact test on a single
CpG level or some variant of the t-test if a single CpG or a genomic region harboring
multiple cytosines is compared across conditions (Becker et al., 2011, Bock, 2012, Lister
et al., 2009). However, on the single cytosine level the use of Fisher’s exact test might
be to conservative as it does properly reflect the underlying sampling process giving
rise to the cytosine methylation measurements. In addition, Fisher’s exact test does
not allow for the estimation of confidence intervals, a feature highly desirable in the
context of differential methylation assessment. Similarly, the assumptions underlying
the frequently used two proportion z-test are not met in the low coverage regime.
To overcome some of these drawbacks and in order to minimize the impact of noise on
our estimates and improve dynamic CpG detection sensitivity, we devised a model based
on the beta distribution to model single CpG methylation levels.
The underlying random process of the sampling procedure is modeled by a binomial
distribution for the number of methylated reads per CpG i with methylation probability
θij :
mij ∼ Bin(nij , θij) (4.1)
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with the total number of reads covering CpG i in sample j nij = mij + uij . The
true fraction of CpGs methylated in the profiled cell population θij is unknown and we
therefore follow a Bayesian approach treating θij as random variable itself. To that end,
we assume further that θij follows a beta distribution with parameters αi, βi:
θij ∼ Beta(αi, βi) (4.2)
The posterior distribution for θij then has also beta distribution form:
P (θij |mij , nij) = Beta(θij |mij + αi, βi + nij −mij) (4.3)
The parameters of the prior distribution αi, βi are unknown and if only one replicate
per sample is available we assume a uniform prior with αi = βi = 1. If more than one
replicate is available, we employ an empirical Bayes approach to estimate the unknown
prior variables αi, βi. First, we reparameterize the beta prior distribution in terms
of its mean µi =
αi
αi+βi
and precision Mi = αi + βi. The marginal distribution for
the number of methylation events mi is then given by the beta-binomial distribution.
The parameters µi and Mi of the beta-binomial model are estimated by the method of
moments (Martuzzi and Elliott, 1996):
µˆi =
R∑
j=1
nijeij
R∑
j=1
nij
is the weighted mean of the observed methylation ratios eij across R replicates. An
estimate of Mi can be obtained via (Martuzzi and Elliott, 1996):
Mˆi =
µˆi(1− µˆi)− s2
s2 − 1n¯ µˆi(1− µˆi)
with the total weighted sampled variance s2:
s2i =
R∑
j=1
nij(eij − µˆi)2
R∑
j=1
nij
Please note that Mˆi
2
can be negative when the observed total variation is less than
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expected. In this case the inter-sample variation should be considered zero (Howley and
Gibberd, 2003, Martuzzi and Elliott, 1996) and we set µi and Mi to zero and model the
distribution of the methylation probability θi based on the replicate with the highest
sampling frequency nik using the beta-posterior distribution (4.2):
P (θi|mik, nik) = Beta(θi|mik + 1, nik −mik + 1)
Transforming back to the original parameterization of the beta distribution using the
definitions µi =
αi
αi+βi
and precision Mi = αi + βi yields:
αˆi = µˆiMˆi
βˆi = Mˆi(1− µˆi)
In terms of biology, the beta-distribution captures the natural biological variability en-
countered when comparing multiple biological samples of the same class and we subse-
quently use the estimated beta-distribution to describe the CpG of interest.
4.2.2 Estimating the difference in CpG methylation levels between two
samples
In order to compute the difference in CpG methylation levels between two samples
(groups) δi = θi1−θi2 in a probabilistic framework, we take advantage of the parametric
model of CpG methylation probability (4.3) to determine the distribution of the differ-
ence in CpG methylation probability between two samples. To that end we subtract the
two random variables Θi1 and Θi2 from each other and obtain the new random variable
∆i = Θi1 −Θi2 quantifying the difference in CpG methylation levels. ∆i then follows a
beta difference distribution (BD) (Phamgia et al., 1993): Wlg., let (δi > 0):
BD(δi|αi1, βi1, αi2, βi2) =B(αi1, βi2)δβi1+βi2−1i (1− δi)αi2+βi1−1
F1(βi1, αi1 + βi1 + αi2 + βi2 − 2, 1− αi1;
βi1 + αi2, (1− δi), 1− δ2i )/(B(αi1, βi1)B(αi2, βi2))
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With B is the beta function normalization factor and F1 Appell’s first Hypergeometric
function in two variables, and
BD(δ = 0|α1, β1, α2, β2) = B(α1 + α2 − 1, β1 + β2 − 1)/A
for δ = 0 with A = B(α1, β1)B(α2, β2) (Phamgia et al., 1993). Since the resulting
distribution quickly approaches the normal distribution with increasing CpG coverage
n1, n2, we distinguish two cases for the computation of the 100(1−α)% credible interval
(Pham-Gia and Turkkan, 2003).
1. For low CpG coverage (n1 ≤ 30 or n2 ≤ 30) we estimate the probability density
for δ by simulation, drawing R samples from the joint posterior distribution. The
100∗(1−α)% credible interval is then given as [p100×α/2, p100×(1−α/2)] with px being
the respective percentile computed over all sample combinations {θki1, θki2}k=1|...,R.
The nominal p-value for each one-sided test is then determined by the number of
instances where δi was larger/smaller.
2. For high CpG coverage n1, n2 we approximate the BD distribution δ = µ1 − µ2
by the normal distribution, with µl = αl/(αl + βl) and variance (Pham-Gia and
Turkkan, 2003):
σ2i =
2∑
j=1
αjβj
(αj + βj)2(αj + βj + 1)
4.2.3 Determining CpG cluster effects
Given a genomic region of size l harboring N individual CpGs and measurements of
the methylation level eij for all CpGs i = 1, .., Nk in two distinct sample groups j, we
want to determine the region methylation level difference δ¯k, k = 1, .., R and signifi-
cance between the samples for R regions. To this end we use a classic random effects
model (DerSimonian and Laird, 1986) to describe the region/CpG cluster methylation
differences. Within the framework of this model, we define δ¯k as the abstract summary
methylation difference of the entire region k. The observed CpG level methylation dif-
ferences δki are then considered to be a function of the region methylation difference δ¯k.
Let δki, i =, 1 . . . ,K be a collection of CpG level methylation differences for region k
and let Vki be the corresponding variance associated with each measurement. Further-
more, let ∆2k be the population variance across all CpG difference measurements. The
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observed CpG level methylation differences δki are then considered to be a function of
the region methylation difference δ¯k, deviating from this quantity by variations induced
through sampling errors for the particular CpG i as well as deviation from the mean
region methylation level difference ζki:
δki = δ¯k + ζki + ki (4.4)
A non-iterative estimate of this quantity can be obtained from the variance-weighted
deviation of individual CpG methylation differences from the mean difference (DerSi-
monian and Kacker, 2007, DerSimonian and Laird, 1986):
∆ˆ2k =
Qk − dfk
Ck
,
with
Qk =
Nk∑
i=1
wkiδ
2
ki −
(
Nk∑
i=1
wkiδi
)
Nk∑
i=1
wki
, dfk = Nk − 1 and
Ck =
Nk∑
i=1
wki −
Nk∑
i=1
w2ki
Nk∑
i=1
wki
where each CpG is weighted according to its associated sampling variance wik:
wi =
1
Vki
.
δi and their associated variances Vi are determined based on the parametric model
developed in the previous paragraphs. The total CpG difference variance per CpG is
then given as:
Vˆki = Vki + ∆ˆ
2
k
which in turn allows to compute the contribution of each CpG methylation difference
wˆi to the region level methylation difference:
wˆki =
1
Vˆki
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Given these estimates, the region level methylation difference can be determined as
(DerSimonian and Laird, 1986):
δ¯k =
Nk∑
i=1
wˆkiδki
Nk∑
i=1
wˆki
and associated variance:
V¯k =
1
Nk∑
i=1
wˆki
The estimated standard error then becomes:
∆¯k =
√
V¯k.
These values can then be used to compute the (1−α) confidence intervals and p-values
using the standard normal cumulative distribution function:
cL = δ¯ − Φ−1(1− α)
cU = δ¯ + Φ
−1(1− α)
and the associated p-value for a one-tailed test:
pk = 1− Φ
(
± δ¯k
∆¯k
)
The methylation level of CpG clusters is determined by computing the coverage-weighted
mean across all CpGs within a cluster, limiting the maximal overage contribution per
CpG to 25:
µ¯ =
nj∑
i=1
wij ∗ eij
with the coverage-based mij weights:
wij =
nij
nj∑
j=1
mij
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4.2.4 Methylation Specificity
The methylation specificity of a genomic region k is defined based on the Jensen-Shannon
divergence (Endres and Schindelin, 2003):
JS(m1,m2) = H
(
m1 +m2
2
)
−
(
H(m1) +H(m2)
2
)
with m1,m2 two discrete probability distributions fulfilling
n∑
i=1
mi = 1 and 0 ≤ mi ≤ 1
and entropy H:
H(m) = −
n∑
i=1
mi log2(mi)
Here, we exploit the well-known fact that the square root of the Jensen-Shannon di-
vergence is metric to determine the methylation specificity (Cabili et al., 2011). For
each genomic region k we first normalize the methylation level distribution across all N
samples mk to fulfill
n∑
i=1
mi = 1. Next, we determine the Jensen-Shannon divergence
between mk and N prototypic methylation profiles representing the N possible extremes
where the region k is completely methylated in only one of all samples and unmethylated
in all other samples or vice versa:
JS(mk, rj)sp = 1−
√
JS(mk, rj)
with rjl = δ
K
jl for hypermethylation specificity and rjl = 1 − δKjl for hypomethylation
specificity, where δKjl is the Kronecker delta. The hyper (HR)/hypomethylation (HO)
specificity is then given as:
JSHR(mk)sp = arg max
j=1,...,N
JS(mk, r
HR
j )sp (4.5)
JSHO(mk)sp = arg max
j=1,...,N
JS(mk, r
HO
j )sp (4.6)
4.2.5 Estimation of saturation curve
To get an estimate of the rate of newly discovered dynamic CpGs as a function of number
of samples, we randomly select sample subsets from our developmental cohort at different
cell type coverage levels (5, 10, 15, 20, 24). For coverage levels 5 and 10 we create 10
distinct sample subsets, for 15 cell types five subsets and for 20 cell types two distinct
Chapter 4 Charting a dynamic DNA methylation landscape of the human genome 34
subsets. Subsequently we run our standard dynamic CpG identification procedure on
each of the defined subsets and average the number of dynamic CpGs found for each
cell type coverage level. Based on these data points we compute a cubic spline fit and
plot (Fig. 4.16).
4.2.6 Signature set derivation and classification
In order to derive cell group-specific signature regions, we utilized the mean and vari-
ance estimates derived for all dynamic regions across all samples. Assuming normal
distribution of methylation levels for each region, we determined the average mean and
variance across all samples within a group for each region separately, giving rise to the
region’s group methylation level and variance. Next, we computed all pairwise Euclidean
differences between this region group methylation level and all samples. Based on this
calculation, we computed the mean intra-group and inter-group distance for each re-
gion’s group methylation level and all samples. Regions exhibiting mean intra-group
distance smaller than 0.1 and a mean inter-group distance of larger 0.2 were classified as
signature regions for each group of samples. The following groups were used: ectoderm
(HUES64d EC, H1d NPC, fetal brain, hippocampus, substantia nigra), neural (H1d
NPC, fetal brain, hippocampus, substantia nigra), hESd (hESd EC, hESd ME, hESd
EN, H1d mesendo, H1d NPC), ES(HUES64), endoderm(HUES64d EN, liver), meso-
derm (HUES64d ME, CD34, CD4, CD8, fetal heart, colonic mucosa, adipocyte nuclei),
blood(CD34, CD4, CD8, Bcell, HSPC), adult stem cells (dMesenchyme, dNPC, CD34),
fetal (fetal heart, fetal brain, fetal thymus, fetal muscle, fetal adrenal).
4.2.7 Sample deconvolution
To test the discriminatory performance of cell type-specific dynamic regions, we created
a hybrid sample from scratch, merging two sequencing lanes from one of our hippocam-
pus WGBS samples and two lanes from one of our HUES64 WGBS samples on the
read level. Subsequently, we performed methylation calling using our standard pipeline.
Next, we determined the methylation level in this particular hybrid sample for the pre-
viously identified dynamic regions. We filtered all dynamic regions according to sample
specificity as described previously and used this set for our deconvolution approach. We
assume that the hybrid sample’s methylation profile h across the reduced dynamic region
set is composed of a linear combination of the methylation profiles of all N = 17 samples:
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h =
N∑
i=1
aimi , with the coefficients ai defining the scalar mixture proportions. Here, the
coefficients ai are required to fulfill ai ≤ 0 and
N∑
i=1
ai = 1. To find the mixture propor-
tions, we can reformulate the problem as a linear program. However, for simplicity’s
sake we decided to pose the deconvolution problem as a quadratic optimization problem
and incorporate the constraint on the sum of the coefficients into the objective function
and optimize this function directly using a quasi-Newton method for bound constrained
optimization (L-BFGS-B) as implemented in the R optim (Team, 2012) package.
4.2.8 Genomic features
We obtained TSS, exon and intron coordinates for RefSeq genes from UCSC. Promoters
were defined as 2 kb upstream and 500 bp downstream of RefSeq TSS. CpG islands
were determined using CgiHunter (http://cgihunter.bioinf.mpi-inf.mpg.de/), requiring
a minimum CpG observed vs. expected reatio of 0.6, a minimum GC content of 0.5 and
a minimum length of 700 bp. CpG island shores were defined as 2 kb regions directly
upstream and downstream of CpG islands. Experimentally determined CpG islands were
taken from Illingworth et al. (Illingworth et al., 2010). HCP promoters were defined
as RefSeq promoters containing a 500 bp window with a CpG observed over expected
ratio > 0.8. Similarly, ICPs were defined as RefSeq promoters with a maximum CpG
observed vs expected ratio between 0.45 and 0.8 within a 500 bp window and LCPs
everything < 0.457 (Weber et al., 2007).
4.2.9 Transcription factor binding site, enhancer and DNAse I analysis
Processed TFBS .broadPeak files were downloaded from the UCSC ENCODE web-
site (http://genome.ucsc.edu/ENCODE/downloads.html). Replicate experiments were
merged conservatively, only retaining peaks present in both replicates. Subsequently,
summary TFBS tracks for each individual transcription factor or chromatin modifier
were created, merging all peaks from different experimental conditions/cell types. At
this stage, we also included four additional TF-ChIP tracks for OCT4, SOX2, NANOG
and FOXA2 from GSE46130. These tracks were then used for TFBS analysis. Addition-
ally, we pooled all individual factor tracks into one consensus track, merging overlapping
peaks giving rise to a consensus track containing 2,164,835 consensus peaks. In a sim-
ilar fashion, we acquired and processed the DNAse I hypersensitive site data. For the
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global analysis of transcription factor binding site enrichment in DMRs we determined
the overlap of our DMR set and 100 randomly drawn, size matched control regions sets
to estimate the background distribution of TFBS.
Enrichment calculations for all transcription factors and chromatin modifiers (n=165)
were performed on the basis of the individual summary tracks for each factor. To
determine enrichment and significance of a particular factor within a given class of ge-
nomic regions, we generated 100 sets of size matched and mappability filtered control
regions for the particular dynamic region class of interest, most comprising millions
of regions per group. Next, we determined the number of TFBS per individual TF
overlapping with the region class of interest and the control region sets. The ratio of
the two is reported as the enrichment statistic shown in Fig. 4.9b and only TFBS re-
sults significant at p < 0.05 based on the empirical null distribution for the enrichment
statistic and with an enrichment ratio greater than one are reported and set to 0 oth-
erwise. In Fig. 4.9b, we report the top three TFBS discovered for all cell type-specific
regions across the primary cell type/tissue data set. Enhancer regions were defined
using H3K27ac as a proxy for enhancer activity. We obtained 31 H3K27ac profiles
from the REMC and ENCODE project (http://www.roadmapepigenomics.org/data,
http://genome.ucsc.edu/ENCODE/downloads.html) and used MACS (Zhang et al., 2008)
to identify peaks within the individual, replicate merged H3K27ac libraries. We only
retained peaks significant below 10−6 and merged the individual peak lists afterwards
giving rise to n = 285, 344 distinct putative enhancer regions.
4.2.10 Motif analysis
For each region class of interest, which in our case were primarily dynamic regions spe-
cific to a particular sample, we determined all human and mouse motifs contained in the
Jolma et al. database (Jolma et al., 2013) (n=843) that are present within our regions.
For Fig. 4.10 we additionally included all human and mouse motifs from the TransFac
professional database 2009 (n=673) (Matys et al., 2006). Motif matching was performed
using FIMO (Grant et al., 2011), retaining only motifs significant below 10−5. As con-
trols, we trained a 0th order hidden Markov model on the input regions and generated
ten size distribution-matched sets of control regions that were also subjeced to motif
matching. Subsequently, we computed the ratio of motif instances in the region set of
interest and the average over the 10 control region sets for each motif separately. With
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this procedure we control for base composition as well as sequence length. To determine
not only motifs enriched over genomic background but also differentially enriched in
dynamic regions specific to individual cell types, we determined the enrichment z-scores
over all cell type specific regions across the primary cell type/tissiue data set. To cor-
rect for samples not enriched over background, we set the z-scores for motifs with an
enrichment ratio below 1.2 to 0 in that particular sample. Finally, we rank the motifs
by z-score for each of the nine samples individually and plot the top three motifs for
each sample.
4.2.11 Cell type specific regions and cohort definition
Cell type-sepcific hypomethyalted regions are defined as exhibiting a Jensen-Shannon
divergence (JS) of ≥ 0.15 across the sample set of interest. Each region fulfulling this
criterion was assigned to the cell type where it exhibited the lowest methylation level,
giving rise to the set of cell type-specific hypomethylated regions.
In our main analysis, we consider four different sample cohorts that divide our data
set. The first cohort termed developmental or normal developmental cell types consists
of all primary tissues, in vitro derived cell types and HUES64 (n=24). The long-term
cell culture cohort harbors three cell lines (newborn foreskin fibroblasts, IMR90 and
HepG2). The cancer cohort consists of one colon cancer sample. Dynamic CpGs were
determined against a matching control of adjacent tissue. The Alzheimer’s disease (AD)
cohort comprises two AD frontal cortex brain samples derived from different patients
with severe AD symptoms. Dynamic CpGs were determined against two control samples
from patients of similar age but normal cognitive, molecular and physiological brain
parameters.
4.2.12 Dynamic CpG identification algorithm
We identified dynamic CpGs in a multi-step procedure (see Fig. 4.1 for entire workflow).
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Library construction
HiSeq 2000 sequencing
Alignment
DMR detection 1 - merge
Final DMR setDMR detection - filter for 
maximum difference
Methylation calling
Dynamic CpG detection 2
filter DynCpGs from DMRs Final DynCpG set
Dynamic CpG detection 1
All pairwise comparisons
on DMR set
Figure 4.1: Complete workflow for methylation data generation and analysis
First, we use our probabilistic description of single CpG methylation levels to determine
whether each CpG is differentially methylated based on the beta difference distribution.
For this step, only methylation differences significant below ≤ 0.01 are retained. For the
next comparisons (n ≥ 3) we compare the CpG methylation level for each CpG of the
new sample to the minimum and maximum methylation levels that have been observed
so far based on the previous comparisons. If no comparison for a particular CpG has been
significant yet, the initial values are still stored. If in the current comparison a significant
deviation from the current minimal/maximal methylation level is found, the current
minimum/maximum is replaced if the new estimated methylation difference exceeds the
current difference between minimum/maximum. We initialize our comparison algorithm
with the CpG methylation values in HUES64 and hippocampus and proceed in random
order with the rest of the dataset.
In the next step we filter all dynamic CpGs identified so far and remove all CpGs
overlapping HapMap SNPs (Abecasis et al., 2010) or exhibiting a mappability score
below 50 (Lee and Schatz, 2012). Next, we merge all dynamic CpGs located within 500
bp of each other to give rise to a dynamic region set. The merging process is limited to
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a maximum region size of 10 kb, beyond that a new region is started. For CpGs without
a neigbhor within 500 bp, we define a genomic interval by extending the dinucleotide
region by 50 bp in either direction. Therefore our region catalog size is limited to 100-
10000 bp.
In the last step, we compute the CpG cluster methylation differences across the dynamic
region set for all pairwise comparisons in our dataset and retain only regions meeting
our threshold criteria. The latter were set to minimum effect size ≥ 0.3 and significance
level ≤ 0.01 for all main analysis.
4.2.13 Analysis of 450K and tDMR data
To gain further confidence in the identification methodology, we compared our dynamic
region set to previously identified tDMRs (Irizarry et al., 2009) as well as DMRs obtained
from publically available Illumina 450K array data for 23 distinct cell and tissue types
(Nazor et al., 2012). Strikingly, we also recover between 50−75% of previously identified
dCpGs (Fig. 4.5a,b). We obtained preprocessed 450K Infinium Bead Chip data from
GEO (GSE30654)(Nazor et al., 2012) and filtered for primary cells and tissues contained
in this large data set. Next, we averaged individual CpGs over replicates leaving us 23
diverse human samples (Bladder Adult, Lymph Node Adult, Stomach Fetal, Stomach
Adult, Blood Adult, Heart Fetal, Heart Adult, Tongue Fetal, Kidney Fetal, Liver Fetal,
Brain Fetal, Brain Adult, Pancreas Adult, Thymus Fetal, Spleen Fetal, Spleen Adult,
Ureter Adult, Lung Fetal, Lung Adult, Adrenal Fetal, Adrenal Adult, Skeletal Muscle
Adult, Adipose Adult).
Subsequently, we determined the number of 450K CpGs contained in our final dynamic
region set (n=153,454) and assessed the CpG-wise maximum difference observed across
the 450K dataset. To determine to what extent the dynamics observed in the WGBS
dataset are recapitulated based on the array data, we computed the fraction of overlap-
ping 450K CpGs that exhibited a methylation level difference larger than a particular
threshold and plotted the results in (Fig. 4.5b).
We obtained the coordinates of tDMRs from the publications supplementary website
(Irizarry et al., 2009) and performed liftover to hg19 using the UCSC liftover tool prior
to overlapping these regions with our dynamic region set.
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4.2.14 Sensitivity and specificity calculation
We carried out sensitivity and specificity analysis as a function of coverage by directly
downsampling the bam files for our highest coverage sample (hippocampus) to 2, 5, 10,
15, 20, 30 and 40x total coverage. Subsequently, we processed the resulting files with
our standard pipeline and applied our canonical dynamic CpG identification approach
by comparing the downsampled data sets to HUES64 samples. We defined true positives
(TP) as those differentially methylated CpGs found at a given coverage threshold that
were also detected at the maximum coverage level. False positive were defined similarly.
The true positive rate or sensitivity was then defined as TPR = TP/(TP + FN) and
the false-positive rate FPR as FPR = FP/(FP + TN). The results of this analysis are
shown in (Fig. 4.3c-e).
4.2.15 FDR estimation
We estimated the false positive rate and false discovery rate based on our two deeply
sequenced hippocampus replicates. First, we created ten pseudo replicates subsampling
sets of reads from both samples giving rise to new pseudo samples. In order to reflect the
coverage diversity in our dataset, we created pseudo samples at distinct total sequencing
depths ranging from 10-40x. Next, we ran our standard dynamic CpG identification pro-
cedure on this hippocampus sample set of 12 and determined the number of differentially
methylated CpGs at distinct minimal difference thresholds. Finally, we extrapolate the
number dynamic CpGs discovered in the replicate set to the number of samples used in
the main dataset (24), giving rise to (Fig. 4.3a).
4.2.16 Estimation of saturation curve
To get an estimate of the rate of newly discovered dynamic CpGs as a function of number
of samples, we randomly select sample subsets from our developmental cohort at different
cell type coverage levels (5, 10, 15, 20, 24). For coverage levels 5 and 10 we create 10
distinct sample subset, for 15 cell types five subsets and for 20 cell types two distinct
subsets. Subsequently we run our standard dynamic CpG identification procedure on
each of the defined subsets and average the number of dynamic CpGs found for each
cell type coverage level. Based on these data points we compute a cubic spline fit and
plot the result in (Fig. 4.16).
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4.2.17 SNP and GWAS analysis
To determine overrepresentation of single nucleotide polymorphisms in the dynamic re-
gion set, we determined the number of CEPH HapMap SNPs (Abecasis et al., 2010)
(Utah residents with ancestry from northern and western Eruope, CEU) overlapping
with the dynamic regions set. First, we tested overrepresentation of SNPs with respect
to genomic background. To that we determined the fraction of genomic space spanned
by the dynamic regions assuming 89% of the human genome to be uniquely mappable
(Lee and Schatz, 2012) and excluding X and Y chromosomes. Next, we used this fraction
(19.2% of mappable genome) to determine the expected number of SNPs overlapping
with the dynamic regions as s = n× p with n being the number of all autosomal SNPs
and p = 0.192. We assessed significance of enrichment using a one-way binomial test us-
ing the R function pbinom in the standard stats package. In addition, we computed size
and GC content matched randomly drawn control regions from the human genome, also
taking the chromosomal distribution of dynamic regions into account. Fisher’s exact test
was then used to assess the hypothesis that the SNP counts in the dynamic region and
control region classes were independent. In addition, we also generated 100 randomly
drawn size-matched sets of control regions and determined the number of overlapping
SNPs and the empirical distribution function of the background SNP overlap. All of the
control sets contained fewer SNPs than the DMR set giving rise to an empirical p-value
(p < 0.01) and median odds ratio of 1.48.
The genome wide association analysis (GWAS) was conducted using 5,726 SNPs origi-
nally published in the GWAS catalog (Hindorff et al., 2009) and annotated by Maurano
et al.
(Maurano et al., 2012) (original release September 2010 and 71 additional liver-related
SNPs from several newer GWAS studies (Chambers et al., 2011, Kawaguchi et al., 2012,
Patin et al., 2012)). We grouped SNPs into 17 categories following the classification
suggested by Maurano et al.
(Maurano et al., 2012). We first tested whether SNPs are overrepresented within dy-
namic regions compared to HapMap SNPs using a binomial test b(x;n, p). To that end
we set the expectation p to the fraction of autosomal HapMap SNPs present within our
full dynamic region set, n equal to the number of autosomal GWAS SNPs and x to
GWAS SNPs present in dynamic regions. The enrichment statistic is then reported as
the fraction of observed vs. expected GWAS SNPs.
Chapter 4 Charting a dynamic DNA methylation landscape of the human genome 42
For the cell type-specific GWAS enrichment calculation we again focused on cell type-
specific hypomethylated regions within our primary cell type/tissue cohort. Similar to
the TFBS enrichment calculation, we employed a non-parametric approach based on
100 sets of randomly sampled, size-matched and mappability-filtered control region sets
(each comprising mostly millions of regions). We then report the median ratio of GWAS
SNPs in the cell type-specific dynamic regions over control regions for each disease class.
Associated p-values were computed based on the resulting empirical null distribution for
each cell type and each disease class. Our selection of 100 random draws represents a
compromise between stringency and computational tractability.
4.3 Results
4.3.1 Identification and characteristics of differentially methylated re-
gions (DMRs) in the human genome
In this study, we systematically investigated the DNA methylation state of most human
autosomal CpGs to determine those that show dynamic changes and hence may partic-
ipate in genome regulation in a developmental context (dynamic CpGs). In total, we
included 42 whole-genome bisulphite sequencing (WGBS) data sets, comprising a range
of human cell and tissue types (n = 30). The combined 40.4 billion reads enabled us to
assay 25.71 million autosomal CpGs (≥ 5× coverage in at least ≥ 50% of all samples;
96% of all hg19 autosomal CpGs). We organized the samples into four classes: hu-
man embryonic stem (ES) cells, human ES-cell-derived cell populations, normal somatic
tissues, and disease conditions (Fig. 4.2a and the electronic table CH4 DataSet Table
located in the electronic archive accompanying this work within the folder correspond-
ing to Chapter). On a global scale, human ES cells and their derivatives exhibit the
highest DNA methylation levels, followed by primary tissues (≈ 5% less), which is in
sharp contrast to the global hypomethylation observed in colon cancer (≈ 10−15% less)
and long-term cultured cell lines (10-30% less).
Focusing initially on our developmental sample set (n = 24 total, ES cells, in-vitro-
derived cell types and somatic tissues) we identified ≈ 5.6 million dynamic CpGs (min-
imum methylation difference ≥ 0.3, false discovery rate (FDR) = 10.4%, 21.8% of cap-
tured autosomal CpGs; Fig. 4.2b,c and see Section 4.2.12) distributed across 716,087
discrete DMRs (19.2% of the mappable human genome). In addition to this moderately
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Figure 4.2: a. Principal component (PC) analysis based on CpG methylation levels
for 1-kb tiles across 30 diverse human cell and tissue samples. Coloring indicates clas-
sification of samples into subgroups and group-wise mean DNA methylation. Detailed
sample annotations are listed in the electronic table CH4 DataSet Table located in the
electronic archive accompanying this work within the folder corresponding to Chapter.
Grey area indicates Alzheimer’s disease (AD) samples. b. Density scatterplot of CpG-
wise DNA methylation level differences (x axis, P ≤ 0.01) and CpG median methylation
(y axis) across the 24 developmental samples (excluding cancer and long-term culture).
Coloring indicates CpG density from low (blue) to high (red). The red box highlights
dynamic CpGs (≥ 0.3). c. Pie chart showing the fraction of static and dynamic CpGs.
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stringent cut-off, we also tested thresholds as low as 10% methylation difference that
may account for DNA methylation changes arising from relevant small subpopulations
in heterogeneous tissue samples or noise, but still only find 10.4 million CpGs to be
dynamic (Fig. 4.3a). To confirm the validity of our approach, we evaluated the sensi-
tivity and false positive rate as a function of coverage and methylation difference (Fig.
4.3b-e). Focusing on the more stringent set (≥ 0.3 difference), we find approximately
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Figure 4.3: a. Number of detected dynamic CpGs across our developmental sam-
ples (n=24) as a function of minimum CpG cluster methylation difference (x-axis black
line). b. Distribution of false positive rate as a function of minimum CpG cluster
methylation difference (x-axis) for 7 individual samples with 2 replicates each. c. Sen-
sitivity analysis of dynamic CpGs recovered as a function of coverage. Analysis is based
on downsampling of a high coverage hippocampus sample. Differentially methylated
CpGs were determined with respect to HUES64. d. False positive rate of dynamic
CpGs as a function of coverage. Analysis is based on downsampling of a high coverage
hippocampus sample. Differentially methylated CpGs were determined with respect
to HUES64 (right). e. Fraction of genomic CpGs recovered that are differentially
methylated between hippocampus and HUES64 as a function of coverage. Analysis for
different minimum methylation differences between CpG clusters are shown as colored
lines.
70% are on average highly methylated (> 75% methylation ratio), whereas less than 2%
are on average unmethylated (< 10% methylation ratio); (Fig. 4.4a). In line with this
observation, we find that hypomethylation of DMRs shows greater sample specificity
than hypermethylation (Fig. 4.4b).
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Figure 4.4: a. Fraction of median methylation levels across all samples grouped into
unmethylated, intermediate and highly methylated for dynamic and static CpGs. b.
Cumulative distribution of DMR specificity. High hypo/hypermethylation specificity
indicates that a particular region is methylated/unmethylated in most tissues and de-
viates from this default state in only one or a few cases.
Interestingly, most of the DMRs are small (> 75% are smaller than 1 kb; Fig. 4.5a) and
located distal to transcription start sites (Fig. 4.5b).
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Figure 4.5: a. Size range distribution for all DMRs. b. Distance distribution of
DMRs to the closest ENSEMBL TSS truncated at 100 kb.
However, the average variation in DNA methylation levels across all RefSeq promoters
(n = 30,090) does still exhibit a clear increase specifically at the transcription start sites,
with most of this variation occurring at intermediate and low CpG density promoters
(Fig. 4.6). For CpG islands in general, we observe distinct dynamic regimes, high-
lighting that different classes of CpG islands are probably subject to different modes
of regulation (Cohen et al., 2011, Lienert et al., 2011, Meissner et al., 2008)(Fig. 4.6,
bottom). Consistent with previous reports (Irizarry et al., 2009), we find CpG island
shores (regions within 2 kb of an island) to be among the most variable genomic regions
(Fig. 4.6, bottom).
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Figure 4.6: Top, composite plot of mean DNA methylation differences across various
genomic features. Black lines indicate the median of the average DNA methylation dif-
ference across each feature. Grey areas mark twenty-fifth and seventy-fifth percentiles.
Bottom, distribution of mean DNA methylation difference for each genomic feature.
Black bars indicate twenty-fifth and seventy-fifth percentiles; white dots mark the me-
dian. For CGI islands, a smaller, experimentally determined set (eCGI; n=525,490)
is also shown. Promoters are broken down into high CpG content (HCP; n=524,899),
intermediate CpG content (ICP; n=510,920) and low CpG content (LCP; n=57,946) re-
gions (n=543,765 total). Shore denotes regions within 2 kb of an island; eShore denotes
experimentally determined shore. pEnhancer, putative enhancer.
These observations are exemplified at the OCT4 locus (also known as POU5F1), in which
the promoter and large parts of the gene body exhibit high DNA methylation dynamics,
whereas the strong downstream CpG island as well as the surrounding CTCF-binding
sites remain static (Fig. 4.7a). Only 12.2% of our DMR set overlap with at least one of
568,430 annotated classic, gene-centric genomic features (promoter, exon, CpG island
(CGI) , CGI-shore) (Fig. 4.7b). To gain insights into the role of the remaining set, we
first investigated their co-localization with DNase I hypersensitive sites across 92 distinct
cell type (Thurman et al., 2012) as well as a catalogue of putative enhancer elements for
31 cell and tissue types (Zhu et al., 2013). Notably, we found that 42.3% of our DMRs
overlap with at least one DNase I hypersensitive site (Fig. 4.7b), and 26.1% co-localize
with enhancer-like regions, which cover more than 50% of all H3K27ac regions in our
catalogue (n = 285,344) and represent one of the most differentially methylated features
(Fig. 4.6).
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Figure 4.7: a. Methylation level variation across the OCT4 locus (chr6: 31,119,000-
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4.3.2 Dynamic CpG methylation regions frequently co-localize with
transcription factor binding sites (TFBS)
Next, we examined DMR overlap with transcription-factor-binding site (TFBS) clusters
compiled from 165 transcription factors profiled by the ENCODE project (Gerstein
et al., 2012) and uncovered a highly significant overlap of the two feature classes (odds
ratio 1.14, p ≤ 0.01 empirical test). Interestingly, we find that more than 50% of all
DMRs overlap with at least one and 25% with more than three TFBSs, accounting for an
additional 13.0% of DMRs (Fig. 4.8a). Consistent with this, we find markedly increased
variation in DNA methylation levels specifically across TFBSs (Fig. 4.8b).
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Figure 4.8: a. Overlap of DMRs with ENCODE TFBSs. b. Average of the maximal
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In summary, we were able to attribute 64.2% of all DMRs to at least one putative gene
regulatory element or coding sequence, suggesting that they demarcate various classes
of putative regulatory elements.
We determined all cell-type-specific hypomethylated regions (n = 396,995; see Section
4.2.4) and investigated the enrichment for 161 ENCODE factors (excluding MBD4,
SETDB1, POL2P and HDAC2 from the previous set). Notably, we observe significant
enrichment of cell-type-specific transcription factors that are known to be involved in
the regulation of the respective cellular states (Fig. 4.9). For instance, the top three
factors bound in HUES64-specific DMRs are OCT4, SOX2 and NANOG (Fig. 4.9).
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regions.
Similarly, PU.1 and TAL1 are highly enriched in CD34 cells and hepatocyte nuclear
factors in adult liver (Fig. 4.9). In further support of this, motif enrichment analysis
revealed many more interesting cell-type-specific transcription factor associations, such
as enrichment of distinct NKX factors in fetal heart and brain, and ESRRG in fetal
adrenal cells (Fig. 4.10).
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Figure 4.10: Normalized motif enrichment z-scores for the top three enriched motifs
for DMRs specific to each of the selected somatic samples indicated on the left. For
enrichment levels of full motif library was used (n=843).
Moreover, we tested whether the DMR set can be used to gain insights into the combina-
torial control of cellular states by transcription factors. To that end, we determined all
unmethylated (< 10% methylation) PAX5 motif instances (±100 base pairs (bp)) across
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the human genome in CD34 or fetal brain cells (Fig. 4.11a). Although both footprint
sets show a large overlap (11,031 sites), regions exclusively unmethylated in CD34 or
fetal brain are enriched for distinct sets of other known lineage-specific transcription
factor motifs; such as PU.1 in CD34 and LMX1A or EN1 in fetal brain (Fig. 4.11a).
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Figure 4.11: a. Overlap of PAX5 motifs (±100 bp top) unmethylated in CD34
cells or fetal brain across the entire human genome. Regions specifically unmethylated
in CD34 or fetal brain were subjected to motif analysis, and top differentially co-
occurring motifs are highlighted on the left for CD34 and on the right for fetal brain. b.
Density scatterplot of maximum DNA methylation difference across 24 developmental
samples for TFBS cluster track (n = 2.7 million) and median methylation level across
all samples. Colour code indicates density of TFBSs from low (blue) to high (red).
Taken together, these findings highlight that cell-type-specific DNA methylation pat-
terns can be used to detect footprints and infer potentially regulatory transcription
factors. In fact, more than 60% of all ENCODE TFBSs are hypermethylated in most
samples, but become hypomethylated very specifically in only one or two cell types (Fig.
4.11b), whereas 25% are constitutively unmethylated and never change (Fig. 4.11b).
Breaking down this distribution of TFBSs reveals distinct patterns of variation for dif-
ferent types of transcription factor (Fig. 4.12a). More generally, we find that DNA
methylation variation across TFBSs is strongly correlated with its median methylation
level and therefore the (hypo-)methylation specificity (Fig. 4.12b), as well as the tissue
specificity of transcription factor expression patterns (Ravasi et al., 2010) (Fig. 4.12c).
These observations support the notion (Stadler et al., 2011) that selective transcription
factor binding creates spatially highly constrained hypomethylated regions and confers
cell type-specificity.
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Figure 4.12: a. Median variation (y-axis left) and median methylation level (y-axis
right) across all TFBS for 165 transcription factors profiled by ENCODE. Factors (x-
axis) were ordered by increasing maximum median methylation level variation. Curves
were determined by cubic-spline fit to the median variation and methylation levels.
b. Cubic-spline fitted transcription factor expression specificity (see main text) as a
function of TFBS methylation variation rank. c. Frequency distribution of maximum
difference in DNA methylation levels for three selected TFs.
4.3.3 DMRs exhibit elevated SNP frequency and show non-random
GWAS SNP enrichment
On the basis of these findings and previous reports (Maurano et al., 2012), we asked
whether DMRs are more susceptible to point mutations that are functionally conse-
quential. Even with strict filtering criteria, we found a significant enrichment of single
nucleotide polymorphisms (SNPs) in DMRs compared to genomic background as well
as different sets of random control regions (odds ratio 1.06, P < 10−16, binomial test).
We then determined the overlap of DMRs with recently evolved human-specific CpGs,
termed CpG beacons (Bell et al., 2012), which shows a marked enrichment (odds ratio
1.37-1.6 compared to genomic background and random control regions, P < 10−16).
This suggests overall higher genetic intra-species variability specifically at regions that
change their DNA methylation state. In accordance with the increased SNP frequency,
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DMRs are also significantly enriched for genome-wide association study (GWAS) SNPs
from the GWAS catalog (Hindorff et al., 2009) (odds ratio 1.16, P = 3.27× 10−10, bino-
mial test). Similar to our observations on TFBSs, GWAS SNPs exhibit a non-random
enrichment distribution across cell-type-specific DMRs (Fig. 4.13). For instance, we find
DMRs specific to adult liver to be enriched for liver and serum metabolite-related GWAS
SNPs, fetal heart DMRs enriched for cardiovascular disease SNPs and many of our blood
cell type DMRs enriched for autoimmune disease and haematological parameter related
SNPs.
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Figure 4.13: Odds ratio of significantly overrepresented (p < 0.05, empirical test,
see Section 4.2.17) GWAS SNPs grouped into 16 categories in regions specifically hy-
pomethylated within the sample indicated on the left. * p < 0.1
4.3.4 Effective classification and sample deconvolution using only the
DMR set
It is well known that many cancers exhibit considerable DNA methylation changes
(Ehrlich, 2009), we therefore compared a colon cancer to a matched control and found
532,665 differentially methylated CpGs. Forty % of these overlapped with the previ-
ously identified developmental dynamic set (Fig. 4.14a). Similarly, 36% of differentially
methylated CpGs found in Alzheimer’s disease samples compared to normal controls (n
= 12,408) overlapped with our previous set of developmental CpGs. The most notable
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change in the number of dynamic CpGs occurs when comparing our developmental sam-
ple cohort to the long-term cell culture cohort, leading to the identification of 8.4 million
additional dynamic CpGs (Fig. 4.14b). Importantly, this expanded set differs notably
in terms of their sequence features, with cancer and Alzheimer’s disease dynamic CpGs
residing in less conserved regions that also exhibit lower motif complexity compared to
the developmental and cell culture (Fig. 4.15a, b). The cell-culture-specific CpGs ex-
hibit increased repeat content relative to developmental CpGs, a feature that is shared
with Alzheimer’s disease (Fig. 4.14c). Although the disease samples clearly add more
dynamic CpGs, our analysis suggests a notable overlap with our previous set for CpGs
that may participate in actual regulatory events.
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Figure 4.14: a. Overlap of dynamic CpGs (P≤ 0.01; |methylation| ≥ 0.3 in normal
samples and between colon cancer and matching control CpG numbers (in millions).
b. Distribution of autosomal CpGs across three conditions. Class name indicates
sample group in which a CpG was observed dynamic (developmental (n = 24), cell
culture (n = 3), cancer (n = 2)) or remained unchanged over the entire sample set
(n = 30). c. Repeat content distribution of DMRs (sets as in b). AD, Alzheimer’s
disease. d. Hierarchical clustering using Pearson correlation coefficient (PCC) of the
DMR values across the entire sample set (n = 30). e. Distance of the fetal brain sample
to different sets of signature regions defined for sample classes or individual samples,
but excluding regions identified by means of the fetal brain sample. f. Contribution of
individual sample signature region sets to an in-silico-generated hybrid sample (HUES64
and hippocampus).
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Figure 4.15: a. Distribution of average region conservation scores for dynamic CpG
sets defined based on the developmental CpG, the cell culture cohort, cancer and the AD
cohort. b. Distribution of motif complexity per base for dynamic CpG sets discovered
based on the developmental CpG, the cell culture cohort, cancer and the AD cohort.
Motif complexity is defined as sum over all motif occurrences within a region set. Each
motif occurrence is thereby weighted by its complexity.
Finally, we investigated the utility and power of the reduced region set to accurately
classify unknown samples or help to deconvolute a mixture of samples. We first clustered
our developmental sample set based on the DMRs only (Fig. 4.14d) and found the
result to be in excellent agreement with genome-wide 1-kb tiling-based clustering. To
probe the potential of our DMR set to classify unknown samples accurately, we derived
signature region sets for different sample groups. These signature regions turned out to
be excellent classifiers of an unseen sample (Fig. 4.14e, fetal brain). Next, we tested as
a proof of principle whether it is possible to use our DMR set to infer the different cell
populations present within a heterogeneous sample. To that end, we deconvoluted an in
silico mixture of HUES64 and hippocampus WGBS libraries using our DNA methylation
signatures. Notably, the two top hits after application of a very simple deconvolution
algorithm indeed proved to be hippocampus and HUES64 (Fig. 4.14f).
4.4 Discussion
Our study highlights and defines a relatively small subset of all genomic CpGs that
change their DNA methylation state across a large number of representative cell types.
Although we expect that number to increase with more diverse cell types as more WGBS
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data sets becoming available, our analysis suggests that the rate of newly discovered reg-
ulatory CpGs will drop rapidly once all major cell and tissue types have been mapped,
mostly owed to the fact that between tissue variability exceeds within tissue variability
by one order of magnitude (Fig. 4.16a, b). Future studies are likely to fine-map dy-
namics occurring in more specific subpopulations, giving rise to smaller changes in DNA
methylation that we were unable to detect or include because of power constraints. Ex-
treme conditions in vitro or in vivo such as loss or misregulation of DNMT1 may affect
a larger subset including many intergenic CpGs that are generally static, but most of
these additional CpGs are unlikely to overlap with functional elements such as TFBSs
or enhancers. In combination with the fact that sequencing of WGBS libraries is very
inefficient, as about 65% of all 101-bp reads in our set did not even contain any CpGs
to begin with, were PCR duplicates or didn’t pass the quality control, this amounts to
an approximate combined loss of around 80% of sequencing depth on non-informative
reads and static regions. Furthermore, once defined, it will probably be sufficient in
most cases to profile only a representative subset of CpGs across a comprehensive set
of DMRs using an array-based (Dedeurwaerder et al., 2011) or hybrid-capture-based
(Gnirke et al., 2009) technology to recover representative dynamics and measure reg-
ulatory events. Using these results as a guiding principle, we expect further improved
efficiencies in mapping DNA methylation and enhance its applicability as a marker for
various regulatory dynamics in normal and disease phenotypes.
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Figure 4.16: a. Number of differentially methylated CpGs (p ≤ 0.01) between hip-
pocampus and substantia nigra (black, within tissue variance) as well as betweenhip-
pocampus and liver (green, between tissue variance) for different thresholds of minimal
methylation difference. b. Estimated saturation curve for thediscovery of dynamic
CpGs as a function of sample number. Estimates for different minimal methylation
thresholds (δmin) at a significance level of p ≤ 0.01 are shown. See Section 4.2.5 for
details.
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However, DNA methylation changes are frequently accompanied by changes in overall
chromatin and transcriptional landscapes. In order to understand the relationship be-
tween distinct epigenetic remodeling events as well as their impact on transcription it
is essential to investigate the coordinated dynamics along these distinct dimensions in
the same cell populations. In addition, it is important to not only examine distantly
related cell types that reside in steady states but also closely related cell populations
representing transient cellular states, a situation frequently encountered in development.
Chapter 5
Transcriptional and epigenetic
dynamics during specification of
human embryonic stem cells
5.1 Introduction
The content of this chapter has previously been published in Gifford & Ziller et al. 2013
(Gifford et al., 2013). This project was a joint research effort with equal contributions
by Casey A. Gifford (leading wet lab scientist) and Michael J. Ziller (leading computa-
tional scientist). While most wet lab experiments including cell culture, FACS and next-
generation sequencing library production (ChIP-Seq and RNA-Seq) were carried out by
C.A. Gifford, computational analysis and design of analysis strategy was contributed by
M.J. Ziller. Differential splicing analysis was contributed by C. Trapnell. M.J. Ziller
and C.A. Gifford interpreted the data and wrote the paper together.
In order to gain a deeper understanding of the interplay between transcription, epigenetic
remodeling and transcription factor binding, we implemented an in vitro differentiation
system employing human ES cells. To overcome limitations of previous studies that
either utilized distantly related cell types (Bernstein et al., 2012, Lister et al., 2009) or
highly heterogeneous differentiation conditions (Laurent et al., 2010, Lister et al., 2011),
we employed directed differentiation for five days into three distinct populations using
defined culture conditions combined with FACS sorting. In contrast to earlier studies,
this approach enabled us to investigate epigenetic and transcriptional dynamics that
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might only arise transiently in the differentiation process, since the examined popula-
tions represent transient cellular states at time of collection.
Coordinated changes to the epigenome are essential for lineage specification and mainte-
nance of cellular identity. DNAme and certain histone modifications critically contribute
to epigenetic maintenance of chromatin structures and gene expression programs (Smith
and Meissner, 2013, Zhou et al., 2011). Genetic deletion of histone methyltransferases
and the catalytically active DNA methyltransferases are embryonic or postnatally lethal
(Li, 2002) providing evidence for their essential role in proper execution of develop-
mental programs. Several groups have reported genome-wide maps of chromatin and
DNAme in pluripotent and differentiated cell types. From these efforts, a global picture
of the architecture and regulatory dynamics is beginning to emerge. For example, active
promoters generally contain modifications such as H3K4me3 and H3K27ac, while active
enhancers are generally enriched for H3K4me1 and H3K27ac (Creyghton et al., 2010,
Ernst and Kellis, 2010, Heintzman et al., 2009, Rada-Iglesias et al., 2011). Repressed
loci exhibit enrichment for H3K27me3, H3K9me2/3, DNAme, or a combination of the
latter two modifications. The enrichment of repressive histone modifications, such as
H3K27me3, which is initiated at CpG islands (CGI), is considered a facultative state
of repression, while DNAme is generally considered a more stable form of epigenetic
silencing (Smith and Meissner, 2013).
Recent studies have reported dynamics that suggest epigenetic priming such as the ap-
pearance of euchromatic histone modifications prior to gene activation during in vitro
T-cell differentiation (Zhang et al., 2012) and cardiac differentiation (Wamstad et al.,
2012). These results are reminiscent of changes that occur during the early stages of
reprogramming towards the induced pluripotent state (Koche et al., 2011) and highlight
possible similarities between differentiation and de-differentiation. In parallel to these
advances, whole-genome bisulfite sequencing (WGBS) has been used to map DNAme
genome-wide. Examination of WGBS data from murine ES cells (mESCs) and neural
progenitor cells highlighted lowly methylated regions (LMRs) at distal sites that fre-
quently overlap with DNAse I hypersensitive sites (HS) and/or displayed an enhancer
signature defined by H3K4me1 and p300 enrichment (Stadler et al., 2011).
Studying the role of epigenetic modifications in the dynamic rewiring of human transcrip-
tional programs in vivo is complicated by numerous technical and ethical limitations.
However, models for in vitro differentiation of hES cells offer a unique opportunity to
explore and characterize critical events that prepare, guide and possibly regulate cell
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fate decisions. Populations representing each embryonic germ layer have been produced
from human embryonic stem cells (hESCs) (Chen et al., 2012, Kriks et al., 2011, Wei
et al., 2012).
To dissect the early transcriptional and epigenetic events during hESC specification,
we used two-dimensional, directed differentiation of hESCs to produce representative
populations from the three germ layers, namely ectoderm, mesoderm, and endoderm
(Evseenko et al., 2010, Hay et al., 2008, Lee et al., 2010) followed by fluorescence-
activated cell sorting (FACS) to enrich for the desired differentiated populations. These
three cell types, in addition to undifferentiated hESCs (HUES64), were then subjected to
ChIP-Seq for four histone marks (H3K4me1, H3K4me3, H3K27me3, H3K27ac), WGBS
and RNA-Sequencing (RNA-Seq). To complement this data, we also performed ChIP-
Seq for three TFs (OCT4, SOX2, NANOG) in the undifferentiated hESCs, as well as
ChIP-BS-Seq for FOXA2 in the endoderm population. The combined data sets provide a
wealth of information, including holistic views of transcriptional and epigenetic dynamics
that help further dissect the molecular events during human germ layer specification.
5.2 Experimental methods
Human ES cell line HUES64 for differentiated for five days into cell populations from the
three proper germ layers by inhibiting TGFbeta, WNT and BMP signaling for ectoderm,
addition of ACTIVIN A, BMP4, VEGF and FGF2 for mesoderm and ACTIVIN A
and WNT3A for endoderm. Cells were isolated by FACS using germ layer specific
surface markers. RNA-Seq, ChIP-Seq and WGBS was then carried out on the purified
populations as described in detail in (Gifford et al., 2013) and Appendix A.1.3
5.3 Computational methods
5.3.1 RNA-Seq data analysis
To identify a gene or transcript as differentially expressed (DE), Cuffdiff 2 tests the ob-
served log-fold change in its expression against the null hypothesis of no change (i.e. the
true log-fold change is zero). Because of measurement error, technical variability, and
cross-replicate biological variability might result in an observed log-fold-change that is
nonzero, Cuffdiff assesses significance using a model of variability in the log-fold-change
under the null hypothesis. This model is described in detail by Trapnell et al. (Trapnell
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et al., 2013). Briefly, Cuffdiff 2 constructs, for each condition, a table that predicts how
much variance there is in the number of reads originating from a gene or transcript. The
table is keyed by the average reads across replicates, so to look up the variance for a
transcript using the table, Cuffdiff estimates the reads originating from that transcript,
and then queries the table to retrieve the variance for that number of reads. Cuffdiff 2
then accounts for read mapping and assignment uncertainty by simulating probabilistic
assignment of the reads mapping to a locus to the splice isoforms for that locus. At
the end of the estimation procedure, Cuffdiff 2 obtains an estimate of the number of
reads that originated from each gene and transcript, along with variances in those esti-
mates. The read counts are reported along with fragments per kilobase per million rads
sequenced (FPKM) values and their variances. Change in expression is reported as the
log fold change in FPKM, and the FPKM variances allow the program to estimate the
variance in the log-fold-change itself. Naturally, a gene that has highly variable expres-
sion will have a highly variable log-fold-change between two conditions.
The modifications made to Cuffdiff 2 improve sensitivity in calling DE genes and tran-
scripts while maintaining a low false positive rate. They stem from the method used to
calculate the variability in the log fold change in expression. In Trapnell et al. , Cuffdiff
2 used the delta method to estimate the variance of the log fold change estimate for a
gene or transcript. This method yields a simple equation that takes as input the mean
and variance of the transcript’s expression in two conditions and produces a variance
for the log fold change. However, the equation contains no explicit accounting for the
number of replicates used to produce those estimates - they are assumed to be perfectly
accurate.
The improved version of Cuffdiff 2 more accurately estimates the variance in the log-
fold-change using simulated draws from the model of variance in expression for each of
the two conditions. Imagine an experiment that has n replicates in condition A and
m replicates in condition B. To estimate the distribution of the log-fold change in ex-
pression for a gene G under the null hypothesis, Cuffdiff first draws n times from the
distribution of expression of G according to the algorithm’s model of expression. Cuffdiff
then takes the average of the n draws to obtain an expression ”measurement”. Cuffdiff
then takes the log ratio of these averages, places this value in a list, and then repeats
the procedure until there are thousands of such log-fold-change samples in the list. The
software then makes a similar list, this time using the expression model for condition B
- the null hypothesis assumes both sets of replicates originate from the same condition,
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but we do not know whether A or B is the better representative of that condition, so we
must draw samples from both and combine them. To calculate a p-value of observing
the real log-fold-change under this null model, we simply sort all the samples and count
how many of them are more extreme than the log fold change we actually saw in the
real data. This number divided by the total number of draws is our estimate for the
p-value.
Cuffdiff 2 reports not only genes and transcripts that are significantly differentially ex-
pressed between conditions, but also groups of transcripts (i.e. the isoforms of a gene)
that show significant changes in expression relative to one another. The test for this is
similar to what is described in Trapnell et al. , but comparably modified along the lines
described above for single genes or transcripts. Draws of expression are made for each
transcript in a group according to the number of replicates in the experiment. These are
averaged, and the shift in relative transcript abundance for the draw is made using the
Jensen-Shannon metric. These draws are added to a list and used to calculate p-values
for significance of observed shifts in relative abundance under the null hypothesis.
Clustering of gene expression profiles was achieved with the csDendro() function from
CummeRbund (http://compbio.mit.edu/cummeRbund/). This function first transforms
the FPKMs of all genes in each sample by adding one and then takes the logarithm.
Next, it converts each genes transformed expression into a fraction of the total trans-
formed expression. The distances between these transformed expression profiles are
then measured by the Jensen-Shannon metric. The distances are then used to build a
dendrogram via complete linkage hierarchical clustering using the R function hclust().
5.3.2 WGBS data analysis
To ensure comparability of region DNAme levels across all samples, only CpGs cov-
ered by ≥ 5x in 85% of the samples qualified for the computation of region DNAme
levels. To assess the DNAme state of various genomic regions, we resorted to our pre-
viously published protocol estimating a genomic region’s methylation state as the cov-
erage weighted average across all CpGs within each region. Subsequently, we averaged
a region’s DNAme level over replicates. DMRs were defined as exhibiting significantly
(p ≤ 0.05, Fisher’s exact test) different DNAme levels of at least 0.1.
Many gene regulatory elements (GREs) are marked by spatially highly constrained re-
duced DNAme levels. It has recently been suggested that besides CpG islands, which
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are mostly unmethylated (UMR) a second class of GRE is marked by low to interme-
diate DNAme (IMR) (Stadler et al., 2011). We reasoned that these regions might be
of particular regulatory importance in our system and might be missed by looking at
histone modification enrichments alone. Therefore we adopted a similar Hidden Markov
model approach as proposed in Stadler et al. to identify regions of reduced DNAme
level. Briefly, we utilized a three-state Hidden Markov Model operating on the methy-
lation levels of each CpG in the human genome. Each state’s emission probabilities for
the DNAme levels were modeled by a normal distribution. The model was trained on
all CpGs of chromosome 19 in the HUES64 dataset using an adaption of the well-known
Baum-Welch algorithm to incorporate the normal distribution (Press, 2007). After ini-
tial parameter estimation, we utilized the approach reported by Stadler et al. (Stadler
et al., 2011) to determine the FDR for IMR regions and adapted the initial parameter
estimates for the IMR and HMR states to finally 0.01(UMR), 28.8 (IMR), 81.6 (highly
methylated, HMR), yielding an FDR of 2%. This parameter set was subsequently used
to segment all WGBS datasets. Finally, we used the Viterbi algorithm to compute the
most probable path through each chromosome separately and assigned the CpG states
accordingly to either unmethylated, intermediate or highly methylated. Subsequently,
we merged neighboring CpGs residing in the same state and being less than 200 bp apart
into unmethylated, intermediateor highly methylated regions. Only regions harboring
more than three CpGs were retained for subsequent analysis. The resulting region set is
more likely to pick up DMRs due to the highly spatially constrained nature of the marked
GRE (often 200-400 bp) which easily gets masked by a coarse grained tiling based ap-
proach. The HMM inference framework was implemented as custom software in Python
(http://python.org/) and extended to incorporate other state distribution types. To
determine DMRs between two samples, we followed our previously established protocol
(Bock et al., 2011).
5.3.3 ChIP-Seq data analysis
In order to identify regions enriched for chromatin modifications we employed a two step
approach, first identifying all regions enriched for any chromatin modification. Next, us-
ing this comparatively small region set, we determined the quantitative enrichment level
as well as significance of enrichment using a Poisson background model based on the
WCE see Section 3.3.2. Finally, we utilize conservative enrichment and significance
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cutoffs to binarize our enrichment signal in order to increase robustness and simplify
subsequent analysis. First, we segmented the genome into non-overlapping windows
and classified each window into either enriched or no enriched. This analysis was con-
ducted separately for two groups, 1. H3K27ac, H3K4me3 using 200 bp windows and
H3K27me3, K3K4me1 using 400 bp windows according to Section 3.3.2 retaining only
windows significant at p ≤ 0.05 and enrichment above background greater than three.
Next, enriched windows within a distance of 850 bp were merged into larger regions.
Regions smaller than 400 bp (600 bp for broad marks) after merging were discarded
as due to noise and regions greater than 10 kb were split. This procedure was carried
out for three groups of histfour cell types. The resulting three lists of enriched regions
were then merged in a hierarchical fashion: first regions identified based on H3K4me3
& H3K27ac and H3K4me1, retaining all H3K4me3 & H3K27ac regions but merging or
splitting enriched H3K4me1 regions.
After completion of this initial processing step, regions were again filtered for minimal
size discarding regions smaller than 400 bp. Next, the same procedure was repeated
for the new H3K4me3, H3K27ac, H3K4me1 region set and the H3K27me3, H3K9me3
region list. Finally, the resulting list was merged with the regions classified as UMRs
and IMRs, adding only regions not overlapping with any region identified so far. This
procedure gave rise to the region catalog used in subsequent analysis.
In the second processing step, comparative analysis of ChIP-Seq experiments and assign-
ment of chromatin states was carried out. First, for each region in the region catalog the
significance and enrichment over WCE was determined using Poisson statistics (Section
3.3.2) applied to the duplicate filtered and insert size extended sequencing tag counts
overlapping each identified region. Regions with tag counts deviating at a significance
level of p < 0.001 from the WCE and exhibiting enrichment of WCE ≥ 3 were classified
as enriched. We chose these moderately stringent thresholds in order also pick up chro-
matin state changes that occur only in a subset of the investigated cell population and
therefore have lower signal. However, this comes at the expense of a higher false-positive
rate. Next, we compared the enrichment levels for all four cell types (hESC, dEC, dME,
dEN) for each epitope separately again using the method outlined in Sction 3.3.2. We
defined regions deviating by more than three-fold at a significance level of p ≤ 0.05 as
being different. Next, we reconciled these differential enrichment calls with our enrich-
ment over background classification. Since in our setting we were mostly concerned with
incorrectly called differences between cell states (false positives) due to heterogeneity in
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the distinct populations and varying ChIP-Seq library complexity, we redefined regions
that were classified as enriched in hESC and not enriched in one of the differentiated
cell types but exhibiting no significant difference according to our differential analysis as
being enriched in the differentiated cell type under study. This approach yields a lower
false positive rate in terms of dynamics at the expense of a higher false negative rate.
However, at this point it still remains to be determined what magnitudes of differences
in chromatin modifications are actually meaningful. In this sense, our binary classifica-
tion approach is rather conservative and relies on previously established observations.
Subsequently, we classified each genomic region identified in this way into one of eleven
epigenetic states based on the binary classification of enrichment levels for the vari-
ous modifications. DNA methylation levels were not taken into account when histone
modification based states were assigned. Only states devoid of significant enrichment
for one of the histone modifications were classified based on DNA methylation levels.
Genomic regions were associated with their nearest RefSeq gene using the R package
ChIPpeakAnno (Zhu et al., 2010) and classified into promoter, intragenic, distal (≤ 50
kb from TSS and not promoter) and intergenic.
5.3.4 TF ChIP-Seq Analysis
For OCT4, SOX2, NANOG and FOXA2 aligned read files were processed with macs
version 1.4 (Zhang et al., 2008) using the following parameters: -g 2.7e9 –tsize=36 –
pvalue=1e-5 –keep-dup=1 and the HUES64 WCE as input control. All other parameters
were left at their default setting. For our 25 bp libraries, tsize was set to 25. FDR was
calculated using macs built-in function essentially comparing the original read count
distribution with a randomly shuﬄed distribution. Following this initial peak calling,
only peaks significant at an FDR of 0.05 and present in both replicates were retained. As
a second replicate for our OCT4 ChIP-Seq experiment we took advantage of publically
available OCT4 data (Kunarso et al., 2010).
5.3.5 ChIP Bisulfite Sequencing Analysis
For the FOXA2 ChIP-bisulfite sequencing experiment, the bisulfite treated ChIP library
was processed similarly to the WGBS processing described above and subsequently over-
laid with the peak calling results from the FOXA2-ChIP-Seq library that was not bisulfite
treated.
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5.3.6 Motif Analysis
Predefined sets of genomic regions were scanned for occurrences of motifs contained in
the Transfac professional database (2009) using the FIMO program from the MEME
suite (Grant et al., 2011). Only motifs with at least one known associated human
TF and detected at a significance level of p ≤ 10−5 were used for further analysis.
Next, the total number of occurrences was calculated for each motif. To correct for
sequence composition, we trained a Hidden Markov Model on each set of input sequence
sets and generated ten sets of number and size matched region sets using the inferred
probabilities as controls. Subsequently, these sequence sets were also subjected to the
same motif identification procedure and motif enrichment results were averaged over the
10 control runs. We defined the final motif enrichment score as the fraction of total motif
occurrences in the region set of interest and the total number of motif occurrences in the
averaged control region set. To determine differentially enriched motifs between region
sets from different hESC-derived cell types, we calculated the fraction of motif scores
between the two conditions, retaining only motifs with a differential enrichment ≥ 1.2.
For the H3K27ac motif analysis, we computed overall motif enrichment scores for each
region class separately as described above. Next, we correlated the motif enrichment
scores only focusing on those motifs with scores ≥ 1.2. To that end we multiplied the
motif enrichment score for the cell type of interest with the log2 fold change of the
associated TF in that cell type, giving rise to a new combined motif score. If multiple
TFs mapped to one motif, we took the average motif score. For each cell type we rank-
ordered the motifs according to their enrichment scores and report the top 20 motifs
with their raw motif score.
For the H3K4me1 analysis, we wanted to focus on all potential TFBS gaining H3K4me1
and not only those that also become expressed as in the H3K27ac analysis. First, we
again determined the motif enrichment scores over background. To focus on motifs
differentially enriched between the different cell types, we subtracted the mean motif
enrichment across hESd cell types for each motif separately from the enrichment level
and rank-ordered the motifs. For each cell type, we then report the top 20 enriched
motifs.
For the analysis of potential upstream regulators of TFs that exhibit changes in their
promoter region, we first scanned all distal and proximal regions associated with these
TF genes for motif occurrences. Next, we determined whether any of the observed motifs
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were associated with TFs differentially expressed in any of the cell types and correlated
the sign of the differential expression in each cell type with the sign of the epigenetic
state change of the region the motif occurred in (gain of open chromatin mark: +1,
loss of open chromatin mark or acquisition of a repressive state: -1). Next, we rank-
ordered all observed TF motifs that were differentially expressed in at least one of the
cell types based on their occurrence/epigenetic state change correlation for each cell type
separately and reported the gene expression levels of top 30 motifs for each cell type.
5.4 Results
5.4.1 High resolution transcriptional measurements during directed
differentiation of hESCs
To better understand the molecular dynamics involved in hESC differentiation, we pro-
duced populations representative of each embryonic germ layer, namely ectoderm (Lee
et al., 2010), mesoderm (Evseenko et al., 2010) and endoderm (Hay et al., 2008) (see Ap-
pendix A.1.3). We chose the male hESC line HUES64, an NIH-approved line that readily
differentiates into each of the three germ layers. These hESCs can be differentiated into
a neuroectoderm-like progenitor population positive for SOX2 and PAX6 by inhibition
of TGFb, WNT and BMP signaling (Fig, 5.1a, top). Alternatively, canonical mesoderm
markers, such as GATA2 (Fig. 5.1 middle), can be induced using ACTIVIN A, BMP4,
VEGF and FGF2 treatment. Lastly, differentiation towards a definitive endoderm-like
fate, positive for markers such as SOX17 and FOXA2 (Fig. 5.1, bottom), is induced
using ACTIVIN A and WNT3A.
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Figure 5.1: Left: Low (43) and high (403) magnification overlaid immunofluores-
cent images of the undifferentiated hESC line HUES64 stained with OCT4 (POU5F1)
and NANOG antibodies. Right: Established directed (two-dimensional) differentiation
conditions were used to generate representative populations of the three embryonic
germ layers: hESC-derived ectoderm, hESC-derived mesoderm, and hESC-derived en-
doderm. Cells were fixed and stained after 5 days of differentiation with the indicated
antibodies. Representative overlaid images at low (103) and high (403) magnification
are shown. DNA was stained with Hoechst 33342 in all images. Scale bars, 200 mm
(43), 100 mm (103), and 30 mm (403).
We began by measuring the expression of 541 selected genes, including many devel-
opmental TFs and lineage markers (Bock et al., 2011), at 24-hour intervals during
differentiation towards each respective germ layer. We found that 268 of these genes
exhibit expression changes (z-score log2 expression) during the first five days of differ-
entiation (Fig. 5.2). Mesendodermal genes, such as EOMES, T, FOXA2 and GSC, are
upregulated at 24 hours of mesoderm and endoderm induction, but not ectoderm dif-
ferentiation (Fig. 5.2,5.3a). GSC expression decreases within 48 hours of differentiation
in the mesoderm-like population, while the expression level is maintained in the endo-
derm population (Fig. 5.2, 5.3a). EOMES and FOXA2 expression is also maintained in
the endoderm population accompanied by upregulation of GATA6, SOX17 and HHEX
((Fig. 5.2). After transient upregulation of mesendodermal markers, activation of meso-
dermal markers such as GATA2, HAND2, SOX9 and TAL1 is detected specifically in
the mesoderm conditions (Fig. 5.2, 5.3a). None of these markers are detected during
early ectoderm differentiation, which instead upregulates neural markers, such as PAX6,
SOX10 and EN1 (Fig. 5.2, 5.3a).
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Figure 5.2: NanoString nCounter expression data (z-score log2 expression value of
two biological replicates) for a time course of in vitro differentiation using the conditions
shown in (Fig. 5.1) 541 genes were profiled, and 268 changing by more than 0.5 are
displayed. Selected lineage-specific genes are shown on the left for each category that
was identified based on hierarchical clustering. The average log2 expression value of
two biological replicates is displayed. Error bars represent 1 SD.
We found that POU5F1 (OCT4), NANOG and to some extent SOX2 expression is
maintained in our endoderm population (Fig. 5.2,5.3a). This is consistent with prior
studies indicating that OCT4 and NANOG expression is detected during the course
of early endoderm differentiation and supports NANOG’s suggested role in endoderm
specification (Teo et al., 2011). SOX2 expression is downregulated in mesoderm and to
a lesser degree in endoderm, but maintained at high levels in the ectoderm population
(log2 expression 10.9) (Fig. 5.3b), while ZFP42 (REX1) is similarly downregulated in
all three lineages (Fig. 5.2).
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Figure 5.3: a. The average log2 expression values of two biological replicates of
lineage-specific genes highlighted in a. are shown. Error bars represent 1 SD. If no
error is evident, SD < 0.5 log2 expression units. b. The average log2 expression values
of two biological replicates of pluripotent genes highlighted in a. are shown. Error bars
represent 1 SD. If no error is evident, SD< 0.5 log2 expression units. c. NanoString
nCounter profiling of FACS-isolated ectoderm (dEC), mesoderm (dME), and endoderm
(dEN). Expression levels for MYOD1 (right) are included as a negative control. The
average log2 expression value of two biological replicates is shown. Error bars represent
1 SD. If no error is evident, SD < 0.5 log2 expression units.
We confirmed that these populations indeed represent a precursor stage for each respec-
tive lineage by inducing them to differentiate further, which resulted in upregulation of
genes such as OLIG2 and SST in the ectoderm (Chambers et al., 2012), TRPV6 in the
mesoderm (Evseenko et al., 2010), and AFP and HGF in the later endoderm popula-
tions (Fig. 5.4a) (DeLaForest et al., 2011). Lastly, multidimensional scaling confirmed
that at 24 hours the mesoderm population is very similar to the endoderm, while the
ectoderm population has already moved in an alternative direction (Fig. 5.4b). These
high temporal resolution gene expression signatures suggest that expression programs
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associated with the three unique cell populations, representing early stages of each germ
layer are established within a similar timeframe of hESC differentiation.
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Figure 5.4: a. Median Nanostring expression values (log2) of populations derived
from dEC, dME and dEN. b. Multidimensional scaling of populations included in
differentiation time course.
5.4.2 Global transcriptional dynamics between hESCs and hESC-derived
cell types
Based on these results, we selected day five as the optimal time point to capture early
regulatory events in well-differentiated populations representing all three germ layers. To
reduce heterogeneity, we used FACS to enrich populations based on previously reported
surface markers (see Appendix (A.1.4)); populations isolated by FACS are referred to
as dEC for the ectoderm, dME for the mesoderm and dEN for the endoderm. Ex-
pression analysis of the sorted populations confirms further enrichment for the desired
populations (Fig. 5.3b). We next expanded on our selected gene signature profiles by
performing strand specific RNA-Seq on poly-A fractions from each day 5 differentiated
FACS-isolated populations and undifferentiated HUES64. Hierarchical clustering based
on the global expression profiles of each cell type reveals that the dME population is
the most distantly related cell type and that dEN and dEC are more similar to each
other than to dME or hESCs (Fig. 5.5a). This was unexpected given that the dME
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and dEN populations are putatively derived through a common mesendoderm precur-
sor stage (Fig. 5.2 5.3a) while the dEC does not upregulate markers associated with
this stage (EOMES, T, GSC;). Overall, 14,196 RefSeq defined coding and non-coding
transcripts (38% of defined transcripts) are expressed (FPKM > 1) in at least one of
the populations, with 11,579 (81.6% of the total number of transcripts detected within
our cell types) being expressed in all three populations. Examining the overlap of genes
expressed (FPKM > 1) in each population reveals that the dME population exhibits
expression of the largest number of unique genes (n=448, (Fig. 5.5b)), such as RUNX1
(FPKM: 3.4) and HAND2 (FPKM: 17.8). Examining genes unique to pairs of the differ-
entiated cell types also reveals that dEC and dME have the least in common (n=37, Fig.
5.5b), while the dEC and dEN have the most number of transcripts in common (n=171,
Fig. 5.5b) consistent with our clustering analysis. Genes such as PAX6 (dEC FPKM:
25.9, dEN FPKM: 5.6) and NKX6.1 (dEC FPKM: 2.3, dEN FPKM: 3.3), which are
each required for both brain (Ericson et al., 1997) and pancreas development (Sander
et al., 1997), are expressed in both the dEC and dEN. Canonical markers of embryonic
development, such as FOXA2 (FPKM: 12.7) in the dEN and EN1 (FPKM: 5.8) in the
dEC are restricted to their expected germ layers at our early stages.
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Figure 5.5: a. Hierarchical clustering of global gene expression profiles as measured by
strand-specific RNA-seq for biological replicates of HUES64 and dEC, dME, and dEN
is shown as a dendrogram. Pairwise distances between the replicates were measured
using the Jensen-Shannon distance metric. b. Venn diagram illustrating unique and
overlapping genes with expression (FPKM > 1) in HUES64 and the FACS-isolated
directed differentiation conditions are shown. c. Differential splicing of DNMT3B
in response to directed differentiation. Relative expression of isoforms 1 (NM006892,
green) and 3 (NM175849, purple) as measured by RNA-seq are shown on the right.
Notably, we also identified 1,296 splicing events (FDR=5%) as well as alternative pro-
moter usage within our populations (Trapnell et al., 2013). For example, we detected
expression of multiple isoforms of DNMT3B (p = 5×10−5). Expression of DNMT3B iso-
form 1 (NM006892) was restricted to the undifferentiated hESCs (FPKM: 214.3), while
the differentiated cell types predominantly express an alternative isoform, DNMT3B
isoform 3 (NM175849) (dEC FPKM: 33.9, dME FPKM: 14.2, dEN FPKM: 20.0) (Fig.
5.5c). The presence of this isoform, as well as others, has previously been reported in
more advanced stages of embryonic development as well as normal adult (Robertson
et al., 1999) and cancerous tissues (Ostler et al., 2007). Our results suggest that this
switch coincides with the exit from the pluripotent state, regardless of the specified lin-
eage. We also identified expression of three PITX2 isoforms, with differential splicing
leading to different isoform expression between the dEN and dME. In the Chick PITX2
is essential for heart looping and each isoform is responsible for executing distinct func-
tions (Yu et al., 2001). Taken together, this suggests that both transcript levels and
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isoform expression contribute to cellular identity.
5.4.3 Generation of Comprehensive Reference Epigenome Maps
To gain a more complete picture of the underlying molecular mechanisms and investigate
the regulatory events during the specification of the three germ layers, we collected ap-
proximately 12 million cells of the respective dEC, dME and dEN populations as well as
HUES64. All samples were subjected to ChIP-Seq (H3K4me1, H3K4me3, H3K27me3,
H3K27ac, H3K36me3, and H3K9me3) and WGBS (Fig. 5.6a), producing a total of 32
data sets with over 12 billion aligned reads (data are publicly available through the NIH
Roadmap Epigenomics Project data repositories: http://www.roadmapepigenomics.org/,
Gifford and Ziller et al. (Gifford et al., 2013), GSE46130 and in the electronic table ac-
companying this work in Table CH5 DataSet Table in the subfolder corresponding to
this chapter).
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Figure 5.6: WGBS (% methylation), ChIP-seq (read count normalized to 10 mil-
lion reads), and RNA-seq (FPKM, read count normalized) for the undifferentiated
hESC line HUES64 at three loci: NANOG (chr12:7,935,038-7,957,818) and GSC
(chr14:95,230,449-95,250,241). CGI are indicated.
5.4.4 Integrative analysis of epigenetic state transitions
We focused our analysis on previously identified informative chromatin states associ-
ated with various types of regulatory elements (Ernst et al., 2011, Rada-Iglesias et al.,
2011), including the following specific combinations: H3K4me3+H3K27me3 (bivalen-
t/poised promoter); H3K4me3+H3K27ac (active promoter); H3K4me3 (initiating pro-
moter); H3K27me3+H3K4me1 (poised developmental enhancer); H3K4me1 (poised en-
hancer), H3K27ac+H3K4me1 (active enhancer); H3K27me3 (Polycomb-repressed). In
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addition, we segmented the WGBS data into three DNAme states: highly methylated
regions (HMRs: > 60%), intermediately methylated regions (IMRs: 11-60%) and un-
methylated regions (UMRs: 0-10%). The latter differs from the highly methylated back-
ground of the genome and likely indicates functional importance as previously suggested
(Stadler et al., 2011). We next assigned each genomic region to one of the resulting states
(see Section 5.3.3) and determined all regions that change their assigned epigenetic state
from hESC to at least one of the 3 hESC derived poplations (n = 157, 443, Fig. 5.6a).
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Figure 5.7: a. Epigenetic state map of regions enriched for one of four histone
modifications in at least one cell type or classified as UMR/IMR in at least one cell
type and changing its epigenetic state upon differentiation in at least one cell type
(n = 157,433). b. Regions bound by OCT4, SOX2, and NANOG, as determined by
ChIP-seq and organized using the chromatin states in b.
The majority of epigenetically dynamic regions are not located near promoters (6.8%
+2 kb to -500 bp of the TSS- Promoters; 48.8% > 50 kb upstream of TSS- Intergenic;
15.1% > 500 bp downstream of TSS- Intragenic/Gene body). Correlating epigenetic
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changes with transcriptional dynamics, we find that overall the majority (62-67%) of all
epigenetic remodeling events are not directly linked to transcriptional changes based on
the expression of the nearest gene.
The loss of H3K4 methylation (me1 and me3) is commonly associated with a transition
to high DNAme (Fig. 5.7a), which is most prominent in the dEN population and
preferentially eliminated from genes involved in neural development (i.e. neural tube
development q = 9.6× 10−12). We identified 4,639 proximal bivalent domains in hESCs
and observe that 3,951 (85.1%) of these domains resolve their bivalent state in at least
one hESC-derived cell type (Fig. 5.6a and 5.8a). When we specifically investigated
the promoters of TF-encoding genes, we found that 463 of these promoters are in a
bivalent state in hESCs, and 400 of them change in at least one differentiated cell type
(Fig. 5.8b). The majority transitions to H3K4me3-only or H3K27me3-only in a lineage-
specific manner. In dME, H3K4me3 is gained at the ISL1 locus while H3K27me3 is
lost, leading to expression (FPKM: 14.3). The lineage specific dynamics in this region
are interesting given that this gene has known roles in all three germ layers, although
at later time points (Ahlgren et al., 1997, Cai et al., 2003, Pfaff et al., 1996). Notably,
in contrast to the limited overall association between many epigenomic dynamics and
changes in expression, we found that a large proportion of these bivalent TFs (275)
change their expression level during the differentiation (Fig. 5.8b).
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Figure 5.8: a. Venn diagram showing the overlap of identified proximal bivalent
domains. b. Left: Chromatin state map for all TFs that are bivalent in hESCs and
change their epigenetic state in at least one cell type (n=400). Right: Hierarchical
clustering ordered heatmap of TF expression (log2FC relative to hESCs).
5.4.5 Pluripotent TF binding is linked to chromatin dynamics during
differentiation
To further explore potential regulators of chromatin dynamics during the exit from
pluripotency, we performed ChIP-Seq for OCT4, NANOG and SOX2 in HUES64 (Fig.
5.9a,b). We found that regions bound by all three factors (n=1,556), by SOX2-only
(n=923) or by NANOG-only (n=14,531) are frequently associated with inter- and in-
tragenic regions (Fig. 5.9c-e, top). In contrast, regions bound by OCT4-only (n=8,599)
are more frequently associated with promoter regions (Fig. 5.9c). Examination of re-
gions bound by OCT4, NANOG and SOX2 in hESCs showed H3K4me1 regions enriched
for OCT4 binding sites frequently become HMRs in all three differentiated cell types
whereas NANOG and SOX2 sites are more prone to change to an HMR state in dME
(Fig. 5.9f). In general, many regions associated with open chromatin that are bound by
NANOG are more likely to retain this state in dEN compared to dME and dEC (Fig.
5.9f). We also found that regions enriched for H3K27ac in hESCs that maintain this
state in dEN or dEC are likely to be bound by SOX2 and NANOG. This is in agreement
with the reported role of SOX2 during ectoderm development and differentiation (Wang
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et al., 2012), but also supports our observation that SOX2 expression is maintained in
the dEN. Motif enrichment analysis detected the GATA3 motif in regions bound by
OCT4 and SOX2 that transition to an active state in dEC. Furthermore, we found
that regions bound by OCT4, NANOG and SOX2 that gain an active mark in dEC
are enriched for the motifs PAX9, p63 and STATs. Examining epigenetic dynamics at
sites of OCT4, NANOG and SOX2 binding further supports the observation that some
pluripotency associated TFs are also involved in the downstream specification.
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Figure 5.9: a. Venn diagram of the overlap between OCT4, NANOG and SOX2
binding sites identified in hESCs (total overlap = 1,556) b. Fold enrichment of OCT4,
NANOG and SOX2 binding at the NANOG locus in hESCs, and each differentiated
population on day 5 of differentiation. c. Genomic features of OCT4 binding sites
(top) and the associated epigenetic states (bottom) (n=8,599). d. Genomic features of
NANOG binding sites (top) and the associated epigenetic states (bottom) (n=21,186).
e. Genomic features of SOX2 binding sites (top) and the associated epigenetic states
(bottom) (n=4,902). f. Enrichment of OCT4, SOX2 and NANOG within various
classes of dynamic genomic regions changing upon differentiation of hESC, computed
relative to all regions exhibiting the particular epigenetic state change in other cell
types. Epigenetic dynamics are categorized into three major classes: repression (loss
of H3K4me3 or H3K4me1 and acquisition of H3K27me3 or DNAme), maintenance of
open chromatin marks (H3K4me3, H3K4me1, H3K27ac) and activation of previously
repressed states.
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5.4.6 Gain of DNAme occurs at open chromatin enriched for TF motifs
We next utilized the WGBS data that cover approximately 26 Million CpGs (at ≥ 5
coverage) across all four cell types. Hierarchical clustering analysis of the WGBS data,
which included human adult liver and hippocampus for comparison, revealed that the
pluripotent hESCs and the hESC-derived cell types form a separate cluster arm with
respect to the somatic tissues (Fig. 5.10a). We determined DMRs defined as exhibiting
a significant (p ≤ 0.05) minimal difference of CpG methylation level of 0.1 among our
four cell types. The majority of all DMRs occur at CpG-poor intergenic regions in line
with previous reports (Fig. 5.10b bottom) (Stadler et al., 2011). The dEN exhibits more
than twice the number of regions that gain DNAme compared to dEC and dME (Fig.
5.10b, top).
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Figure 5.10: a. Hierarchical clustering of hESCs, hESC-derived populations (dEC,
dME and dEN), human adult hippocampus and human adult liver based on mean
DNAme levels of 1kb tiles across the human genome using Pearson Correlation Co-
efficient (PCC). Y-axis indicates sample distance in terms of 1 minus PCC. Red box
indicates cell types interrogated in this study. b. Regions that significantly (p ≤ 0.05)
increase their DNAme levels by at least 0.1 between hESCs and the differentiated cell
types. The color code indicates the DNAme state found in hESCs. Bottom: Genomic
features associated with DMRs gaining DNAme in each of the differentiated cell types
based on RefSeq gene annotation and de novo discovered promoters by RNA-Seq.
Interestingly, only 65 of the total number of DMRs identified are shared between all
three populations. However, reaffirming that our populations are depleted of pluripo-
tent cells, this group of DMRs includes the regulatory region of OCT4. In line with
the small number of shared regions, more than 60% of regions that gain DNAme are
lineage specific (Fig. 5.11a) and include loci such as SMAD3 (dEC), CTNNA3 (dME)
and FOXA2 (dEN). FOXA2 has an upstream CGI that exhibits gain of DNAme (Fig.
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5.11b), and transcription in dEN is initiated downstream of this DMR at an alternative
TSS, suggesting that TSS usage may be regulated, stabilized or reflected by DNAme
(Maunakea et al., 2010).
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Figure 5.11: a. The overlap of these differentially methylated regions (DMRs) that
increase their DNAme level in the three hESC-derived populations. b. DNAme levels
and RNA-Seq expression values of FOXA2 (chr20:22,559,343-22,571,189) in hESCs and
differentiated cell types. The heat map below shows the DNAme values of individual
CpGs within the highlighted region. The average DNAme value for the entire high-
lighted region is shown on the right in red. CpG islands (CGI) are shown as green bars.
Expression values (FPKM) are displayed on the right. The arrows indicate two known
TSSs.
We find significant enrichment of various TF motifs as DNAme targets upon differenti-
ation, which has some analogy to the gain of methylation observed at myeloid targets
in the lymphoid lineage in vivo (Bock, 2012, Deaton and Bird, 2011, Ji et al., 2010).
To extend this observation, we examined the DNAme state at regions bound by SOX2,
OCT4 and NANOG in hESCs. For example, two regions 20 kb downstream of DBX1,
a gene associated with early neural specification, are bound by all three TFs and gain
DNAme in dME and dEN. In contrast, this region maintains low levels of DNAme in
dEC, which has activated transcription of DBX1 (Fig. 5.12a). We generally find that
co-bound sites gain DNAme in the dME and dEN, but not dEC. Further supporting the
functional relevance of these dynamics, we find that regions with gain DNAme frequently
coincide with DNAse I hypersensitive sites (Fig. 5.12b) (Thurman et al., 2012).
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Figure 5.12: a. DNAme levels and OCT4, SOX2 and NANOG ChIP-Seq at the
DBX1 locus (chr11:20,169,548-20,277,940). b. Frequency distribution of overlapping
DMRs gaining DNAme in the differentiated populations with DNAse I hypersensitive
sites across 48 cell ENCODE types (Thurman et al., 2012)
While transcriptional silencing was infrequently correlated with gain of DNAme at distal
elements (Fig. 5.13a, left), the promoters that gain DNAme in dEC and dME, are
associated with a decrease in expression as expected Fig. 5.13b, right). In examining
the chromatin state of regions that gain DNAme during differentiation, we find that
most regions exhibited enrichment of one or more histone modifications in hESCs (Fig.
5.13b). These results confirm that in particular distal regulatory elements show highly
dynamic regulation of DNAme during specification.
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Figure 5.13: a. Distal elements (left) and Promoters (right) that gain DNAme sep-
arated by the changes in FPKM at associated genes. b. Chromatin state in hESCs
at regions that gain DNAme during differentiation. Regions devoid of any detected
chromatin marks are categorized according to their DNAme state in hESCs
5.4.7 Loss of DNAme is biased towards dEC
Loss of DNAme is asymmetric between the three populations (Fig. 5.14a, top) and
occurs in a more lineage-specific fashion than gain (Fig. 5.14b). However, loss also
occurs mainly at intergenic regions (Fig. 5.14a, bottom). Notably, the dEC has the
most DMRs and many were associated with neuronal gene categories (for instance:
neural tube development, q = 3.13× 1013). This includes the ectodermal TF POU3F1,
which has a bivalent promoter in hESCs, resolves to a H3K4me3-only state and exhibits
transcriptional activation in dEC. Chromatin remodeling and activation at this locus
coincides with specific loss of DNAme at a putative regulatory element downstream of
the 3’UTR of this gene in dEC (Fig. 5.14c).
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Figure 5.14: a. Regions that significantly (p ≤ 0.05) decrease their DNAme levels by
at least 0.1 between hESCs and the differentiated cell types. The color code indicates
the DNAme state distribution in the differentiated cell types, revealing that most re-
gions reside in an IMR state after they lost DNAme (left). Genomic features (bottom)
associated with DMRs losing DNAme in each of the differentiated cell types based
on RefSeq gene annotation and de novo discovered promoters by RNA-Seq. b. Venn
diagram of identified DMRs that decrease their DNAme level between the three hESC-
derived populations. c. DNAme at the POU3F1 locus (chr1:38,493,152-38,532,618).
The heat map below shows the DNAme values of individual CpGs within the grey re-
gion. The average DNAme value for the entire highlighted region is shown on the right
in red. CGIs are shown as green bars. Expression values (FPKM) are displayed on the
right.
On a global scale, an immediate correspondence between loss of DNAme and expression,
such as that observed at POU3F1, occurs at about half the regions (Fig. 5.15a). More
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than 70% of DMRs that lose DNAme during differentiation are enriched for one of
our profiled histone modifications in particular H3K4me1 or H3K27ac (Fig. 5.15b).
Taken together, our hESC differentiation system reveals several interesting DNAme
dynamics, including the lineage specific silencing of regulatory regions in default or
alternative lineages. The asymmetric loss may also explain why our chromatin state
analysis revealed fewer regions that gained H3K4me3 in the dEC population.
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rated by the changes in FPKM at associated genes. b. Chromatin state in differentiated
cell types at regions that loose DNAme during differentiation.
5.4.8 Gain of H3K27ac reveals putative regulatory elements
In addition to methylation on H3K4, open chromatin is also demarcated by enrichment of
H3K27ac. It has also been suggested that the combination of H3K4me1 and H3K27ac
at distal regions identifies active enhancer elements, while H3K4me1 and H3K27me3
corresponds to poised enhancer elements (Rada-Iglesias et al., 2011). To extend these
observations, we focused specifically on regions that gain H3K27ac during differentia-
tion and found that more than half of the identified regions are HMRs in hESCs (Fig.
5.16a), while another large fraction is enriched for H3K4me1 in hESCs (Fig. 5.16a). The
majority of regions that gain H3K27ac are intergenic, as shown for the RUNX1 locus
(Fig. 5.16a,b).
We next placed each region into one of three distinct categories (repressed, poised,
open) based on their state in hESCs, and subsequently performed gene set enrichment
analysis using the GREAT toolbox (Fig. 5.17a) (McLean et al., 2010). This analysis
reveals enhancer dynamics in line with the lineage specific differentiation trajectory for
dEC and dME (Fig. 5.17a). In contrast, the dEN population shows an unexpected
enrichment for early neuronal genes (e.g. neural tube development, Fig. 5.17a). This
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Figure 5.16: a. Number of regions and associated epigenetic state distribution in
hESCs of regions that are transitioning to H3K27ac in the three populations. b. Nor-
malized ChIP-Seq tracks (H3K4me1, H3K27me3 and H3K27ac) for the RUNX1 region
(chr21:36,091,108-36,746,447) with corresponding RNA-Seq data in dME.
observation is consistent with the correlation that we reported between our dEC and
dEN RNA-Seq data, suggesting that similar networks are induced in the early stages of
both our ectoderm and endoderm specification (van Arensbergen et al., 2010).
Moreover, we find strong enrichment of downstream effector genes of the TGFb, VEGF
and BMP pathways in dME, directly reflecting the signaling cascades that were stim-
ulated to induce the respective differentiation. In dEN we find enrichment of genes
involved in WNT/b-CATENIN and retinoic acid (RA) signaling (Fig. 5.17a). While
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we did not use RA, this signaling cascade has previously been implicated in endoder-
mal tissue development including pharyngeal and pancreatic cell types (Ostrom et al.,
2008, Wendling et al., 2000). Concordantly, we also find high levels of SMAD3 motif
enrichment in the repressed dME and dEN, particularly in the poised putative enhancer
populations (Fig. 5.17b). Similarly, we observe enrichment of key lineage specific TF
motifs such as the ZIC family proteins in dEC, TBX5 in dME and SRF in dEN. Inter-
estingly, we also find the FOXA2 motif highly overrepresented in dEN where the factor
is active, and also dEC where the factor is inactive but becomes expressed at a later
stage of neural differentiation (Kriks et al., 2011), but not in dME (Fig. 5.17b).
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Figure 5.17: a. GO categories enriched in regions transitioning toH3K27ac in
the cell type indicated on the right compared to hESCs as determined by GREAT
analysis. Regions gaining H3K27ac were split up by state of origin in hESC into
repressed (None, IMR, HMR, HK27me3), poised (H3K4me1/H3K27me3) and open
(H3K4me3/H3K27me3, H3K4me3, H3K4me1). Color code indicates multiple testing
adjusted q-value of category enrichment. b. TF motifs enriched in regions changing
to H3K27ac in the cell type indicated on the right compared to hESCs. Color code in-
dicates motif enrichment score incorporating total enrichment over background as well
as differential expression of the corresponding TF in the respective cell type. Regions
were split up by state of origin in hESCs similar to panel a. For each region class, the
eight highest-ranking motifs are shown.
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5.4.9 Acquisition of H3K4me1 without transcriptional activation sug-
gests epigenetic priming
Many regions that exhibit high DNAme in hESCs and transition to H3K4me1 in one
lineage remain HMRs in the two alternative cell types (Fig. 5.18a). Similar to the regions
showing dynamic DNAme during differentiation, these regions are typically intergenic
and > 10 kb from the nearest TSS (Fig. 5.18b).
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Figure 5.18: a. Overlap of regions gaining H3K4me1 in the three differentiated
populations relative to hESCs. b. Genomic distribution of all regions gaining H3K4me1
compared to hESCs in at least one of the three differentiated populations.
GREAT analysis of these regions shows a strong enrichment for categories associated
with brain development such as cerebellum morphogenesis in dEC (q < 10−30) , TGbb
pathway targets (q < 10−10) in dME and suppression of EMT in dEN (q < 0.0001).
To understand if regions that gain H3K4me1 in our system are associated with somatic
identity, we took advantage of published microarray data for 24 human tissues and deter-
mined genes upregulated in these tissues with respect to hESCs (termed, Tissue Atlas,
see Extended Experimental Procedures). Reaffirming the relevance of our dynamics, we
found regions that gain H3K4me1 in dEC are associated with fetal brain and specific
cell types found within the adult brain (Fig. 5.19a) based on region association with its
nearest gene. The dME H3K4me1 pattern was associated with a range of interrogated
tissues, such as heart, spinal cord and stomach, which may be due to heterogeneity of the
tissues collected (Fig. 5.19c). The dEN associations were interesting given that, as with
the RNA-Seq and H3K27ac trends, H3K4me1 was again associated with brain-related
categories (Fig. 5.18c). Overall, less than half of the genes that gain H3K4me1 exhibit
immediate transcriptional changes (Fig. 5.19b).
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Figure 5.19: a. Tissue signature enrichment levels of genes assigned to regions specif-
ically gaining H3K4me1 in the differentiated populations indicated on the bottom. b.
Number and distribution of gene expression changes of genes assigned to regions gaining
H3K4me1 in the differentiated populations. Associated genes were classified as either
being up/down- regulated or unchanged relative to hESCs.
CYP2A6 and CYP2A7 (Fig. 5.20a) are representative examples that do not show a
corresponding change in expression, while LMO2 does (Fig. 5.20b). To investigate
these regions in more detail, we carried out motif enrichment analysis and found lineage
specific enrichment of TF motifs near regions that gain H3K4me1. While the FOXA2
motif is enriched in all three cell types, the DBX1 motif is associated with the gain of
H3K4me1 in dEC (Fig. 5.21a), which coincides with its transcriptional activation in
this cell type (FPKM: 5.36). Conversely, the GLI3, HIC1 and CTF1 motifs are strongly
enriched at regions that gain H3K4me1 in dEN (Fig. 5.21a). To further assess if this
DNAme to H3K4me1 switch acts as a priming event, we differentiated the HUES64
endoderm population for five additional days in the presence of BMP4 and FGF2, leading
to HNF4a positive hepatoblast-like (dHep) cells (data not shown). Interestingly, of the
motifs enriched in dEN that gain H3K4me1, HIC1, KLF4 and CTF1 (Fig. 5.21a),
several of these genes become expressed at the next stage of differentiation (Fig. 5.21b).
Lastly, 1,346 of these putatively primed regions are enriched for the active enhancer
mark H3K27ac in human liver (Fig. 5.21c).
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Figure 5.20: a. Normalized ChIP-Seq tracks (H3K4me1 and H3K36me3) for the
LMO2 locus (Chr.11:33,865,134-33,977,858). Read counts on y-axis are normalized
10 million reads for each cell type. CGIs are indicated in green. b. Normalized
ChIP-seq tracks (H3K4me1 and H3K36me3) for the CYP2A6/CYP2A7 region (Chr19:
41,347,260-41,395,599). Read counts on y-axis are normalized 10 million reads for each
cell type. CGIs are indicated in green.
5.4.10 Loss of DNAme and acquisition of H3K27me3 at putative reg-
ulatory elements
More surprisingly, we observe intergenic regions that switch from high DNAme to
H3K27me3 (n=3,985 in dEN) (Fig. 5.22a). This transition frequently occurred within
CpG poor, distal regions, which is distinct from the common CpG island-centric targets
of Polycomb Repressive Complex 2 and H3K27me3 (Fig. 5.22b). This switch is highly
lineage specific and DNAme is generally retained in the alternative two cell types (Fig.
5.22c). Motif enrichment analysis, combined with the evaluation of publicly available
TF binding site (TFBS) data from the ENCODE project, indicated that many regions
exhibiting this transition in dEN were near binding sites of the pioneering factor FOXA2.
This TF has putative roles in chromatin decompaction, but its distinct functions and
limitations remain somewhat unclear (Li et al., 2012). To investigate this association,
we performed ChIP-Seq for FOXA2 in the endoderm population. This analysis reveals
that FOXA2 binding sites frequently overlap with regions that transition from HMR to
H3K27me3 (Fig. 5.22d). We also confirmed that gain of H3K27me3 at dEN FOXA2
binding sites occurs predominantly in dEN, and not dEC or dME (Fig. 5.22e). A notable
example of this transition can be seen at the ALB locus, where H3K27me3 is gained at
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Figure 5.21: a. Normalized motif enrichment scores for the top 15 motifs enriched in
regions specifically transitioning to H3K4me1 in the differentiated cell type indicated
on the bottom. Motif highlighted in red corresponds to a TF that is upregulated at the
next stage (hepatoblast) of endoderm differentiation while motifs highlighted in green
are specifically upregulated in dEN but downregulated at the dHep stage. b. Gene
expression levels of genes assigned to regions gaining H3K4me1 specifically in dEN
compared to hESC and being upregulated in dEN but not hepatoblast (top). Gene
expression levels of genes being upregulated between dEN and dHep (but not between
hESC and dEN) and gaining H3K4me1 in dEN are shown on the bottom. c. Fraction
of regions changing to H3K4me1 in dEN and being enriched for H3K27ac in human
liver (n=1,346).
AFP and AFM, proximal to FOXA2 binding sites (Fig. 5.23a). This mark is not found
in primary liver tissue, suggesting it represents a transient state (Fig. 5.23a). Many
regions that exhibit this transition are required for later stages of development as with
AFP and AFM or HBB1 in the dME. Importantly, the majority of these regions do not
yet exhibit significant increases in expression (Fig. 5.23b).
A previous report found that FOXA1/FOXA2 could bind to regions exhibiting DNAme
(Serandour et al., 2011), which is not a characteristic shared by all TFs (Zaret and Car-
roll, 2011). Regions bound by these factors subsequently lost DNAme and gained eu-
chromatic histone modifications in our populations. We therefore compared DNAme at
FOXA2 binding sites in hESCs to dEN and found a slight reduction in specifically in the
dEN (Fig. 5.23c). To more directly assess this relationship, we interrogated the DNAme
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Figure 5.22: a. Distribution of genomic features associated with region gaining
H3K27me3 (n=22,643) upon differentiation to any of the three hESC derived cell types
compared to hESC. b. CpG content distribution of regions gaining H3K27me3 upon
differentiation. For reference, the CpG content distribution of CpG islands is shown. c.
Epigenetic state distribution in hESC, dEC and dME of regions that gain H3K27me3 in
the dEN population compared to hESC. d. Binding profile of FOXA2 in dEN (n=357),
OCT4 (n=32), SOX2 (n=12) and NANOG (n=124) in hESC across regions that gain
H3K27me3 in dEN upon differentiation. e. Composite plot of median normalized tag
counts (RPKM) of regions bound by FOXA2 in dEN and gaining H3K27me3 in dEN
compared to hESC (n=357).
state of regions isolated by FOXA2-ChIP-Bisulfite sequencing in dEN (Brinkman et al.,
2012). Interestingly, we saw a major depletion of DNAme at sites isolated by FOXA2-
ChIP (Fig. 5.23c). To determine if these regions exhibit transcriptional activation after
further differentiation we examined again our dHep RNA-Seq data and found that 50
genes, which were bound by FOXA2 and gained H3K27me3 in dEN, increased their
expression (Fig. 5.23d) We also find H3K27ac enrichment at 197 loci in the human liver
that had experienced the gain of H3K27me3 in dEN (Fig. 5.23e).
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Figure 5.23: a. Normalized H3K27me3 and H3K4me3 ChIP-seq tracks for hESCs,
dEN and human adult liver tissue at the ALB locus (chr4:74,257,882-74,377,753). Black
bars (bottom) indicate TF binding of OCT4, SOX2 or NANOG in hESCs. Read counts
on y-axis are normalized to 10 million reads. b. Classification of gene expression as-
sociated with regions gaining H3K27me3 in each germ layer into either up-regulated
(FDR< 0.05), down-regulated (FDR< 0.05), or unchanged. c. Distribution of methy-
lation levels of regions bound by FOXA2 and gaining H3K27me3 in dEN. DNAme in-
formation is depicted for hESC and dEN WGBS datasets and two biological replicates
of FOXA2 ChIP-Bisulfite experiments in dEN (n=357). d. Gene expression profile of
genes upregulated at the hepatoblast stage relative to dEN that are associated with re-
gions bound by FOXA2 and gaining H3K27me3 in dEN (n=50). e. Fraction of regions
gaining H3K27me3 in dEN and being enriched for H3K27ac in human liver (n=197).
5.5 Discussion
Using directed differentiation of hESCs to three distinct, FACS-enriched populations,
representing early stages of embryonic development, we provide an extensive set of new
data and many insights on the transcriptional and epigenetic dynamics that occur dur-
ing human in vitro lineage specification.
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Among other things we describe two very interesting, but distinct lineage specific dy-
namics from high DNAme to H3K4me1 or H3K27me3. These transitions occur at many
sites that do not significantly change gene expression during our early stages of dif-
ferentiation. Notably, we made similar observations for H3K4 methylation during the
early stages of reprogramming to an iPS state (Koche et al., 2011), suggesting that this
type of epigenetic priming event might be common. At this point, however, it is not
clear whether these events reflect a regulatory mechanism to facilitate timely activation
upon differentiation or indicate the absence of a critical co-factor necessary for com-
plete transcriptional activation. We also cannot rule out that a subset of the observed
priming events are due to heterogeneity in the cell population that are not detected by
our RNA-Seq. Our observation that high DNAme switches to H3K27me3 enrichment
in distal, CpG-poor regions is even more interesting. It remains to be tested whether
targeted loss of DNAme at these regions causes a default gain of H3K27me3 in the
absence of additional co-factors due to underlying sequence context (Mendenhall et al.,
2010) or represents a more active recruitment event and regulatory mechanism. It is also
possible that H3K27me3 gain at distal regions is due to genomic conformation changes
and reflects H3K27me3 spreading in three dimensions. It was recently reported that the
combination of H3K27me3 enrichment and a nearby nucleosome-depleted region creates
sites amenable to TF binding (Taberlay et al., 2011). Based on these results, one may
speculate that specific TFs, such as FOXA2, exert chromatin decompaction functions
resulting in loss of DNAme leading to gain of H3K27me3, which creates a platform for
subsequent binding of other TFs that cannot directly remodel a heterochromatic state,
but instead function in transcription machinery assembly and transcriptional activation.
In conclusion, our data provide new insights on transcriptional and epigenetic dynamics
during hESC specification and represent valuable reference maps for many applications,
including regenerative biology and the study of human developmental biology.
Chapter 6
Dissecting neural differentiation
regulatory networks through
epigenetic footprinting
6.1 Introduction
An extended and updated version of this chapter is part of Ziller & Edri et al. is cur-
rently in press at Nature. The paper and analysis strategy was conceived by M. J. Ziller
(MJZ). All analysis and computer code development was carried by MJZ as well as the
writing of the manuscript. R. Edri performed cell culture and FACS. ChIP-Seq library
generation was performed by A. Goren, RNA-Seq library generation was carried out by
C. Gifford and WGBS/RRBS library production was done by H. Gu. All data generated
in this study is publically available udner GEO accession number GSE62193.
Chapter 3 established DNAme as a general marker that is suitable to gain insights into
the regulatory logic of distinct cellular states. This observation was exploited in Chap-
ter 4 where it was shown that the combination of different epigenetic marks and gene
expression data can be used to dissect the differentiation process of human ES cells
into three distinct but related cell populations. The power of this high-resolution pro-
filing approach of related cell types in combination with a TF-centric analysis became
apparent when we identified a novel epigenetic state switch that is likely mediated by
the pioneering TF FOXA2. Furthermore we were able to identify numerous pathways
activated and shutdown in the distinct cell populations using histone modification and
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DNAme information, highlighting the utility of epigenetic information to dissect differ-
entiation processes.
However, even though our previous work and that of others (Ernst and Kellis, 2010,
Thurman et al., 2012) highlights the power of epigenetic information to provide insights
into the underlying transcriptional networks, we are still lacking a coherent conceptual
framework to interpret epigenetic data from regulatory network perspective. This should
permit the extraction of TFs likely to drive specific epigenetic dynamics during cell state
transitions and therefore be suitable to infer key regulators of these transitions. Further-
more, it is unclear what epigenetic marks are most informative for this purpose. Are
certain histone modifications and DNAme complementary or redundant with respect
to the information they provide with respect to the identification of key regulators? In
Chapter 5 we showed that H3K4me1 seems to be associated with transcriptional priming,
suggesting that at regions gaining H3K4me1 at a certain differentiation stage are likely
to be enriched for TFBS of factors that gain expression at a later time point where the
region switches from primed to active, e.g. through acquisition of H3K27ac. Here, we
address these questions and investigate transcriptional and epigenetic dynamics across
a differentiation time series along the neural lineage.
Human pluripotent stem cell-derived models that accurately recapitulate neural devel-
opment in vitro and allow for the generation of specific neuronal subtypes are a major
focus in the stem cell and biomedical research communities. Two of the key challenges
are identifying the proper conditions to derive functional cell types as well as an in-depth
molecular characterization of the regulatory events that establish and maintain the de-
sired cellular states. Here, we report the transcriptional and epigenomic analysis of six
consecutive stages of hESC differentiation along the neural lineage aimed at modeling
key cell fate decisions including specification, expansion and patterning during the on-
togeny of neural stem and progenitor cells. In order to dissect the regulatory mechanisms
that orchestrate the stage-specific differentiation process we developed a computational
framework to infer key regulators of each cell state transition based on the progressive
remodeling of the epigenetic landscape. To do so, we exploited the fact that epige-
netic dynamics help demarcate gene regulatory elements (Ernst et al., 2011, Gifford
et al., 2013, Xie et al., 2013). The coordinated epigenetic changes are likely the result
of differential TF activity and hence relevant to the respective differentiation process.
To identify key regulators, we introduce the novel concept of TF epigenetic remodel-
ing activity (TERA). This concept tries to explain epigenetic changes, e.g. H3K27ac or
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DNAme dynamics during differentiation, through the differential activity of TF motifs
present at footprints located within genomic regions that change their respective epige-
netic state. Since the epigenetic remodeling activity of these motifs is unknown, we infer
the most likely activity level combination at each time point for a large set of motifs and
their corresponding TFs (Fig. 6.1). This idea allows to identify key regulatory factors
likely to mediate distinct sets of epigenetic remodeling events at each cell state transition.
OTX2 PAX6
PAX6
hESC
NE
Figure 6.1: Illustration of the TERA principle. During the inference of TERA levels
for all factors, the most likely activity levels are determined by trying to predict the
epigenetic state at each time point from the TERA scores of all factors. The TERA
scores minimizing the prediction error are then assigned. In the depicted toy example
OTX2 is more likely to drive the epigenetic state in hESCs, whereas increased PAX6
activity can explain the change to NE better than increased OTX2 activity.
Our analysis suggests that a stably expressed core TF network comprising PAX6 and
OTX2 cooperates with stage-specific factors and signaling pathways to regulate com-
mitment and proper differentiation towards neuronal and glial cell types. Notably,
gene regulatory elements involved in this process appear to be frequently disrupted
by SNP’s associated with different neurological pathologies such as Alzheimer’s disease
or schizophrenia, providing insights into potential causes and mechanisms. Taking ad-
vantage of our distinct differentiation stages, we are also able to refine our previous
observation on epigenetic priming at TF binding sites that seems to be mediated by
combinations of core and stage-specific factors. Additionally, we observe widespread
DNAme changes from the pluripotent state to the neural lineage that are targeted to
TFBS and gene regulatory elements involved in the early, but also subsequent stages of
differentiation. This is in sharp contrast to stage-specific dynamics that occur in the
consecutive populations of neural differentiation. Taken together, we demonstrate the
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utility of our reference maps and outline a general framework, not limited to the context
of neural differentiation, to dissect regulatory circuits of differentiation.
6.2 Experimental methods
For a detailed description of the experimental methods see (Edri et al., 2014, Ziller et al.,
2014) and Appendix A.2. Briefly, human ES cell line H9 (H9; WA-09; Wicell) expressing
GFP under the HES5 promoter were directed towards neuroectodermal fate using dual
SMAD inhibition (Chambers and Tomlinson, 2009). Neural rosettes were harvested be-
ginning day 8-10 of differentiation. Rosettes were replated in on DMEM/F12 with N2
supplement as well as SHH, FGF8 and BDNF. In the following two weeks of differentia-
tion, these factors were gradually replaced by FGF2 and EGF. Neuroectoderm/Neural
progenitor cells (NPCs) were collected at day 12, 14, 35, 80 and 220 using FACS sorting
for HES5:GFP and subjected to RNA-Seq, ChIP-Seq for histone modifications and/or
WGBS/RRBS profiling.
6.3 Computational methods
6.3.1 Data processing
Data processing was conducted as described above for ChIP-Seq, RNA-Seq and WGBS
data. Ascl1 ChIP-Seq data for Ascl1 overexpression in NHDF and NHEK was taken
from GSE43916 and was processed in the same way. Subsequent to alignment, peaks
were called using MACS (Zhang et al., 2008) against the matching whole cell extract
(WCE), removing all duplicates and only retaining peaks significant below 10−5 and fold
enrichment ≥ 5.
6.3.2 Differential expression analysis
Differential expression analysis was carried out using Cuffidff 2 (Trapnell et al., 2013)
and only genes with an absolute minimum log2 difference above 1.5 and FDR ≤ 0.11
between any hESC, NE, RG or INP were retained for the NPC analysis. We chose
this moderately stringet cutoff based on two considerations: First, we wanted to elim-
inate expression changes that are confined to the majority of the HES5+ population,
eliminating spurious expression changes due to imperfect FACS isolation etc. Second,
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we determined the overlap of differentially expressed genes at different FDR levels with
known key marker genes expressed at each stage as determined by qPCR and immuno-
histochemistry (see (Edri et al., 2014) for this data). The chosen values represent a
compromise between these two considerations and give rise to the unusual FDR value.
Due to the absence of replicates, we required a minimum log2 difference above 2 and FDR
≤ 0.05 for differentially expressed genes across the terminally differentiated cells NEdN,
E-RGdN, L-RGdO and L-RGdA. These resulting sets of differentially expressed genes
were used in all subsequent analyses involving differentially expressed genes between two
conditions.
6.3.3 ChIP Seq data analysis and normalization
Basic ChIP-Seq data processing and analysis was conducted as described earlier Section
3.3.2). For differential enrichment analysis between the different samples, only regions
significant at a q-value ≤ 0.001 and minimum fold change greater than three were con-
sidered differentially enriched. For partial least square regression (PLS) (Boulesteix and
Strimmer, 2007), we calculated the reads per kilobase per million reads sequenced values
for each footprint region and applied quantile normalization to the log2(RPKM+1) trans-
formed enrichment scores for each epigenetic mark separately. Finally, we subtracted the
whole-cell extract log2(RPKM + 1) counts to normalize for distinct background enrich-
ment levels. Regions with negative enrichment scores were subsequently set to 0. The
resulting normalized gene expression and histone modification datasets were then used
as input for the analysis pipeline outline in Figure 6.2 and described below in detail.
NPC time course: ChIP-Seq, RNA-Seq, WGBS
GRE module identification
Core TF network
 identification
TERA pipeline
GRE module GSEA
Expression analysis
Motif-TF matching
Co-Binding analysis Priming analysis
Figure 6.2: Outline of flow and key analysis modules used to generate the content of
this chapter.
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6.3.4 Gene set enrichment analysis
Gene set enrichment analysis for genomic regions was carried out using the GREAT
toolbox (McLean et al., 2010) and only categories with q-values ≤ 0.05 for both the Hy-
pergeometric and the binomial test as well as a minimal region enrichment level greater
than 2 were considered. A selected subset of the resulting enriched GO categories is
shown in Fig. 6.11a and Fig. 6.12b. In addition, we utilized the MGI expression gene
set collection (Finger et al., 2011) throughout our analysis, only considering neural re-
lated gene sets that contain any of the following substrings: prosencephalon, forebrain,
diencephalon, telencephalon, midbrain, mesencephalon, hindbrain, metencephalon, mye-
lencephalon, rhombencephalon, rhombomere, spinal cord, cerebellum, cerebral cortex,
hippocampus, subventricular zone. Since the resulting gene set collection for the lat-
ter structures is available for multiple developmental time points, we uncoupled the
anatomical structure and temporal information and used the gene set with the lowest
q-value in Fig. 6.11a and Fig. 6.12b. For expression-based gene sets, we also took
advantage of the MGI database but used Fisher’s exact test to determine enriched gene
sets and uncoupled the resulting MGI gene sets in the same fashion for structures and
time points. Only gene sets significant at p-values below 0.05 and odds ratio above 1.5
were considered. Gene set enrichment levels not meeting these criteria in any condition
were set to 0 in the respective plots.
6.3.5 Footprinting detection
To determine small regions depleted of histone modifications but surrounded by regions
of much greater enrichment, termed footprints, we extended an approach used for the
analysis of DNAse I HS data (Neph et al., 2012). Our footprints identification algorithm
consisted of three main phases: In the first phase, we used MACS (Zhang et al., 2008) to
identify regions on a genome scale enriched against background for histone modification
signal (peaks). We ran MACS for each track of histone modifications separately with
the corresponding whole cell extract as control using the following parameter: ”-g 2.7e9
–tsize=36 –pvalue=1e-5 –keep-dup=1”. In the second phase, we identified footprints
located within/around peak regions in the following manner:
1. For each peak, extend by 400 bp from apex in either direction.
2. Split entire resulting region into bins of size 20 bp.
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3. Compute number of RPKM counts for a central sliding window across the entire
region (shifting by increments of one bin) for different window sizes ranging from
two bins to ten bins in increments of one.
4. For each position of the central window and for each window size, compute the
following three quantities: Cij - RPKM count for central window at current posi-
tion i and window size j, Rij - RPKM count for a 200 bp stretch directly to the
right of the central window and Lij - RPKM count for a 200 bp stretch directly
to the left of the central window.
5. For each resulting position i and window size j compute the depletion score:
eij = f
Cij + 1
2Lij
+ f
Cij + 1
2Rij
With the footprint size normalization factor f = s/b, with s the size of the central
window and b the size of the border regions.
6. Identify non-overlapping, non-adjacent footprint candidates starting from small
to larger central window sizes and recording footprint candidate iff eij > 0 AND
eij < 1 AND Lij > Cij AND Rij > Cij , followed by removing all other po-
tential footprints (central window+borders) of larger size overlapping the current
candidate.
7. Finally, all resulting candidate footprints with a footprinting score eij ≤ 0.8 were
reported.
The outlined entire procedure was carried out for H3K27ac and H3K4me3 indepen-
dently for each sample. Subsequently, we merged all footprints from individual samples
into consensus footprints set for each epigenetic mark separately, collapsing overlapping
footprints by taking the union of all regions with non-zero overlap.
6.3.6 DMR detection
DMR detection was carried out as described in Section 4.2.1. Pairwise comparisons of
consecutive samples (hESC, NE, E-RG, M-RG, L-RG, LNP) were carried out on a single
CpG level using a beta-binomial model and the beta difference distribution requiring
a maximum p-value below 0.01 and an absolute methylation difference greater than
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0.15. Subsequently, differentially methylated CpGs within 500 bp were merged into
discrete regions. Differentially CpGs without neighbors were embedded into a 100 bp
region surrounding each CpG. Next, differential methylation analysis was repeated on
the region level using a random effects model. Only regions significant at p-value below
0.01 and an absolute methylation difference above 0.3 were considered differentially
methylated and used for subsequent analysis.
6.3.7 Motif library construction and putative TF binding site identi-
fication
We combined the position weight matrices from Transfac professional database (Fogel
et al., 2005) (2009) with the PWM collection reported in Jolma et al. (Jolma et al.,
2013) only retaining motifs annotated for Homo sapiens or mouse. To eliminate re-
dundant motifs, we clustered all resulting 1,886 PWMs using MATLIGN (Kankainen
and Loytynoja, 2007) using the following parameters: ”-transv=-4 -transi=-4 -match=5
-gopen=-10 -gext=-1 -term=5 -norm=4 -spacer=1 -mode=1 -zscore=1 -random=0 -
pseudo=0 -freqat=0.5 -freqcg=0.5”. A total of 551 motifs was retained after redundancy
filtering and used for subsequent analysis. In order to determine putative binding sites
in a given genomic region, we used a biophysical model of TF affinities to DNA (Manke
et al., 2008, 2010) to determine putative binding to our footprint sets. This biophysical
model requires the training of generalized extreme value distributions of binding affini-
ties based on a PWM matrix for each TF and each set of genomic regions in order to
generate a suitable background model. In order to take the distinct properties of foot-
prints determined from different epigenetic marks as well as promoter and distal regions
into account, we determined the GEV parameters for footprints arising from H3K27ac,
H3K4me3 and DNAme as well as for promoters (±1 kbp of the TSS) and distal regions
(everything except promoter) separately using the framework outlined by Manke et al.
(Manke et al., 2008, 2010). The resulting six binding matrices were then filtered for
minimal significant binding affinity at p-values below 0.05. All other entries with higher
p-values were set to one. Next, we took the negative log10 of the entire matrix as a
quantitative measure of binding affinity in subsequent analysis.
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6.3.8 Inference of TF epigenetic remodeling activity based on epige-
netic data
In order to infer the TF epigenetic remodeling activity (TERA) from epigenetic data,
we first focused on motif activity analysis and associated each motif in a second step
with its corresponding TF. For each epigenetic mark, we used the normalized epigenetic
enrichment scores as input and only considered genomic regions that exhibited a score
change of greater than 0.3 (H3K27ac), 0.2 (H3K4me1), or 0.5 (H3K4me3) and minimal
DNAme difference of at least 0.3 to include only dynamic regions. To determine the
unobserved epigenetic remodeling activity of a TF binding motif, we took advantage
of recent developments in the microarray field (Boulesteix and Strimmer, 2005, 2007)
and adapted this approach to epigenetic data. To that end we modeled the enrichment
level yit of a particular epigenetic mark at genomic region i and time point t as a linear
function the unknown TF activities. Considering p predictor variables (TERA) and k
time points we describe the unknown TERA X as a p × k matrix. For each epigenetic
modification H3K27ac, H3K4me3 and DNAme separately, we determine the region set of
size n that fullfills the above listed criteria of minimal change and assemble the observed
epigenetic enrichment score matrix Y (n× k). We then employ the linear model:
Y = A+BX + E
With a constant offset matrix A (n× k), the connectivity matrix B (n× p), describing
the filtered binding affinities for all TF motifs to all regions and an error term matrix E.
Subsequently, we followed the approach outlined by Boulesteix and Strimmer (Boulesteix
and Strimmer, 2005) and applied partial least square (PLS) regression and specifically
the SIMPLs algorithm (Dejong, 1993) to determine the unknown TF motif activities.
The idea in PLS is to employ a linear dimensionality reduction
T = BR
where the p predictors in X are mapped onto c ≤ rank(X) ≤ min(p, n) latent compo-
nents T (n× c matrix) and to compute the weight matrix R not only based on the data
matrix B but explicitly taking into account the response matrix Y . The latter strategy
maximizes predictive power even for a small number of latent components.
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In order to determine the number of latent components for each epigenetic mark and ge-
nomic context, we follow the procedure described by Boulesteix and Strimmer (Boulesteix
and Strimmer, 2005). In this approach, the region set is randomly splitted into two
sets, one for training purposes (2/3 of the regions) and one for test purposes compris-
ing 1/3 of all regions. Next, the TERA values are determined for different numbers
p = 1, 2 . . . , pmax of hidden components based on the training dataset. Subsequently, we
use each of the resulting inferred TERA values sets to predict the epigenetic enrichment
scores on the test set. After repeating this entire process 20 times we then compute the
mean squared prediction error for each tested number of hidden components p and choose
p such that it minimizes the mean squared prediction error. The corresponding analysis
methodology was implemented in the statistical programming language R adapting the
implementation provided by Boulesteix and Strimmer (Boulesteix and Strimmer, 2005)
and can be found in the code archive accompanying this work in the TERA folder.
Raw ChIP-Seq data
Peak detection
Footprint (FP) detection
Normalized FP enrichment
TRAP parameter inference
TRAP binding scores in FP
ERA analysis
Figure 6.3: Outline of flow and key analysis steps in the computation of the TF
epigenetic remodeling activities.
Finally, we determined the TF gene that best matches a given motif by correlating all
gene expression measurements for TFs reported to be associated with a particular motif
and its inferred motif activity score for each epigenetic mark and promoter/distal class
separately across our differentiation time course. We then chose the factor with the
highest absolute Pearson correlation. The raw associations of motifs with TFs can be
found in Table 6.2 in the electronic archive accompanying this work. The TF-motif
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associations were derived based on the reported associations in either the TRANSFAC
database or the original publication of the motif sets (Jolma et al., 2013). A summary
of the entire pipeline workflow is given in Figure 6.3.
6.3.9 GRE-module detection
To identify global trends in epigenetic changes that are associated with distinct sets
of TFs, we took advantage of the decomposition in terms of latent components that
result from the PLS analysis. To that end, we first associated each motif with the latent
component for which this motif exhibited the highest loading score bi. Next, we took
advantage of our motif to TF-mapping (see previous Section) and assigned each motif to
one TF. To associate individual genomic footprint regions with one latent component,
we computed the correlation of each latent component’s activity with the H3K4me3
enrichment levels of H3K4me3 based footprints that exhibited a minimal estimated
binding strength of ≥ 1.3 for at least one of the motifs that were associated with the
latent component of interest. Finally, we assigned each footprint to the latent component
for which it exhibited the highest absolute Pearson correlation. The resulting footprint
subsets were then individually subjected to GREAT (McLean et al., 2010) analysis.
6.3.10 Co-binding analysis
Co-binding relationships were evaluated using an empirical approach with the entire set
of footprints for each epigenetic mark as background. For a given factor i, we determined
the footprint set Fi relevant for the current comparison (e.g. changing their epigenetic
state in particular cell state transition) that were predicted to harbor a TFBS based
on the binding model outlined above. Next, we computed the frequency of motif co-
occurrence Fij across Fi for all other motifs j in our database. To generate a proper
null distribution, we randomly sampled K = 100 size standardized footprint sets Gk
of cardinality |Fi| from the entire footprint collection for the epigenetic mark under
study and computed the same test statistic Gkij on these sets. Finally, we determined
an empirical p-value and odds ratio based on these quantities by counting the number
of instances for which sGki j ≥ sFij :
pij =
∑
k
sGkij ≥ sFij
K
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Only co-binding relationships significant at p-value ≤ 0.01 and odds ratio ≥ 1.5 were
retained.
6.3.11 GWAS analysis
The GWAS analysis was conducted using 11,027 GWAS SNPs from the GWAS catalog
(Hindorff et al., 2009) (August 2013). For each footprint set k, we sampled K = 100
randomly selected, size and GC-content matched control region sets of equal size and
determined the overlap with GWAS SNPs for control and footprint sets of interest.
Subsequently, we computed an empirical p-value for each trait/disease i in the catalog
by determining the number of trait-associated SNPs skij overlapping with each control
region set Ckj and the number overlapping with the original footprint set k according to
pki =
∑
j
ski ≥ sC
k
j
ki
K
6.3.12 Determination of core network
The core network was defined as those TFs that fulfilled the following criteria: Let xi be
the vector of normalized gene expression values for factor i across the entire time course
except hESCs and let x′i be the TF expression only in the NPCs (NE, E-RG, M-RG),
then a factor was considered part of the core network iff:
1. (max(x′i)−min(x′i))/(x¯′i) ≤ 0.3 and
2. (max(xi)−min(xi))/x¯i ≥ 1 and
3. xij ≥ 4 in all NPC states
4. Significantly upregulated (FDR ≤ 0.05 and log2 fold change ≥ 1.5) during neural
induction from hESC to NE.
In addition to the factors identified by these means, we added PAX6 that failed to meet
criterion 2 and was still expressed in a subset of the terminally differentiated populations.
However, image-based analysis suggests absence of this gene in the truly differentiated
populations and highly expressed in the NPCs, which is also supported by the literature.
Since PAX6 was excluded from the core network because of technical reasons, we decided
to manually add the factor to our core network.
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6.3.13 TF binding site priming analysis
To determine TFs associated with TFBS priming prior to factor activation, we deter-
mined all TFs significantly upregulated (FDR≤ 0.05 and log2 fold change ≥ 1.5) for the
following pairwise comparisons: NE vs. E-RG, E-RG vs. M-RG, M-RG vs. L-RG, NE
vs. NEdN, E-RG vs. E-RGdN, M-RG vs. L-RGdO, M-RG vs. L-RGdA. Only factors
with expression levels ≥ 1 FPKM in the first condition of each pairwise comparison was
considered. Next, we filtered all motifs associated with each candidate factor for those
motifs with an increase in motif activity score based on H3K4me1 and DNAme during
the cell state transition prior to the induction of the gene, e.g., hESC to NE for TFs
gaining expression during NE to E-RG and NE to NEdN.
Factors with motifs fulfilling the latter condition were considered candidate primed fac-
tors, some of which are depicted in black in Fig. 6.15b. Finally, we determined which of
the primed candidate factors exhibited a significantly increased predicted binding fre-
quency (p-value ≥ 0.05, for both Fisher’s exact test and permutation test) in DNAme
and/or H3K4me1 footprints associated with genes changing their expression level (log2
FPKM change ≥ 1) during the transition in which the particular TF also does become
induced. For this analysis, footprints were assigned to their closest gene.
6.4 Results
6.4.1 Validation on REMC data and ENCODE data
To validate the outlined strategy in silico we took advantage of publically available TF
ChIP-Seq data in four cell lines from the ENCODE project (Bernstein et al., 2012) as
well as H3K27ac and RNA-Seq data for 39 cell types from the REMC project. To that
end, we investigate the following steps in detail:
1. Evaluation of footprinting based inference of TF binding.
2. Evaluation of distinct normalization strategies for histone modification ChIP-Seq
data.
3. Evaluation of inferred TF epigenetic remodeling activities.
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6.4.1.1 Evaluation of footprinting based inference of TF binding
In order to evaluate the performance epigenetic footprints - essentially dips in histone-
modification peaks - we downloaded H3K27ac data as well as processed TF binding
data from the ENCODE project (Bernstein et al., 2012) for the cell line K562 since
abundant TF binding data based on ChIP-Seq was available for these lines. In addition,
this dataset has been successfully used in several studies to benchmark TF binding
predictions (Sherwood et al., 2014, Thurman et al., 2012). We then applied our TERA-
pipeline to the H3K27ac datasets and computed the TF-binding affinities for a set of
557 distinct motifs. With these datasets at hand, we computed the true positive rate
(TPR), the false positive rate (FPR) and the positive predictive values (PPV) for all TFs
that could be matched to at least one motif with available binding affinities (46/117).
In the event that one factor matched multiple motifs, we chose the motif with the
highest AUC, similar to previous reports (Sherwood et al., 2014). While the overall
performance is moderate with a median AUC of 0.73 and a PPV of 0.26 for p = 0.05
computed across all 46 TFs (Fig. 6.4), the results are within the range of current
state of the art methods based on DNAse I hypersensitive sites (Sherwood et al., 2014),
especially when considering the fact that we did not filter our TF ChIP-Seq peak sets
for the presence of a PWM match within each TF ChIP-Seq binding site. However, only
TF binding sites harboring a binding motif can be identified by motif based methods.
Binding sites without motifs frequently correspond to indirect binding events indicating
looping interactions which are frequently occurring at active enhancer. Earlier reports
indicate that on average more than 50% of binding events measured by ChIP-Seq might
be indirect as assessed by the absence of a corresponding TF motif (Thurman et al.,
2012).as been successfully used in several studies to benchmark TF binding predictions
(Sherwood et al., 2014, Thurman et al., 2012). We then applied our TERA-pipeline to
the H3K27ac datasets and computed the TF-binding affinities for a set of 557 distinct
motifs. With these datasets at hand, we computed the true positive rate (TPR), the false
positive rate (FPR) and the positive predictive values (PPV) for all TFs that could be
matched to at least one motif with available binding affinities (46/117). In the event that
one factor matched multiple motifs, we chose the motif with the highest AUC, similar
to previous reports (Sherwood et al., 2014). While the overall performance is moderate
with a median AUC of 0.73 and a PPV of 0.26 for p = 0.05 computed across all 46 TFs
(Fig. 6.4), the results are within the range of current state of the art methods based
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on DNAse I hypersensitive sites (Sherwood et al., 2014), especially when considering
the fact that we did not filter our TF ChIP-Seq peak sets for the presence of a PWM
match within each TF ChIP-Seq binding site. However, only TF binding sites harboring
a binding motif can be identified by motif based methdos. Binding sites without motifs
frequently correspond to indirect binding events indicating looping interactions which
are frequently occuring at active enhancer. Earlier reports indicate that on average more
than 50% of binding events measured by ChIP-Seq might be indirect as assessed by the
absence of a corresponding TF motif (Thurman et al., 2012).
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Figure 6.4: a. Median TPR (red), FPR (blue) and PPV (black) for n=46 TFs
with matching motif for H3K27ac footprints (n=27,292) in K562 cells as a function
of confidence in predicted binding (− log10 p-value). True positives were defined as
predicted binding events overlapping with peaks determined by ChIP-Seq and false
positives accordingly. The entire set of positives was defined as all TF ChIP-Seq peaks
for a particular factor that overlapped with any H3K27ac footprint. b. ROC curve of
the median TPR/FPR values from a.
It is very likely though, that the true PPV values at low to medium predicted binding
strength threshold are significantly better than depicted in Figure 6.4. This hypothesis
stems from the fact that TF binding is not a binary event but rather a continuum of
different binding strengths (Biggin, 2011). However, stringent peak calling as done for
example by the ENCODE project (Landt et al., 2012) not only binarizes the signal,
but also tends to focus on the high to medium-high affinity binding sites. Therefore
it is likely that this methodological problem causes a great inflation of the number
of false positives and reduction of true positives in the low to intermediate binding
strength regime, contributing to the low PPVs. However, we try to overcome this
general drawback of a binarization of TF binding signal by using a continuous measure
of predicted binding strength in our computation of the gene regulatory element to
motif connectivity matrix and the estimation of TERA scores by taking advantage of
the TRAP framework (Manke et al., 2008).
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In addition to the reasonable performance of TF-binding inference, H3K27ac footprints
are also more likely to be of functional importance: Genomic regions located under a
dip in a H3K27ac region perform much better in transgenic reporter assays compared
to the flanking regions (personal communication with T. S. Mikkelsen).
6.4.1.2 Evaluation of distinct normalization strategies for histone modifica-
tion ChIP-Seq data
To identify the most suitable normalization strategy to obtain a robust, quantitative
enrichment signal for ChIP-Seq data we evaluated 12 different approaches that test the
impact of five distinct variables. More specifically, we evaluate the benefits of using
no input control (raw), an input control specifically matching each dataset (WCE) as
well as normalization to the average across the input controls of all cell types under
investigation (meanWCE). In addition, we test whether it is advantageous to use a nor-
malization strategy that does not only account for sequencing depth and differences in
the background read distribution but also for differences in immunoprecipitation (IP)
efficency. Finally, we also evaluate whether standard quantile normalization is bene-
ficial to overcome differences in library quality. Since quantile normalization assumes
comparable total enrichment levels, it is only reasonable to use this approach for open
chromatin marks such as H3K4me3 or H3K27ac for which this is in general fullfilled.
In order to normalize for distinct IP efficiencies, we computed a sample specific normal-
ization factor based on the number of non-duplicate reads located in regions identified
as peaks compared to the number of reads present in the rest of the genome. The ratio
of these two numbers can be interpreted as the signal to noise ratio, proportional to the
IP efficiency. We then scaled the RPKM normalized values by this factor.
To evaluate the performance of each normalization approach, we use three distinct met-
rics:
1. Intra-group versus inter-group Pearson correlation: We compute the distribution
of Pearson correlation coefficients between all replicate pairs (intra-group) after
normalization as well as between all non-replicate pairs (inter-group) and deter-
mine the medians across the resulting distributions separately. The ratio of the
two can be interpreted as a measure of the within-group variation eliminated over
the between group variation preserved.
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2. Intra-group versus inter-group euclidean distance: Similar to the approach listed
above but using the Euclidean distance between samples as metric instead of the
Pearson correlation.
3. Clustering of all samples based on the absolute pairwise Pearson correlation co-
efficients. Evaluation of the clustering was performed in a less rigorous fashion
by determining whether biologically related samples would tend to cluster more
together for each normalization strategy.
We applied each normalization strategy to a set of 70 distinct cell types from the REMC
project, of which 38 had replicates. Prior to normalization, we determined the number
of non-duplicate reads in regions identified as peaks using the IDR peak calling frame-
work (Li et al., 2011) and normalized the counts in each region to reads per kilobase
per million reads sequenced (RPKM) to account for differences in sequencing depth.
Furthermore, we log2 transformed the all RPKM counts after adding a pseudocount of
one to each region.
The results for the different normalization schemes are summarized in Table 6.1, sug-
gesting that normalization to the mean across all WCEs in combination with quantile
normalization performs best. Evaluation of the clustering results confirmed this (Ap-
pendix Fig. A.1).
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normStrategy WGP BGP WGE BGE P-ratio E-ratio
log2 RPKM/mWCE quantile 0.88 0.33 183.72 424.75 2.63 2.31
soph log2 RPKM/mWCE quantile 0.84 0.32 311.22 628.26 2.57 2.02
log2 RPKM/mWCE 0.86 0.34 189.02 438.69 2.53 2.32
log2 RPKM quantile 0.88 0.35 138.63 321.25 2.52 2.32
soph log2 RPKM/mWCE 0.82 0.33 441.54 759.94 2.51 1.72
soph log2 RPKM quantile 0.85 0.34 261.05 542.96 2.48 2.08
log2 RPKM/WCE quantile 0.87 0.36 189.92 426.31 2.45 2.24
log2 RPKM 0.83 0.34 363.28 638.49 2.41 1.76
soph log2 RPKM 0.83 0.34 363.28 638.49 2.41 1.76
soph log2 RPKM/WCE quantile 0.82 0.35 334.30 626.57 2.36 1.87
log2 RPKM/WCE 0.81 0.34 465.70 761.73 2.35 1.64
soph log2 RPKM/WCE 0.81 0.34 465.70 761.73 2.35 1.64
Table 6.1: Results for various normalization methods described in the text. WGP:
average within-group Pearson correlation; BGP: average between-group Pearson cor-
relation; WGE: average within-group Euclidean distance; P-ratio: ratio of within- to
between-group Pearson correlation; P-ratio: ratio of within- to between-group Eu-
clidean distance.
Finally, we also tested the presence of batch effects since our collection of ChIP-Seq
datasets originates from two different labs. To that end we performed principal com-
ponent analysis on the entire normalized dataset and computed the correlation and
significance of association of all principal components with various surrogate variables
such as lab of origin and project (roughly corresponding to time). While this analysis
yielded significant association of several principal components with the the surrogate
variable lab of origin, removal of distinct principle components lead to the close cluster-
ing of not-related cell types (data not shown). However, the original, normalized dataset
showed excellent clustering performance, including correct clustering of biologically re-
lated cell types that were obtained from different labs. This observation in combination
with the fact that several sub cohorts of samples generated in different labs are closely
related, leads us to the conclusion that the surrogate variables are confounded to some
extend and that the high variance components are not driven by batch effects.
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6.4.1.3 Evaluation of inferred TF epigenetic remodeling activities
To test the validity of the idea to infer an epigenetic remodeling activity for each mo-
tif/TF, we inferred TERA scores for 557 distinct motifs across our 70 cell types REMC
reference set for H3K27ac using all footprints identified across that dataset as input. We
normalized the H3K27ac enrichment levels according to the optimal strategy outlined
previously and then averaged across replicates. The resulting values were then used for
PLS analysis, using our standard TERA pipeline (Fig. 6.3). If the TERA approach is
valid, we expect a reasonable correlation of the TERA scores with the expression of cor-
responding TFs. However, we do certainly not expect a perfect linear correlation since
it is unlikely that the total expression level of a TF is linearly related to its epigenetic
remodeling activity as well as its overall binding profile. It is more likely that the TF
gene expression shows a moderate correlation to TERA scores of corresponding motifs,
following the idea that epigenetic remodeling events that can most likely be explained by
the presence of a TF-motif in general requires that factor to be expressed at a minimal
level. However, since it is unclear what a cutoff for a binary classification of expressed
and not-expressed TFs in a particular cell type might be (in addition to probably being
TF-specific), we choose the standard Pearson correlation coefficient to measure the as-
sociation between TERA and TF gene expresssion.
To determine the correlation between these two measruements, we took advantage of
RNA-Seq data from the Epigenome Roadmap Project (REMC) (Bernstein et al., 2010)
for 39 distinct cell and tissue types for which also H3K27ac data was available (see Epi-
geneticDynamics folder for full RPKM normalized gene expression table in electronic
archive accompanying this work). With this data at hand, we computed the Pearson
correlation coefficient of each TF with all motifs that could be mapped to this factor
and selected the motif with the highst absolute correlation coefficient. The results show
moderate to high correlation for the vast majority of motifs (Fig. 6.5a), indicating that
the TERA approach is valid.
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Figure 6.5: a. Distribution of absolute Pearson correlation coefficients for H3K27ac
based TERAs and TF gene expression levels across 39 cell types from the REMC
project. For each motif, we chose the highest Pearson correlation coefficient across all
TFs mapping to the respective motif. b. Distribution of Pearson correlation coefficients
for H3K27ac based TERAs and TF gene expression levels across 39 cell types from the
REMC project. For each motif, we chose the highest Pearson correlation coefficient
across all TFs mapping to the respective motif.
A large set of motifs shows anti-correlation with H3K27ac based TERA scores, suggest-
ing a role in enhancer decommissioning or repression (Fig. 6.5b). Finally, several motifs
show no association with any of the their corresponding TFs. This can be explained by
multiple causes: 1. The motifs are of low quality; 2. the mapping to their corresponding
TF genes is inaccurate; 3. These motifs and the corresponding TFs have no role in
H3K27ac remodeling and therefore their inferred TERA levels are not informative. 4.
The corresponding TF genes change their expression very little 5. The corresponding
TFs’ epigenetic remodeling activities are disconnected from their expression level as long
as a minimal level of expression is maintained. Since the class of motifs to which this
applies is relatively small and indeed encompasses many constitutively expressed factors,
we leave a more detailed investigation of this point open for future studies.
In addition to the presented in silico validation, we are also carrying out a large scale
shRNA knockdown screen against 250 TFs expressed across our time course at each
stage of differentiation. The goal of this screen is to validate the ranking and identifi-
cation of key TFs based on their TERA scores and co-binding patterns. However, the
screen is still pending and will not be part of this work but is rather going to be part of
the final journal publication.
Chapter 6 Dissecting neural differentiation regulatory networks through epigenetic
footprinting 116
6.4.2 Consecutive stages of in vitro neural specification are character-
ized by distinct transcriptional states and differentiation poten-
tial
While great progress has been made in the directed differentiation of neural precursors
cells (NPCs) (Elkabetz et al., 2008) as well as regionally specified neuronal subtypes
from human ES cells (Kirkeby et al., 2012, Maroof et al., 2013) the origin and relation
of distinct NPC types is less well understood. In particular, the molecular mechanism
underlying changes in NPC differentiation potential over time and the resulting capac-
ity to differentiate into distinct neural subtypes remain elusive (Elkabetz and Studer,
2008, Temple, 2001). Using clearly defined stages along the neural lineage we created
high-quality reference epigenome maps as part of the NIH Roadmap Epigenome Project
(Bernstein et al., 2010).
The human ES cell line WA9 (or H9) was differentiated into neuroectoderm (NE), fol-
lowed by the transition to early radial glial (E-RG) cells and then further into three
additional distinct NPC populations (mid radial glial (M-RG), late radial glial (L-RG)
and long term neural progenitor (LNP); Fig. 6.6a). The first three differentiated popu-
lations (NE, E-RG and M-RG) as well as the undifferentiated hESCs were subjected to
strand-specific RNA-Seq, chromatin immunoprecipitation followed by sequencing (ChIP
Seq) for H3K4me1 and me3, H3K27ac, and H3K27me3 as well as DNAme by whole-
genome bisulfite sequencing (WGBS) while the last two stages (L-RG and LNP) were
profiled by RRBS.
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Figure 6.6: a. Schematic of our differentiation model including the times of sam-
ple collection. Human ESC were differentiated into neuroectoderm (NE) using dual
inhibition of TGFb and BMP followed by the transition to neural base media. Sub-
sequently, sonic hedgehog and FGF8, are used to transition to the early radial glial
stage (E-RG). For the rest of the differentiation experiment the cells were constantly
maintained in FGF2 and EGF2 neural base media to reach the mid radial glia (M-RG)
stage after 35 days, the late radial glia (L-RG) stage after 80 and the long term neural
progenitor (LNP) stage after 200 days of in vitro culture. Cell type names indicated
in red were profiled for gene expression, histone modifications as well as DNAme by
WGBS, while names shown in grey for gene expression only and names in black for
DNAme by RRBS only. Cell type names in orange are just indicated as intermedi-
ates and were not profiled here. b. Gene expression patterns shown as z-scores for
all differentially expressed genes (fold change ≥ 1.5) across hESCs and three neural
precursor differentiation stages. Genes were grouped into 16 clusters using k-means
clustering and Jensen-Shannon- based metric. Pie charts below indicate fraction of up
(red) and down-regulated (green) genes during each transition out of all transcripts
assayed (53,490). c. Gene set enrichment analysis for each cluster using MGI neural
expression based genes sets. Only significantly enriched results are shown (at least
p ≤ 0.05 and odds ratio ≥ 2 (fisher’s exact test)). d. Gene expression patterns shown
as z-scores for all significantly differentially expressed genes (fold change ≥ 2) across
four terminally differentiated cell types: NEdN- neurons derived from the NE stage,
E-RGdN- neurons derived from the E-RG stage, L-RGdO/dA- oligodendrocytes and
astrocytes derived from the L-RG stage. Genes were grouped into 16 clusters using
k-means clustering and Jensen-Shannon-based metric.
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We began with differential gene expression analysis to determine whether our differen-
tiation system is capable of recapitulating expression changes observed during in vivo
embryonic development and neurogenesis. To that end we investigated the dynamics of
several well known marker genes for different stages of neural development and performed
various types of gene set enrichment analysis to show activation of distinct neural expres-
sion programs during in vitro differentiation. We found 6,663 differentially expressed
genes across the entire time course that can be grouped into 16 separate clusters (Fig.
6.6b). Genes that are upregulated upon exiting the pluripotent state and remain ac-
tive in all subsequent stages include key neural TFs such as PAX6, HES5 and FOXG1
(Fig. 6.6b; cluster 1). Pluripotency associated genes such as OCT4 and NANOG are,
as expected, rapidly downregulated (cluster 16), while SOX2 progressively increases in
expression towards the M-RG stage (cluster 2). Clusters 1, 2 and 4 represent pan-neural
genes, clusters 8 and 11 represent early NE fates (SIX1, TFAP2A, NGFR), cluster 5
and 6 correspond to the E-RG stage (FGF10, DKK1, LRP2, FOSB) and clusters 9 and
10 show the gliogenic bias that is already present at the M-RG stage (S100B, OLIG1).
Gene set enrichment analysis using the MGI database (Finger et al., 2011) revealed a
progressive change of NPC identity from more anterior regions (forebrain) to posterior
(mid and hindbrain) (Fig. 1c) and a progression towards later developmental stages
(Fig. 6.7a). To expand on this analysis we also profiled terminally differentiated popu-
lations derived from three distinct stages (Fig. 6.6a,d). We find 2,653 genes differentially
expressed across the four subtypes, illustrating the distinct identity of the neuronal as
well as glial populations (Fig. 6.7b,c) arising from each stage. While neuronal and glial
cell types exhibit the most dramatic transcriptional differences including key markers
such as NEUROD1 and AQP4, neurons derived from NE (NEdN) express the serotonin
receptor HTR2C in contrast to neurons generated from E-RG (E-RGdN), which express
the neuronal TF DBX1 (Fig. 6.6d). Notably, NE and E-RG can give rise to neurons
(NEdN, E-RGdN) but are not yet capable of giving rise to glial cell types, while only
the L-RG stage (and later NPCs) demonstrate the potential to generate both neuronal
as well as glial cells (L-RGdA/dO, Fig. 6.6d). This is also compatible with the in vivo
shift from neurogenic cell fate potential in neuroepithelial cells as well as early and mid-
gestation radial glial cells during neurogenesis, towards gliogenic cell fate bias in late
gestation radial glial cells (Ramon y Cajal, 1995). Taken together, these observations
suggest a progressive change of neural precursor identity reminiscent of the sequence of
neural cell populations and processes arising during in vivo brain development.
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Figure 6.7: a. Enrichment analysis for RNA Seq based expression clusters for dif-
ferentially expressed genes across hESC, NE, E-RG and M-RG determined by k-means
clustering and Jensen-Shannon divergence based metric (Fig. 6.6b). Enrichment was
determined for genes with mouse orthologs using the MGI expression database and neu-
ral related gene categories. For each murine developmental stage, we plotted the odds
ratio of the highest significantly enriched gene set (p-value ≤ 0.01 and odds ratio ≥ 1.5
Fisher’s exact test). b. Enrichment analysis for RNA Seq based expression clusters for
differentially expressed genes across NEdN, E-RGdN, L-RGdO/dA determined by k-
means clustering and Jensen-Shannon divergence based metric (Fig. 6.6d). Enrichment
was determined for genes with mouse orthologs using the MGI expression database and
selected neural structure related gene categories. For each structure, we plotted the
odds ratio of the highest significantly enriched gene set across all developmental time
points (p-value ≤ 0.01 and odds ratio ≥ 1.5 Fisher’s exact test). c. Enrichment anal-
ysis for RNA+Seq based expression clusters for differentially expressed genes across
NEdN, E-RGdN, L-RGdO/dA determined by k-means clustering and Jensen-Shannon
divergence based metric (Fig. 1d). Enrichment was determined for genes with mouse
orthologs using the MGI expression database and selected neural structure related gene
categories. For each murine developmental stage, we plotted the odds ratio of the high-
est significantly enriched gene set (p-value ≤ 0.01 and odds ratio ≤ 1.5 fisher’s exact
test).
6.4.3 Developmental progression along the neural trajectory is accom-
panied by widespread epigenetic remodeling
In order to gain more insights into the underlying molecular mechanism we took advan-
tage of our novel computational framework to infer TF epigenetic remodeling activities
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in combination with epigenetic footprinting. To that end, we exploited the substruc-
ture of histone tracks for H3K4me3 and H3K27ac and identified chromatin-based foot-
prints, small dips between peaks demarcating a nucleosome-depleted region (NDR) more
amenable to protein binding (Fig. 6.8a, top). In addition, we also included DNAme-
based footprints that are known to frequently coincide with TF binding sites (TFBS)
(Ziller et al., 2013). Next, we combined this set of typically 80-200 bp long stretches
of the genome with a quantitative model of TF binding potential based on published
motifs (Manke et al., 2008, 2010) to infer possible condition-specific TF binding (Fig.
6.8a, bottom).
We applied this strategy to our time course data and identified 408,416 distinct footprints
(FPs).
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Figure 6.8: a. Illustration of genomic footprinting. Grey boxes highlight exam-
ple footprints (FP) determined based on H3K4me3 methylation patterns. H3K4me3
methylation patterns across the PAX6 locus (chr11:31,809 kb - 31,852 kb) for four
stages are shown on a scale from 0 to 1 and normalized to 1 million reads. Below,
methylation levels for individual CpGs are shown in blue on a scale from 0 to 100%
methylation (y-axis). The TERA labeled boxes show the inferred difference in epige-
netic remodeling activity (TERA) for each TF between the hESC and NE stage for
motifs found at this location. Below, the expression change of the corresponding TFs
is shown. The magnification on the right shows a high-resolution view of the H3K4me3
peak structure and the corresponding footprints identified as blue boxes underneath as
well as an example motif found at this location. b. Venn diagrams of the overlap of
DNAme, H3K27ac and H3K4me3 based footprints for promoters (top) and distal re-
gions (bottom). c. Barplot of the frequency and associated mark of epigenetic changes
at footprints for all cell state transitions broken up into gain and loss.
To investigate whether it might be sufficient to solely focus on one epigenetic modification
instead of three, we first computed the overlap of all identified footprints at proximal
and distal sites. H3K4me3 and H3K27ac based FPs show over 50% overlap in promoter
regions, but only about 12% for distal regions (Fig. 6.8b). Next, we sought to better
understand whether the same TFs are identified as key regulators based on distinct
epigenetic marks. To that end we investigated the fraction of the top 20 differentially
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expressed TFs between consecutive stages (n=57) that could be recovered based on the
top 20 motifs ranked by differences in their TERA scores between the corresponding
consecutive stages. This analysis revealed excellent recovery of distinct TFs (Fig. 6.9a)
and indicated that distinct epigenetic marks indeed provide complementary information
on key regulatory TFs as approximated by differential expression ranking (Fig. 6.9b).
5
4 2
3
3
0
0
1
4
1
2
10
0
1
H3K4me3
H3K27ac
H3K4me1
DNAmeTop20 covered
Top 20 not
covered
n=37
TFs with motif
TFs without motif
n=57
a b
Figure 6.9: a.Left: Fraction of top 20 differentially expressed TFs in the transition
from hESC to NE, NE to E-RG and E-RG to M-RG that have at least one reported
motif. Right: Fraction of top 20 differentially expressed TFs and a reported binding
motif that are recovered in the top 20 motifs predicted to be key regulators of the cell
state transitions hESC to NE, NE to E-RG and E-RG to M-RG based on H3K27ac,
H3K4me3, H3K4me1 and DNAme remodeling at distal footprints. b. Contribution of
each epigenetic mark to the recovery of the top 20.
Interestingly, H3K4me3 footprints are enriched for schizophrenia and bipolar disorder
related GWAS SNPs (p < 0.05, empirical test see Section 6.3.11 for details) and H3K27ac
footprints for AD, t-tau protein and glioma associated SNPs (p < 0.01 empirical test).
Among them is the prominent AD SNP rs157580 located upstream of the APOE gene
(Fig. 6.9m). Using a biophysical model of TF binding (Manke et al., 2010), we identified
putative binding sites for MEIS1 and beta-catenin as predicted to have a higher (2.2
and 1.2 fold) binding affinity for the minor allele. This observation suggests a possible
mechanism for altered APOE expression levels through altered TF binding affinity within
a putative enhancer region and demonstrates the power of high-resolution epigenomic
footprinting. In particular, our analysis highlights an approach to identify key regulators
and dissect their potential roles during cell state transitions.
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Figure 6.10: a. Epigenetic dynamics across the APOE locus (chr19:45,391 kb - 45,414
kb) for hESC and 3 stages of NSCs. H3K4me3 read counts normalized to 1 million reads
are shown on a scale of 0 to 2 (green). DNAme levels for single CpGs are indicated
as blue dots on a scale of 0 to 100% of methylation (y-axis). H3K27ac read counts
normalized to 1 million reads are shown on a scale of 0 to 1 (purple). For reference
footprints (FP) and CpG islands (CGIs) are indicated as blue boxes (bottom). Shaded
gray box indicates the position of the putative enhancer element overlapping with the
Alzheimer-related SNP rs157580.
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6.4.4 TF modules drive stage specific epigenetic transitions
In order to dissect the epigenetic dynamics in more systematic and high resolution
fashion, we identified ten distinct clusters of dynamic footprints based on H3K4me3,
each associated with a specific subset of putative regulating TFs (Fig. 6.11a). Gene
set enrichment analysis using the GREAT toolbox (McLean et al., 2010) highlighted
two key neural clusters that exhibit widespread gain of H3K4me3 at the NE stage,
are depleted of active marks in hESCs and remain partially active during the entire
differentiation process (Fig. 6.11a, top 1,2). While both clusters are highly enriched for
GREs involved in stem cell differentiation and somatic stem cell maintenance, cluster
1 is accordingly highly enriched for telencephalic fates. In contrast, cluster 2, while
also active at the NE and E-RG stages, reaches peak activity at the M-RG stage and
shows strong enrichment for telencephalon, midbrain and metencephalon related GREs.
Interestingly, the former are also enriched for NOTCH targets, compatible with early
NOTCH activation in the corresponding NE and E-RG stages in vivo. Consistent with
their presumptive role, these clusters are regulated by OTX2, POU5F2, LHX2 and
NR4A2 - key developmental genes widely expressed in telencephalic to metencephalic
germinal zones. Furthermore, downstream targets of the WNT pathway are prominent
(Fig. 6.11b), consistent with the key roles of this pathway at different stages of neural
development (Ille and Sommer, 2005).
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Figure 6.11: a. Top: Decomposition of H3K4me3 dynamics at distal footprints into
10 distinct components. Median RPKM level in each of the four cell states is shown
as a bar in grey shading for each of the 10 components. Bottom: Gene set enrichment
analysis for regions associated with each component. b. TFs associated with each
component based on TF motif presence and expression, see Section 6.3.8 for details on
motif-TF association.
In order to pinpoint upstream regulators potentially driving the differentiation related
epigenetic remodeling events, we determined the top 15 TFs associated with H3K27ac
(Fig. 6.12a), and H3K4me3 gain as well as loss of DNAme for each cell state transition
(Extended Data Fig. 6.13a,b). Among the top TFs during the transition from hESCs to
NE are various SOX motifs, e.g. SOX9/1 as well as MEIS3 known to play an important
role in the spatial specification of the early neural plate (Elkouby et al., 2010, Ng et al.,
1997, Pevny et al., 1998). In addition, we observe various proliferation related-genes
with high H3K27ac remodeling activity, including MYC and MAF, of which the latter
directly interacts with SOX9 (Huang et al., 2002). Interestingly, we also find differential
activity of distinct downstream components of signaling pathways such as LEF1, TCF3
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and betacatenin (WNT signaling) as well as ATF proteins downstream of FGF signaling
(Fig. 6.12a, Fig. 6.13c), all integral parts of neural induction and neural development.
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Figure 6.12: a. Inferred TERA changes based on distal H3K27ac footprints for three
cell state transitions. b. Top: Epigenetic dynamics at the IRX3 locus (chr16:54,300kb
- 54,340kb) during the hESC to NE transition. Chromatin enrichment levels are nor-
malized to 1 million reads and indicated on the right. Methylation levels are shown for
individual CpGs (blue dots) on a scale from 0 to 100% of methylation (y-axis). Grey
boxes highlight REST binding sites. CpG islands (CGI) are indicated in blue on the
bottom. Bottom: Selected gene set enrichment categories for REST motifs losing (up-
per part) and gaining (lower part) H3K4me3 during the transition to NE (left). REST
motif activity changes inferred based on H3K27ac, H3K4me3 and DNAme for all three
cell state transitions are shown on the right.
Furthermore, SMAD3 binding sites exhibit a decrease in H3K4m3 activity during the
transition from hESC to NE consistent with inhibition of BMP and TGFb signaling
promoting NE specification (Chambers and Tomlinson, 2009). In contrast, GLI binding
sites show an increase in H3K4me3 as well as loss of DNAme during the transition from
NE to E-RG, in line with the onset of SHH signaling (Fig. 6.12a, Fig. 6.13c). These
observations highlight the possibility to infer the stimulation of specific signaling path-
ways solely based on epigenetic data as the temporal activity pattern of these pathways
during the differentiation time course mimics our data-driven observations (Fig. 6.13c).
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Figure 6.13: a. Inferred TF activity changes based on distal H3K4me3 footprints for
three cell state transitions. b. Inferred TF activity changes based on distal DNAme
footprints for 3 cell state transitions. c. ERA dynamics for key signaling factors
across 3 cell state transitions. TERA changes based on four distinct epigenetic marks
(H3K27ac, H3K4me3, H3K4me1, DNAme) and two genomic contexts (proximal and
distal) are shown.
In addition to stage specific regulators, we also identified a core network of TFs that
is up-regulated at the onset of neural induction (hESC to NE) and remains active in
all stages of NPC progression. This network is comprised of EMX2, FOXG1, FOS,
OTX2, PAX3, SIX3, DMRT3, ARX, PAX6 and LHX2, some of which remain active
in a subset of the terminally differentiated populations (Fig. 6.14a). Interestingly,
these core factors show only moderate epigenetic dynamics individually (Fig. 6.14b,c)
but exhibit widespread, stage-specific co-binding relationships (Fig. 6.14a,b). These
observations suggest a model where NPC core factors dynamically rewire a subset of
their binding sites in cooperation with distinct stage specific TFs to facilitate specific
epigenetic changes modulating the differentiation propensity.
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Figure 6.14: a. Gene expression levels for the NPC core network of TFs induced at
the NE stage and maintaining high expression levels up to the INP stage are shown
as z-scores. In addition, expression patterns for TFs exhibiting significant motif co-
localization with the core factors at footprints gaining H3K4me3 during the transitions
to NE, E-RG and M-RG (left). Inferred TERA based on H3K4me3 patterns are shown
on the right. b. Motif co-occurrence relationships for core factors (black boxes) and TFs
with significantly co-occurring motifs at footprints gaining H3K4me3 at the NE (blue),
E-RG (red) and M-RG (grey) stage. c. TERA dynamics for all motifs associated
TFs upregulated during neural induction and maintained expression at least up to
the INP stage (core network). Name of core factor is indicated on the left while the
motif identifier is shown on the right. TERA dynamics are displayed for each cell
state transition and four distinct epigenetic marks (H3K27ac, H3K4me3, H3K4me1,
DNAme) and two genomic contexts (proximal and distal).
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6.4.5 Epigenome based inference identifies priming factors
Lastly, we repeatedly noticed an increase in inferred TERA for factors not yet expressed
at the corresponding time point. To investigate the possibility and relevance of TFBS
priming prior to factor activation, we identified TFs in each NPC population with in-
creased TERA for H3K4me1 and DNAme but with low expression levels and induced
at the next stage of differentiation (Fig. 6.15a). Surprisingly, more than half of the
corresponding TF motifs were significantly enriched (p ≤ 0.05 Fisher’s exact and per-
mutation test; Fig. 6.15b; green) in GREs associated with genes changing expression at
the next stage of differentiation, strongly supporting the notion that the epigenetic state
can predict the downstream activation of TFs. The top set of primed binding sites is
associated with the Achaete-scute homolog TF ASCL1, a key pro-neural factor that is
regulated by the NOTCH pathway (Bertrand et al., 2002, Guillemot et al., 1993) and the
core factor for successful transdifferentiation of fibroblasts to neurons (Vierbuchen et al.,
2010). Binding sites for this TF lose DNAme and gain H3K4me1 at the NE stage and
gain H3K27ac and H3K4me3 during the transition to E-RG. Moreover, these putative
GREs are significantly enriched at genes that become induced in neurons specifically
derived from the NE stage (NEdN) as well as the E-RG stage (E-RGdN), concomitant
with increased expression of ASCL1. In line with these observations, we find highly
significant overlap of primed Ascl1 motifs with Ascl1 binding site in human NHEK and
NHDF cells (Wapinski et al., 2013) (p = 3.9×10−5, odds ratio= 2.91 Fisher’s exact test,
Fig. 6.16).
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Figure 6.15: a. Characterization of TFs associated with motifs gaining TERA at
the NE stage (grey factors) based on H3K4me1 and/or DNAme, not significantly up-
regulated/expressed at the hESC or NE stage, induced at the E-RG stage and/or in
NEdN and significantly (p ≤ 0.05) enriched at gene regulatory elements associated with
genes changing expression (FC≥ 1) at the E-RG stage and/or in NEdN. The latter TFs
are defined as primed TFs. TFs shown in black exhibit significant co-occurrence of
TF associated motifs at footprints gaining H3K4me1 and/or losing DNAme at the NE
stage, are expressed (FPKM≥ 3) at the NE or hESC stage and are associated with
genes gaining expression (FC≥ 1) at the E-RG stage (blue lines) and/or in NEdNs (red
lines). Outermost heatmaps for each factor show expression as z-scores of particular
factor in hESC, NE, E-RG, M-RG, NEdN, E-RGdN, L-RGdO/dA (right half of circle)
and the other way around in the left half of the circle. Inner heatmaps show H3K4me1,
DNAme, H3K27ac and H3K4me3 based inferred TFs activity changes for the transi-
tions from hESC to NE, NE to E-RG and E-RG to M-RG (right half) and the other
way around in the left half of the circle. Magnification on the right shows ASCL1 as an
example b. Left: Absolute expression in FPKM for primed TF candidates identified
based on gene expression and motif activity patterns at the NE stage but not tested
for significant association with GREs associated with genes gaining expression at the
E-RG stage and/or in NEdN. TF names associated with significantly (p ≤ 0.05) en-
riched motifs are highlighted in green. Motif activity scores for primed candidates are
highlighted on the right for H3K4me1, DNAme, H3K27ac and H3K4me3.
However, since the TFBS priming events cannot be caused by the primed factors them-
selves, we investigated significant (p ≤ 0.01, odds ratio ≥ 1.5, permutation test) co-
binding relationships with factors already active at the NE stage. This analysis re-
vealed distinct co-binding relationships at binding sites associated with genes induced
at the NEdN and E-RGdN stage (Fig. 6.15a). While ASCL1 shows significant motif co-
localization for PAX3, MSX1 and TEF for genes gaining expression at the E-RG stage,
only the co-occurrence of with TEF and MSX1 are conserved for genes that increase
their expression in the NEdN populations (Fig. 6.15a). Likewise, we identified the
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bHLH factor BARHL2 which is involved in diencephalon development (Juraver-Geslin
et al., 2011) as a second TF associated with binding site priming specifically at genes
induced at the E-RG and M-RG stage (Fig. 6.15a). Similar to ASCL1, binding sites of
BARHL2 frequently gain H3K4me1 at the NE stage as well as H3K27ac and H3K4me3
during the transition to E-RG. Interestingly, this factor co-localizes with various com-
ponents of the previously defined NPC core network such as PAX3 and DMRT1A/3 as
well as other key neural genes induced at the NE stage including DLX5 and IRF7 (Fig.
6.15a).
hESC
NEH
3K
27
ac
Genes
FP
Ascl1
NHEK
1
1
0
0
0.5
0
0
0
0.5
100
0
100
2.5
0
H
3K
4m
e1
D
N
A
m
e
hESC
NE
hESC
NE
NR_037658ITGA7
Figure 6.16: Epigenetic dynamics at the NR 037658 locus (chr12:56,104-56,116 kb)
during the hESC to NE transition. Chromatin enrichment levels are normalized to 1
million reads and indicated on the right. Methylation levels are shown for individual
CpGs (blue dots) on a scale from 0 to 100% of methylation (y-axis). Grey boxes
highlight footprints that show evidence of priming for Ascl1 motif during hESC to NE
transition. For reference Ascl1 binding sites in NHEK cells is shown on the below.
Following the same notion, we identified priming events at the E-RG and M-RG stages,
yielding numerous prominent neural and glial factor motifs such as NEUROD4, OLIG3,
TFAP2A and EOMES. These observations suggest, that the TERA framework can not
only by utilized to identify active key regulators for each differentiation stage, but also
provide insights into the priming or preperation of the epigenetic landscape for factors to
be expressed at later stages of differentiation, potentially providing important guidelines
for differentiation and transdifferentiation protocol optimization.
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6.5 Discussion
We have generated extensive reference epigenome maps for several human hESC-derived
neural stages and demonstrated the power of these data for dissecting the regulatory
relationships that dictate and influence key cell fate decisions. The in depth molecular
characterization also provides valuable insights about the identity of the hESC-derived
cell types and will help improve the use of these as in vitro models. Furthermore, we have
outlined a novel, universally applicable strategy to use epigenetic information to obtain
insights into the regulatory logic governing distinct cellular state transitions and infer
key drivers of the associated epigenetic dynamics. Our analysis revealed that different
epigenetic marks carry complementary information with respect to identification of TFs
relevant for the entire cell state transition. Furthermore, we show that H3K4me1 and
DNAme changes frequently demarcate gene regulatory elements and TFs that become
relevant at a later stage in the differentiation process. These insights and our novel
computational framework can be directly extended to other differentiation systems as
well as the study of disease-related cellular states such as the comparison of cancerous
vs. normal cell types. In addition, the computational framework holds great promise
to guide the interpretation of genetic variation in form of SNPs and form the basis of a
more comprehensive network modeling approach to predict gene expression.
Chapter 7
Discussion and Conclusion
7.1 Discussion
The goal of this work was two-fold. First, we wanted to establish that the integration of
epigenetic and transcriptional data on specific cellular states can be used to gain insights
into the underlying regulatory logic maintaining and establishing these states. Second,
we wanted to prove the utility of this approach and obtain a mechanistic understanding
of specific cell state transitions.
To move closer to this goal, we first had to identify suitable epigenetic signatures that
could be used for these purposes. While a lot of previous work examined the utility of
various histone modifications (Ernst and Kellis, 2010, Heintzman et al., 2009, Mikkelsen
et al., 2007) and demonstrated their power in annotating different classes of gene regu-
latory elements (GREs), the descriptive power of DNAme in this context was less clear.
While earlier work focused on a role for DNAme predominantly in the context of pro-
moter and repetitive element silencing (Bird, 2002), more recent evidence has suggested
its involvement in distal regulatory elements such as enhancers as well (Stadler et al.,
2011). Combining these observation with the fact that in somatic cell types most of the
genome is highly methylated raised the questions of the extent to which DNAme partici-
pates in genome regulation and what the targets of this regulation are. Furthermore, we
were interested whether it is possible to obtain insights into the regulatory logic of indi-
vidual cell types. To address these questions, we employed the hypothesis that changes
in DNAme between distinct cellular states suggest its participation in some regulatory
process related to the differences between the compared cell states. In order to ask these
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questions on a global level, we set out to chart the dynamic DNAme landscape of the
human genome, cataloging all regions that change their DNA methylaion state across a
large cohort of normal human cell types.
We identified ≈ 20% of all genomic CpGs that change their methylation status across
this cohort in a highly coordinated and non-random fashion. In particular, we found that
regions differentially methylated across our normal developmental cohort are highly en-
riched for gene regulatory elements such as putative enhancers, TF binding sites (TFBS),
and DNAse I hypersensitive sites. Furthermore, regions hypo-methylated in a cell type-
specific manner are highly enriched for TFBS associated with key TFs relevant to the
biology of the particular cell state. In addition, these regions showed highly significant
enrichment for GWAS SNPs associated with diseases relevant to the specific cell type.
While these findings cannot determine the exact regulatory role of DNAme across these
DMRs, they establish DNAme changes as a great marker for cell state-specific regula-
tory processes. In particular, these observations further establish DNAme as a universal
epigenetic signature to obtain insights into cell state-specific TF and associated networks
of gene regulatory elements.
Our findings also hold great promise to improve current profiling approaches for DNAme
by focusing only on genomic regions that change their DNAme state instead of sequenc-
ing the entire genome using WGBS. While this method captures all DMRs, it is highly
inefficient wasting at least 70% of all sequencing power to non-informative genomic re-
gions. However, our presented analysis of the dynamic methylation landscape is only an
initial draft. In order to complete the map of this landscape, we need to expand the num-
ber of distinct cell and tissue types beyond the 30 types covered in this study to identify
more subtle dynamics between more closely related cell types. With the availability of
close to 100 distinct cell types profiled by WGBS towards the end of this year (2014), it
will be possible to greatly diversify the dataset and provide a more complete picture of
the dynamic methylation landscape of the human genome. However, our inital analysis
of the rate of de novo DMR discovery indicates that we already entered the saturation
phase with our inital sample set, presumably due to its great diversity of sampled cell
and tissue types. The second key question that still requires further investigation is the
definition of the minimal methylation difference at a specific genomic locus that ren-
ders it dynamic. At his point, it is still unclear what range of DNAme changes can be
considered functional. We chose a minimal, significant difference ≥ 30%, however it is
likely that this threshold will not apply to all scenarios. Instead, the proper threshold is
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more likely to depend on the genomic context. In order to derive a context-dependent
methylation variability level threshold, a new statistical model for each CpG or CpG
class will be required. This model should take the sequence composition, repeat content,
mappability, shearing bias as well as general variability of the CpG/CpG class into con-
sideration. Furthermore, it will be necessary to test the functional impact of different
levels of methylation at different classes of gene regulatory elements such as enhancers,
promoters, and TF binding sites using reporter assays.
These questions directly connect to even broader questions on DNAme. Much work still
needs to be done in order to dissect the specific function exerted by DNAme in distinct
genomic contexts such as TF binding sites, promoters and enhancers. Under what cir-
cumstances does DNAme block gene reactivation or TF binding? In which contexts is
it just a gap filler that is easily displaced without any particular function? Dissecting
these and related questions promise an exciting future for DNAme research and will
greatly benefit from the recent emergence of genome and epigenome editing technology.
Furthermore, using these insights in combination with our profiling-based findings and
extended profiling of larger tissue and individual cohorts harbors the potential to yield
novel biomarkers and novel insights into disease biology through a network-centric anal-
ysis of the resulting data sets.
After we established the utility of DNAme to identify gene regulatory elements and asso-
ciated TF networks, we next wanted to combine this power with chromatin modification
and transcriptional information in an integrative analysis to dissect the cell state transi-
tions that occur during the specification of hESCs (hESCs) into three distinct progenitor
populations representing each embryonic germ layer. To that end, we established an in
vitro model system that permits the generation of ectodermal, mesodermal, and endo-
dermal progenitor populations from hESCs. While earlier work focused on distantly
related, mostly somatic cell types, we were specifically interested in understanding the
epigenetic changes that occur during differentiation, potentially capturing also transient
dynamics, which are not detectable when only studying the far endpoints of differen-
tiation trajectories. Our horizontal comparison of three hESC-derived cell populations
revealed complementary pathways and gene regulatory elements that become silenced or
activated across the three germ layers, while pluripotency-associated genes and gene reg-
ulatory elements frequently become silenced. Using our epigenetic signature approach,
we identified a gene regulatory module set shared between early ectoderm and late en-
doderm/pancreas development. Furthermore, we uncovered two unexpected epigenetic
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changes, presumably only detectable in transient cell populations. First, the gain of
H3K4me1 was found to be frequently associated with epigenetic priming and occurring
in the vicinity of genes expressed at later stages of development. Second, the gain of
the repressive mark H3K27me3 at regions of high methylation in the vicinity of genes
also expressed at later stages of development. Detailed motif analysis and subsequent
ChIP-Seq analysis revealed strong association with the binding of the pioneering factor
FOXA2 that was also associated with the loss of DNAme. However, the exact molecular
mechanisms of the pioneering factor action remains to be determined. In addition, it
is unclear whether FOXA2 is indeed required and sufficient to mediate the observed
dynamic and whether or not this remodeling event is required for further differentiation.
While these findings highlight the power of an integrative transcriptional and epigenetic
analysis of closely related cell types, this study lacked the ability to track individual ge-
nomic regions over more than one time point and define their trajectories. In addition,
no coherent framework for a TF centric analysis of the dataset was available. Uncov-
ering the details of the TF networks driving these transitions remains a key challenge.
Currently two basic complementary approaches are available: While the straightforward
strategy would be to identify all TFs exhibiting differential expression in this context
and subsequently perform ChIP-Seq experiments for the selected factors, a less resource-
intensive approach would be to try to utilize the epigenetic patterns in combination with
motif analysis to obtain these insights.
Earlier studies, including the ones discussed here, have yielded already very promising
results and a detailed motif based analysis of mammalian TF networks have been car-
ried out using DNAse I footprinting (Neph et al., 2012, Thurman et al., 2012). However,
using chromatin and DNAme information for this purpose has several advantages over
the use of DNAse I. From a semantic perspective a lot is known about the functional
context in which certain histone modifications occur. Therefore, occurrence of TF bind-
ing in the context of a specific histone modification already suggests a possible function
for this binding. From a practical perspective, ChIP-Seq and WGBS experiments are
by far easier to conduct and require much less input material (as low as 100,000 cells
in contrast to 100,000,000 cells for DNAse footprinting assays). Finally, more than one
laboratory is capable of conducting WGBS and ChIP-Seq as opposed to DNAse I assays.
Furthermore, our studies and that of others (Ernst and Kellis, 2010, Ernst et al., 2011,
Stadler et al., 2011) suggest that a large fraction of the information contained in DNAse
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I HS sites is also captured by histone and DNAme information, although at lower reso-
lution.
To overcome the discussed drawbacks, we developed a novel computational strategy to
perform a TF centric analysis using motif detection to identify potentially driving factors
of specific epigenetic state transitions. Using this method, we evaluated the information
content and overlap of different epigenetic signatures during a 200-day differentiation
time course of hESCs toward the neural lineage.
By combining the epigenetically driven key TF inference with transcriptional informa-
tion on each of the differentiation stages, we identified a core TF network of PAX6
and OTX2 at its center which is active through the entire differentiation process. The
members of this core network dynamically rewire a subset of their binding sites in a
stage-specific fashion by associating with distinct co-binding partners that are expressed
in a stage-specific fashion. In this way, the core factors are likely to orchestrate and es-
tablish distinct differentiation propensities while maintaining proliferative potential over
the course of in vitro neural differentiation. Interestingly, many downstream effectors
of key signaling pathways are among the stage-specific co-binding partners, frequently
coinciding with the stimulation of the corresponding signaling pathway at the respective
stage. This suggests that the activation of distinct signaling pathways can be directly
inferred from its resulting footprint on the stage-specific epigenome.
Our analysis also revealed complementary changes in H3K27ac and H3K4me3 are much
more associated with immediate changes in TFs activity at each particular stage. In con-
trast, regions changing their DNAme or H3K4me1 state frequently contain information
not only on TF-activated at the stage of change but also at later stages of differentia-
tion. These changes can be interpreted as priming events of neuronal TFBS reflecting
the differentiation potential of each stage. In addition to the developmental analysis,
we also utilize this framework to interpret non-coding variants associated with disease
phenotypes related to the specific cell types under study. Specifically, we discuss the
integration of an Alzheimer’s disease-related SNP upstream of the APOE gene in the
stage-specific TF network.
In summary, we have developed a novel computational strategy to identify key factors
and networks of TFs, GREs and genes likely to be driving epigenetic remodeling during
cell state transition and utilized this framework to dissect in vitro neural differentiation
of hESCs. However, the presented work is only a first step to decipher the complex
wiring logic and control structures of the regulatory networks governing these cell state
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transitions. From the computational perspective, it will be important to incorporate as
many distinct cell and tissue types as possible to also understand which gene regula-
tory elements are being controlled by which factor combinations. An increase in sample
number will also greatly increase the predictive power of this model. Furthermore, new
statistical approaches are required to assess the likelihood of regulation and remodeling
of a particular GRE by a specific TF or combination of TFs in a probabilistic fashion.
Moreover, much work needs to be done to interpret the genomic regions controlled by
a specific TF in terms of their biological processes and functions along the lines of a
gene set enrichment analysis. These efforts would then ultimately lead to a probabilis-
tic model, allowing for the prediction of gene expression based on inferred TF binding
at gene associated gene regulatory elements. This would provide a significant concep-
tual and methodological advance in the field, since current approaches either rely on
ChIP-Seq data for TF binding (Wilczynski et al., 2012) or on chromatin state data
(Natarajan et al., 2012). Finally, the approach presented here does only consider TF
binding as key driving events, ignoring all other layers of genomic and transcriptional
regulation. Extending the current model to incorporate protein phosphorylation status
as well as microRNA levels and the cells’ external signaling environment will greatly
improve the power of computational approaches to predict and explain cellular pheno-
types.
Besides improvements on the computational end, we have only laid the groundwork for
understanding the basis of in vitro neural differentiation. Our observations are so far
mainly based on correlation analysis and motif occurrences and therefore indirect. It
will be essential to functionally validate the key TFs predicted to orchestrate each cell
state transition by RNAi-mediated knockdown. In addition, it will be crucial to con-
firm the predicted TF binding and rewiring events by ChIP-Seq for a selected subset of
factors at each stage of the differentiation process. Furthermore, it will be very informa-
tive to assess the role and importance of individual gene regulatory elements and their
associated TF binding by specifically deleting these elements from the genome in the
relevant cell types. Besides these functional validations, it will be key to demonstrate
more conclusively the relation of the dynamics observed in our in vitro system to dy-
namics occurring in vivo. To that end, a collection of micro-dissected brain regions from
developing human fetuses would be required. Since the latter are not easy to obtain,
the collection of a high-resolution time series in mouse and primates poses a reasonable
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alternative. Another dimension so far not touched on is the profund heterogeneity oc-
curring during in vitro differentiation. Even though we use a HES5 reporter to isolate
the neural stem cells, it is unclear what the heterogeneity at each time point within this
population does look like. Within the mature neuronal populations the heterogeneity
is likely to be substantially higher. However, so far we only investigated population
averages with the assays at our disposal. To overcome this drawback and dissect the
occurring cell state dynamcis at higher resolution, high-throughput single-cell assays
such as single-cell RNA-Seq will be required.
Lastly, it will be of great clinical relevance to optimize the numbers, homogeneity, and
maturation level of specific neuronal subtypes that can be obtained from the distinct
stem cell populations. To that end, it will be required to systematically test distinct
growth factor concentrations and differentiation protocols and evaluate their impact on
the differentiation trajectory toward the desired mature neuronal cell types.
7.2 Outlook
The research presented in this work represents a step forward on the route to a predictive
model of cell state maintenance and cell state transitions. However, many improvements
are still necessary that can now be made on the foundation prepared by us and others.
First, a more powerful mathematical framework integrating genetic, epigenetic, and
transcriptional information needs to be developed. In order to incorporate changes in
the environmental conditions, an input-driven model would be ideal. In this context,
dynamic Bayesian networks seem very promising.
This framework can then be applied to a large collection of epigenetic datasets for
more than 100 cell types, generated by the ENCODE and REMC consortia, providing
sufficient power to infer cell type specific gene regulatory networks.
The resulting flexible cell state models can then be used as a general tool to interpret
molecular profiles of other cell states of interest, integrating novel cell state information
as needed. Several interesting applications come to mind:
1. The interpretation of non-coding variants and the inference of their possible mech-
anisms of actions.
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2. Re-interpretation of GWAS studies with improved power, focusing on SNPs lo-
cated in gene regulatory elements, reducing the genome-wide significance level to
a regulatory element significance level.
3. Dissecting complex traits by integrating non-coding variants with small effects on
a network level.
4. Identifying pathways of action of disease-associated rare variants with large pheno-
typic effect in order to uncover potential druggable pathways and infer genetically
and epigenetically informed drug dose-response curves.
5. Interpretation of electronic health record-based pheWAS studies.
All these suggestions arise from the fundamental opportunity that the integration of
genetic, epigenetic, and transcriptional data provides: It structures the high-dimensional
space of possible cellular states by providing constraints on the accessible phase space.
However, in order to overcome several drawback associated with the population-induced
heterogeneity and correlation-based nature of these measurements, the analysis should
be complemented with single-cell measurements as well as focused functional validation
using high-throughput genome and epigenome editing in the cell system under study.
The approach outlined above presents a unique resource allowing for a mechanistic,
causal interpretation of normal cellular trajectories and the deviation from those in
disease phenotypes.
Appendix A
Appendix
A.1 Methods related to chapter 4 and 5
A.1.1 WGBS
To that end Genomic DNA (1-5 µg) was fragmented to 100-500 bp using a Covaris S2
sonicator 9 times for 60 s at duty cycle 20%, intensity 5 and 200 cycles per burst. DNA
fragments were cleaned up using a QIAGEN PCR purification kit. End-repair reactions
(100 µl) contained 1x T4 DNA ligase buffer (NEB), ATP, 0.4 mM dNTPs, 15 units T4
DNA polymerase, 5 unites Klenow DNA polymerase, 50 units T4 polynucleotide kinase
(all NEB) and were incubated for 30 min. at 19 ◦C and 15 min. For some libraries
we used a dCTP-free dNTP mix instead of all four dNTPs during for the end-repair to
avoid artificially unmethylated sites. Adenylation was performed for 30 min. at 37 ◦C
in 50 µl 1x Klenow buffer containing 0.2 mM dATP and 15 units Klenow exo- (NEB).
Adenylated DNA fragments and methylated paired-end adapters (purchased from AT-
DBio) were incubated overnight at 16 ◦C in a 50 µl reaction containing 5,000 units
concentrated T4 DNA ligase (NEB) and 3 µM of adapters. Each enzymatic reaction
was terminated and cleaned-up by phenol/chloroform extraction and ethanol precip-
itation as described above. To determine unmethylated cytosine conversion rates and
methylated cytosine over-conversion rates by sodium bisulfite treatment, adapter-ligated
fully methylated and fully unmethylated internal control DNA fragments, were spiked
into WGBS library preparation at a molar ratio (spike-in to WGBS library) of 1:16,000
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each. Adapter-ligated DNA of 270-370 bp, corresponding to DNA insert sizes of 150-
250 bp, was size-selected on a 2.5% Nusieve (3:1) agarose gel (Lonza). Two consecutive
bisulfite conversions were performed with an EpiTect Bisulfite Kit (QIAGEN) follow-
ing the protocol specified for DNA isolated from FFPE tissue samples. One of 40 µl
bisulfite-converted DNA was used in each of four 10-µl reactions to determine the min-
imal PCR cycle number for library amplification. PCR reactions contained 0.5 U of
PfuTurboCx Hotstart DNA polymerase (Agilent technologies), 1 µl of 10x PCR buffer,
250 µM dNTPs, 1.5 µM of Primer 1.0 and 2.0 (Illumina). The thermocycling profile
was 2 min. at 95 ◦C followed by 5-15 cycles of 30 s at 95 ◦C, 30 s at 65 ◦C, 1 min. at
72 ◦C, and a final 7-min. extension at 72 ◦C. Preparative library amplification using the
empirically determined number of PCR cycles was performed in eight 25-µl aliquots,
each containing 3 µl of bisulfite-converted DNA, 1.25 U of PfuTurboCx Hotstart DNA
polymerase, 2.5 µl of 10x PCR buffer, 250 µM of dNTP, 1.5 µM of Primer 1.0 and
2.0. PCR products were pooled and purified twice using Agencourt AMPure XP SPRI
Beads (Beckman Coulter) as per the manufacturer’s instructions. The final library DNA
was quantified using a Qubit fluorometer and a Quant-iT dsDNA HS Kit (Invitrogen).
The insert size was checked on a 4-20% non-denaturing polyacrylamide gel (Bio-Rad).
Paired-end sequencing with 100 base reads was performed on an Illumina Hiseq 2000
followed the manufacturer’s guidelines.
A.1.2 Bisulfite-ChIP
DNA was first subjected to end-repair in a 30-µl reaction containing 6 units T4 DNA
polymerase, 2.5 units DNA Polymerase I (Large Klenow Fragment), 20 units T4 Polynu-
cleotide Kinase (all New England Biolabs), dATP, dCTP, dGTP, and dTTP (0.125 mM
each), and 1x T4 Ligase buffer with ATP for 30 min at 20 ◦C. DNA was then adenylated
in a 20-µl reaction containing 10 units Klenow Fragment (3’ to 5’ exo-) (New England
Biolabs), 0.5 mM dATP and 1x NEB buffer 2 for 30 min at 37 ◦C. DNA was then ligated
to preannealed Illumina genomic DNA adapters containing 5-methylcytosine instead of
cytosine (ATDBio) using T4 DNA ligase (New England Biolabs). Adapter-ligated DNA
fragments were subsequently purified by phenol extraction and ethanol precipitation and
size-selected on gel. 50 ng sheared and dephosphorylated Escherichia coli K12 genomic
DNA was added to adapter-ligated DNA as carrier during size-selection and bisulfite
conversion. DNA was run on 2.5% Nusieve 3:1 Agarose (Lonza) gels. Lanes containing
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marker (50 bp ladder; New England Biolabs) were stained with SYBR Green (Invitro-
gen), and size regions to be excised were marked with toothpicks and adapter-ligated
DNA fragments from 200-400 and 400-550 bp were excised. DNA was isolated from gel
using the MinElute Gel Extraction kit (QIAGEN). The low and high libraries were kept
separate in subsequent steps.
Adapter-ligated and size-selected DNA was subjected to two subsequent 5-h bisulfite
treatments using the EpiTect Bisulfite kit (QIAGEN) following the manufacturer’s pro-
tocol for DNA isolated from FFPE tissue samples. PCR amplification was done with
1.25 units Pfu Turbo Cx Hotstart DNA Polymerase (Stratagene), primer LPX 1.1 and
2.1 (0.3 µM each), dNTPs (0.25 mM each), 1x Turbo Cx buffer. Amplified libraries were
purified with the MinElute PCR Purification kit (QIAGEN) and subsequently purified
from gel essentially as described above; whole gels were stained with SYBR Green, and
no carrier DNA was added. Final libraries were analyzed on analytical 4%-20% TBE
Criterion precast gels (BioRad), and measured by Quant-iT dsDNA HS Assays (Invit-
rogen).
A.1.3 Cell Culture
All in vitro derived cell types were derived from HUES64 (Chen et al., 2009). Human
embryonic stem cells were expanded on murine embryonic fibroblasts (Global Stem) in
KO-DMEM (Life Technologies) containing 20% Knockout serum replace (Life Technolo-
gies) and FGF2 (10 ng/mL) (Millipore). Cultures were passaged by enzymatic dissoci-
ation using Collagenase IV (1mg/mL) (Life Technologies). Prior to differentiation, cells
were plated on matrigel-coated plates (BD Biosciences) and cultured in mTeSR1 (Stem
Cell Technologies) for 3 to 4 days. Endoderm differentiation was induced in Advanced
RPMI (Invitrogen), 0.5% FBS (Hyclone), Activin A (100ng/mL) (R&D) and WNT3A
(50 ng/mL) (R&D). HUES64- derived hepatoblasts (dHep) were induced by culturing
day 5 endoderm in RPMI media containing B27(1X), FGF2 (10ng/mL)(Millipore) and
BMP4(20ng/mL)(R&D) for five days, and collected after 10 days total of differentia-
tion. Hepatocyte-like cells were derived by culturing the HUES64-derived hepatoblasts
in Lonza hepatocyte culture media containing 10ng/mL of HGF (R&D) for 5 additional
days, or 15 days total. Mesoderm differentiation was induced by the addition of me-
dia consisting of in DMEM/F12 (Life Technologies), 0.5% FBS (Hyclone), Activin A
(100ng/mL) (R&D) (for the first 24 hours only), BMP4 (100ng/mL) (R&D), VEGF
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(100ng/mL) (R&D) and FGF2 (20ng/mL) (Millipore). To induce osteoblast differen-
tiation, the day 5 mesoderm population was dissociated with accutase and replacted
on matrigel coated plates (BD) in EGM-2 media (Lonza) for 7 days, or 12 days total.
Ectoderm differentiation was induced using A83-01 (2um) (Tocris), PNU 74654 (2um)
(Tocris) and Dorsomorphin (2um) (Tocris), DMEM/F12 (Life Technologies) containing
1% Knock serum replacer (Life Technologies). Neurectoderm differentiation was induced
by switching the day 5 ectoderm population to media containing 3 µM CHIR99021
(TOCRIS), 10 µM SU5402 (TOCRIS), and 10 µM DAPT (TOCRIS), and collected af-
ter 6 more days, or 11 days total. N2-supplement (Life Technologies) was added to cells
in 25% increments every other day beginning four days after the initiation of ectoderm
differentiation. For all cell types, media was changed daily.
A.1.4 Antibodies
ChIP was performed using the following antibodies: H3K4me3 (Millipore, 07-473, Lot
DAM1623866), H3K27ac (Abcam, ab4729, Lot 509313), H3K27me3 (Millipore, 07-
449, Lot DAM1514011), H3K36me3 (Abcam, ab9050, Lot 499302), H3K4me1 (Ab-
cam, ab8895, Lot 659352), H3K9me3 (Abcam, ab8898, Lot 484088), POU5F1 (Abcam,
ab19857), SOX2 (Santa Cruz, sc-17320X), NANOG (R&D, AF1997) and FOXA2 (R&D,
AF2400).
For live cell FACS isolation, cells were stained for 30 minutes on ice with the follow-
ing antibodies directed towards extracellular surface proteins: CD326-PerCP-Cy5 (clone
EBA1) (BD Biosciences), CD56-PE (clone NCAM16.2) (BD Biosciences), and CD184-
PE-Cy5 (clone 12G5) (BD Biosciences).
Immunostaining was done with the following primary antibodies: FOXA2 (R&D, AF2400),
GATA2 (Santa Cruz, sc-16044) SOX17 (R&D, AF1924), PAX6 (Covance, PRB-278P)
and HNF4a (abcam, ab41989). Cells were fixed in 4% Formaldehyde, incubated in pri-
mary antibody overnight at 4 ◦C, and then incubated in secondary antibody for 1 hr at
room temperature. DNA was detected using Hoechst 33342 trihydrochloride trihydrate
(Invitrogen).
A.1.5 FACS Analysis
FACS was done on a BD FACSAria II using linear FSC and SSC scaling, followed by
height and width-based doublet discrimination. The viability of the populations was
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assessed by Propidium Iodide staining, with the positively stained populations being
excluded from the sorting gates. Compensation was calculated using FACS Diva au-
tocompensation algorithms, and supplemented by manual compensation to correct for
autofluorescence. Antibodies were used as described in the text.
A.1.6 Genomic DNA isolation
Flash-frozen human tissues or cell pellets were lysed at 55 ◦C overnight in 300-600 µl
lysis buffer (10 mM Tris-HCl pH 8.0, 10 mM EDTA, 10 mM NaCl and 0.5% wt/vol
SDS) supplemented with 50 ng/µl DNase-free RNase (Roche) and 1 µg/µl proteinase K
(NEB). After extraction with an equal volume of phenol:chlorofom:isopropanol alcohol
(25:24:1; Invitrogen) and addition of 0.5 µl (20 µg/µl) glycogen (Roche) and 1/20 vol
5 M NaCl, DNA was precipitated with 2.5 vol ethanol, spun down (30 min/16,000 g)
at ◦C and washed with 70% ethanol. DNA was re-suspended in 30-100 µl of TE buffer
(10 mM Tris-HCl pH 8.0, 1 mM EDTA) and quantified using a Qubit fluorometer and
a dsDNA BR Assay Kit (Life Technologies).
A.1.7 Chromatin immunoprecipitation (ChIP) and ChIP-sequencing
library production
Cells collected by FACS were crosslinked in 1% formaldehyde for 15 minutes at room
temperature, with constant agitation, followed by quenching with 125mM Glycine for 5
minutes at room temperature with constant agitation. Nuclei were isolated and chro-
matin was sheared using Branson sonifier until the majority of DNA was in the range
of 200-700 base pairs. Chromatin was incubated with antibody overnight at 4 ◦C, with
constant agitation.
Co-immunoprecipitation of antibody-protein complexes was completed using Protein A
or Protein G Dynabeads for 1 hour 4 ◦C, with constant agitation. ChIPs were completed
using previously reported methods Mikkelsen et al. (2010). Sequencing libraries were
submitted for sequencing on the Illumina Hiseq 2000. Immunoprecipitated DNA was end
repaired using the End-It DNA End-Repair Kit (Epicentre), extended using a Klenow
fragment (3’ to 5’ exo)(NEB), and ligated to sequencing adapter oligos (Illumina). Each
library was then PCR-amplified using PFU Ultra II Hotstart Master Mix (Agilent), and
a size range of 300-600 was selected for sequencing. We confirmed binding of OCT4,
NANOG and SOX2 at the NANOG promoter using qPCR.
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A.2 Methods related to chapter 6
A.2.1 Culturing undifferentiated hESCs
HES5::eGFP BAC transgenic human ES cells (H9; WA-09; Wicell) expressing GFP un-
der the HES5 promoter were cultured on mitotically inactivated mouse embryonic fibrob-
lasts (MEFs) (Globalstem). Undifferentiated hES cells were maintained as described pre-
viously Elkabetz et al. (2008) in medium containing DMEM/F12, 20% KSR, 1mM Glu-
tamine, 1% Penicillin/Streptomycin, non essential amino acids and beta-mercaptoethanol.
Undifferentiated hES cells were purified with pluripotency markers Tra-1-60 and PE-
conjugated SSEA-3(BD Pharmingen).
A.2.2 Neural induction and long-term propagation of NPCs
Neural differentiation of hES cells was performed as described previously Chambers and
Tomlinson (2009), Elkabetz et al. (2008). Briefly, neuroectodermal cells were generated
either by monolayer induction - with dissociated hES cells plated on Matrigel (BD
biosciences), or by co-culture on MS5 stromal cells. In both cases neural fate was directed
by dual SMAD inhibition protocol Chambers and Tomlinson (2009). Neural rosettes
were harvested mechanically beginning on day 8-10 of differentiation. Rosettes were
replated on culture dishes pre-coated with 15 µg/mL polyornithine (Sigma), 1 µg/mL
Laminin (BD Biosciences) and 1ug/ml Fibronectin (BD Biosciences) (Po/Lam/FN) in
N2 medium composed of DMEM/F12 and N2 supplement (Invitrogen). N2 supplement
contained Insulin, Apo-transferin, Sodium Selenite, Putrecine and Progesterone. This
medium was supplemented with SHH (200 ng/mL), FGF8 (100 ng/mL) and BDNF
(20 ng/mL) (all from R&D Systems) to maintain early anterior regionalization of the
neural plate. These factors were gradually replaced by FGF2 (20 ng/mL) and EGF (20
ng/mL) in the following two weeks of differentiation in order to maintain a proliferative
(FGF and EGF responsive) NPC state. NPCs from all stages were collected at indicated
days and FACS purified for HES5::GFP (NE to L-RG) or EGFR for LNPs to purify for
the highest NPC state for each stage. Neuroectodermal cells were collected at day 12
of differentiation, Neuroepithelial/early radial glial cells were collected at day 14, mid
neurogenesis radial glial cells were collected at day 35, late gliogenic radial glial cells were
collected at day 80, and long term NPCs were collected at day 220. At each stage cells
were either split for next passage or subjected to FACS purification for HES5::GFP as
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described. Cells were replated onto Po/Lam/FN culture dishes. For neuronal, astroglial
or oligodendroglial differentiation, NPCs were seeded at high density and subjected to
differentiated for 17 days in the presence of AA/BDNF, 5% Fetal Bovine Serum (FBS)
(Invitrogen), or AA/BDNF/SHH/FGF8, respectively.
A.2.3 Chromatin Immunoprecipitation followed by sequencing (ChIP
Seq)
We used similar approaches to Garber-Yosef et al. Garber et al. (2012). Particularly,
160.000 thousand Cells were crosslinked in formaldehyde (1%, 37 ◦C for 10 min), fol-
lowed by quenching with glycine (5 min at 37 ◦C), washed with PBS containing protease
inhibitor (Roche, 04693159001) and flash frozen in liquid nitrogen. To lyse the cells, we
used 1% SDS, 10mM EDTA and 50mM Tris-HCl pH 8.1 complemented with protease
inhibitor. The chromatin was then fragmented with a Branson Sonifier (model S-450D)
at 4 ◦C, calibrated to a size range of 200 and 800 bp. For each antibody, 1 to 5 ug was
conjugated to Protein-A and Protein-G Dynabeads mix (Invitrogen, 100-02D and100-
07D, respectively) for 2 hours in blocking buffer (PBS containing 0.5% BSA and 0.5%
TWEEN). Next, the conjugated antibody-beads were added to the sheared chromatin,
and incubated overnight. Samples were washed 6 times with RIPA buffer (10mM Tris-
HCl pH 8.0, 1mM EDTA pH 8.0, 14mM NaCl, 1% TritonX-100, 0.1% SDS, 0.1% DOC),
twice with RIPA buffer containing 500mM NaCl, twice with LiCl buffer (10 mM TE,
250mM LiCl , 0.5% NP-40, 0.5% DOC), twice with TE (10Mm Tris-HCl pH 8.0, 1mM
EDTA), and then eluted in elution buffer (10mM Tris-Cl pH 8.0, 5mM EDTA, 300mM
NaCl, 0.1% SDS; pH 8.0) at 65 ◦C. Eluate was incubated in 65 ◦C over-night, and then
treated sequentially with RNaseA (Roche, 11119915001) for 30 min and Proteinase K
(NEB, P8102S) for two hours, and where then followed by library construction.
A.2.4 ChIP Seq library preparation and sequencing
To extract DNA and create the Illumina library we used AMPure XP beads (Agencourt)
Solid-phase reversible immobilization (SPRI). SPRI beads were added to the samples,
mixed 15 times, incubated at room temperature for 2 minutes. Supernatant was ex-
tracted from the beads from the beads 4 minutes on a magnet. We used 70% ethanol to
wash the beads and then dried for 4 minutes. 40 ul EB buffer (10 mM Tris-HCl pH 8.0)
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was used to elute the DNA. The following steps of Illumina library construction (end-
repair, addition of A-base, ligation of barcoded adaptors and PCR enrichment) we used
a general SPRI cleanup procedure: addition of PEG buffer (20% PEG and 2.5 M NaCl),
and extracted and washed as above. The enzymatic reactions were carried as follows:
1. DNA end-repair: T4 PNK and T4 polymerase (New England Biolabs) incubated at
12 ◦C for 15 min, 25 ◦C for 15 min; 2. A-base addition: Klenow (3’-¿5’ exonuclease;
New England Biolabs) incubated at 37 ◦C for 30 min. 3. Adaptor ligation: DNA ligase
(New England Biolabs) and indexed oligo adaptors and incubated at 25 ◦C for 15 min,
followed by 0.7X SPRI/reaction to remove non-ligated adaptors. 4. PCR enrichment:
PCR mastermix (primer set, dNTP mix, Pfu Ultra Buffer (Agilent), Pfu Ultra-II Fusion
(Agilent), water), for 20 cycles. The PCR amplified libraries we cleaned up using 0.7X
SPRI/reaction (size selection mode) to remove excessive primers. Roughly 5 picomoles
of DNA library was then applied to each lane of the flow cell and sequenced on Illumina
HiSeq 2000 sequencers according to standard Illumina protocols.
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A.2.5 Normalization evaluation
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Figure A.1: Hierarchical clustering of H3K27ac enriched IDR called peaks across 106
distinct REMC samples after normalization using the optimal strategy described in the
main text. Hierarchical clustering was performed using one minus the absolute Pearson
correlation coefficient (PCC) as distance metric and Ward’s method
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